Avon Products (AVP) 10-K 14 Mar 23 2022 FY Annual report Financial data

Cover

Cover - USD ($)	12 Months Ended
	Dec. 31, 2022	Jan. 30, 2023	Jun. 30, 2022
Cover [Abstract]
Document Type	10-K
Document Annual Report	true
Document Period End Date	Dec. 31, 2022
Current Fiscal Year End Date	--12-31
Document Transition Report	false
Entity File Number	1-4881
Entity Registrant Name	AVON PRODUCTS, INC.
Entity Incorporation, State or Country Code	NY
Entity Tax Identification Number	13-0544597
Entity Address, Address Line One	Lancaster House
Entity Address, Address Line Two	Nunn Mills Road,
Entity Address, City or Town	Northampton
Entity Address, Postal Zip Code	NN1 5PA
Entity Address, Country	GB
Country Region	44
City Area Code	1904
Local Phone Number	232425
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	Yes
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
ICFR Auditor Attestation Flag	false
Entity Shell Company	false
Entity Public Float			$ 0
Entity Common Stock, Shares Outstanding		101.34
Entity Central Index Key	0000008868
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	FY
Amendment Flag	false

Audit Information

Audit Information	12 Months Ended
	Dec. 31, 2022
Audit Information [Abstract]
Auditor Name	PricewaterhouseCoopers LLP
Auditor Location	London, United Kingdom
Auditor Firm ID	876

CONSOLIDATED STATEMENTS OF OPER

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Income Statement [Abstract]
Net sales	$ 2,600.5	$ 3,202.9	$ 3,431.2
Other revenue	147	176.4	187.3
Revenue from affiliates of Natura &Co	21.7	25.2	6.7
Total revenue	2,769.2	3,404.5	3,625.2
Costs, expenses and other:
Cost of sales	(1,186.2)	(1,439.1)	(1,588.6)
Cost of sales from affiliates of Natura &Co	(20.4)	(22.4)	(5.9)
Selling, general and administrative expenses (inclusive of provision for doubtful accounts of 2022: $51.7, 2021: $62.4 ,2020: $78.3)	(1,705.4)	(2,001.4)	(2,152.9)
Impairment of goodwill	(35.8)	0	0
Operating loss	(178.6)	(58.4)	(122.2)
Interest expense	(40.3)	(63.5)	(119.6)
Interest expense on Loan from affiliates of Natura &Co	(93.8)	(50.6)	(7.5)
Loss on extinguishment of debt and credit facilities	(15.7)	0	(37.7)
Interest income	13	0.6	2.1
Interest income from affiliates of Natura &Co	3.9	1.6	0
Other income (expense), net	(5.8)	1.6	(20.2)
Gain on sale of business	0	9.9	1.5
Total other (expenses) income	(138.7)	(100.4)	(181.4)
Loss from continuing operations, before taxes	(317.3)	(158.8)	(303.6)
Income taxes	(37.4)	(16.2)	(34)
Loss from continuing operations, net of tax	(354.7)	(175)	(337.6)
Loss from discontinued operations, net of tax	(73.2)	(18.5)	(27.9)
Net loss	(427.9)	(193.5)	(365.5)
Net loss attributable to noncontrolling interests	(0.2)	1.4	2.7
Net loss attributable to Avon	$ (428.1)	$ (192.1)	$ (362.8)

CONSOLIDATED STATEMENTS OF OP_2

CONSOLIDATED STATEMENTS OF OPERATIONS (Parenthetical) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Income Statement [Abstract]
Provision for doubtful accounts	$ 51.7	$ 62.4	$ 78.3

CONSOLIDATED STATEMENTS OF COMP

CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS) INCOME - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Statement of Comprehensive Income [Abstract]
Net loss	$ (427.9)	$ (193.5)	$ (365.5)
Other comprehensive income (loss):
Foreign currency translation adjustments	60.4	(0.9)	(162.9)
Unrealized gains (losses) on revaluation of long-term intercompany balances	(16.8)	(21.3)	67.6
Change in derivative gains (losses) on cash flow hedges	0.3	0	0.6
Amortization of net actuarial loss and prior service cost, net of taxes of 2022: $0.8, 2021: $0.8 and 2020: $0.8	4.9	5.1	8.2
Adjustments of net actuarial loss and prior service cost, net of taxes of 2022: $7.9, 2021: $3.2 and 2020: $3.8	(16)	67.3	(7.1)
Total other comprehensive income (loss), net of taxes	32.8	50.2	(93.6)
Comprehensive loss	(395.1)	(143.3)	(459.1)
Less: comprehensive loss attributable to noncontrolling interests	0.3	0.5	2.5
Comprehensive loss attributable to Avon	$ (394.8)	$ (142.8)	$ (456.6)

CONSOLIDATED STATEMENTS OF CO_2

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (PARENTHETICAL) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Statement of Comprehensive Income [Abstract]
Amortization of net actuarial loss and prior service cost, taxes	$ 0.8	$ 0.8	$ 0.8
Adjustments of net actuarial losses and prior service cost, taxes	$ 7.9	$ 3.2	$ 3.8

CONSOLIDATED BALANCE SHEETS

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Current Assets
Cash, including cash equivalents of 2022: $63.0 and 2021: $15.5	$ 367.6	$ 251.5
Restricted cash	0.3	0
Accounts receivable (less allowances of 2022: $35.4 and 2021: $37.1)	183.4	198.7
Receivables from affiliates of Natura &Co	72.9	34.1
Loans to affiliates of Natura &Co	72.2	46.6
Inventories	332.2	384.1
Prepaid expenses and other	127.9	165.6
Held for sale assets	0	2.8
Current assets of discontinued operations	1.8	0
Total current assets	1,158.3	1,083.4
Property, plant and equipment, at cost
Land	15.4	18.5
Buildings and improvements	356	374.5
Equipment	509.7	549.5
Property, plant and equipment, at cost	881.1	942.5
Less accumulated depreciation	(548.1)	(578.8)
Property, plant and equipment, net	333	363.7
Right-of-use assets	92.1	111.1
Goodwill	25.9	72.1
Deferred tax asset	52.1	121.4
Loans to affiliates of Natura &Co	54.8	46.7
Other assets	445.5	509.4
Total assets	2,161.7	2,307.8
Current Liabilities
Debt maturing within one year	5.7	32.6
Loans from affiliates of Natura &Co	537.2	371.7
Accounts payable	461.5	522.8
Payables to affiliates of Natura &Co	58.1	29.4
Accrued compensation	77.2	81.5
Other accrued liabilities	247.4	273.4
Sales and taxes other than income	67.9	66.8
Income taxes	5.2	11.6
Current liabilities of discontinued operations	79.9	31.7
Total current liabilities	1,540.1	1,421.5
Long-term debt	214.8	676
Loans from affiliates of Natura &Co	1,427.2	736.3
Long-term operating lease liability	71.5	87.5
Employee benefit plans	58.1	84.6
Long-term income taxes	33	81.5
Other liabilities	58.2	75.1
Total liabilities	3,402.9	3,162.5
Shareholders’ Deficit
Common stock, par value $0.01 - authorized 1,000 shares; issued 101.34 shares (2021: par value $0.01 - authorized 1,000 shares; issued 101.34 shares)	0	0
Additional paid-in capital	639.8	631.2
Retained earnings	(832.3)	(404.2)
Accumulated other comprehensive loss	(1,052.2)	(1,085.5)
Total Avon shareholders’ deficit	(1,244.7)	(858.5)
Noncontrolling interests	3.5	3.8
Total shareholders’ deficit	(1,241.2)	(854.7)	[1]
Total liabilities and shareholders’ deficit	$ 2,161.7	$ 2,307.8
[1]The number of shares of Common Stock (par value $0.01 per share) outstanding at December 31, 2022, 2021 and 2020 was 101.34.

CONSOLIDATED BALANCE SHEETS (Pa

CONSOLIDATED BALANCE SHEETS (Parentheticals) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Statement of Financial Position [Abstract]
Cash equivalents	$ 63	$ 15.5
Allowances	$ 35.4	$ 37.1
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, shares authorized (in shares)	1,000	1,000
Common stock, shares issued (in shares)	101.34	101.34

CONSOLIDATED STATEMENTS OF CASH

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions		12 Months Ended
		Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Cash Flows from Operating Activities
Net loss		$ (427.9)	$ (193.5)	$ (365.5)
Loss from discontinued operations, net of tax		(73.2)	(18.5)	(27.9)
Loss from continuing operations		(354.7)	(175)	(337.6)
Adjustments to reconcile net loss from continuing operations to net cash used by operating activities:
Depreciation		44.7	50.4	57.3
Amortization		19.8	22.4	24.5
Provision for doubtful accounts		51.7	62.4	78.3
Provision for inventory obsolescence		22.6	26.8	37.9
Share-based compensation		8.5	6.9	26.4
Foreign exchange (gains) losses		(10.7)	(5.2)	(5.1)
Deferred income taxes		8.9	(20.2)	(0.4)
Impairment loss on assets		35.8	1	3.1
Gain on sale of business / assets		0	(9.9)	(1.5)
Costs associated with debt issue / repayment		15	0	0
Other		4	5.9	54.2
Changes in assets and liabilities:
Accounts receivable		(56.9)	(60.1)	(81.5)
Inventories		15.6	(53)	(65.9)
Prepaid expenses and other		(7.7)	(14.9)	1.2
Accounts payable and accrued liabilities		30.8	(35.1)	(61.7)
Income and other taxes		1.2	(13.1)	2.5
Noncurrent assets and liabilities		8.3	(49.7)	(1.8)
Net cash used by operating activities of continuing operations		(163.1)	(260.4)	(270.1)
Cash Flows from Investing Activities
Capital expenditures		(53.5)	(68.3)	(44.6)
Proceeds from disposal of assets		14.7	3.3	2.6
Net proceeds from sale of business / assets		0	16.9	11.3
Cash receipts from the settlement of corporate-owned life insurance policies		0	0	9.9
Other investing activities		0	0	0.3
Net cash used by investing activities of continuing operations		(38.8)	(48.1)	(20.5)
Cash Flows from Financing Activities
Cash dividend		0	0	(8.6)
Debt, net (maturities of three months or less)		16	(11.1)	13.6
Proceeds from debt		1,102.5	297	1,039.7
Repayment of debt		(739.2)	(68.5)	(956.9)
Repayment of debt to affiliates of Natura &Co	[1]	(83.4)	(38)	0
Repayment of debt from affiliates of Natura &Co		49.7	58.7	0
Repurchase of common stock		0	0	(0.4)
Settlement of stock options		0	0	(25.8)
Settlement of derivative operations		12	0	(0.8)
Costs associated with debt issue / repayment		(15)	0	(21.7)
Proceeds from monetization of COFINS tax credits		0	(15.5)	0
Net cash provided by financing activities of continuing operations	[1]	342.6	222.6	39.1
Cash Flows from Discontinued Operations
Net cash used by operating activities of discontinued operations		(26.7)	(14)	(16.7)
Net cash used by discontinued operations		(26.7)	(14)	(16.7)
Effect of exchange rate changes on cash and cash equivalents		2.4	(22)	(19.5)
Net (decrease) increase in cash and cash equivalents and restricted cash		116.4	(121.9)	(287.7)
Cash and cash equivalents and restricted cash at beginning of year	[2]	251.5	373.4	661.1
Cash and cash equivalents and restricted cash at end of year	[2]	367.9	251.5	373.4
Cash paid for:
Interest		39.1	50.1	133.5
Income taxes, net of refunds received		$ 36.3	$ 37	$ 21.3
[1]On July 1, 2021, the Company sold Avon Luxembourg, including our Mexican business, to a subsidiary of Natura &Co Holding for $150, with the proceeds used to repay maturing loans of $150 borrowed under the $250 Revolving Credit Facility with a subsidiary of Natura &Co Holding. Under the terms of the transaction and the associated Direction and Settlement Agreement, no cash flows in either investing or financing activities arose as a result of the transaction.[2]The following table provides a reconciliation of cash, cash equivalents, restricted cash, and cash held for sale reported within the Consolidated Balance Sheet that sum to the total of the same such amounts shown in the Consolidated Statement of Cash Flows for the years ended December 31, 2022, 2021 and 2020. December 31, 2022 December 31, 2021 December 31, 2020 Cash and cash equivalents $ 367.6 $ 251.5 $ 364.9 Restricted cash 0.3 — 7.8 Held for sale cash and cash equivalents — — .7 Cash and cash equivalents, and restricted cash at end of period per the statement of cash flows $ 367.9 $ 251.5 $ 373.4

CONSOLIDATED STATEMENTS OF CA_2

CONSOLIDATED STATEMENTS OF CASH FLOWS (Parentheticals) - USD ($) $ in Millions		12 Months Ended
		Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Cash and cash equivalents		$ 367.6	$ 251.5	$ 364.9
Restricted cash		0.3	0	7.8
Held for sale cash and cash equivalents		0	0	0.7
Cash and cash equivalents, and restricted cash at end of period per the statement of cash flows	[1]	367.9	251.5	373.4
Net proceeds from sale of business / assets		$ 0	$ 16.9	$ 11.3
[1]The following table provides a reconciliation of cash, cash equivalents, restricted cash, and cash held for sale reported within the Consolidated Balance Sheet that sum to the total of the same such amounts shown in the Consolidated Statement of Cash Flows for the years ended December 31, 2022, 2021 and 2020. December 31, 2022 December 31, 2021 December 31, 2020 Cash and cash equivalents $ 367.6 $ 251.5 $ 364.9 Restricted cash 0.3 — 7.8 Held for sale cash and cash equivalents — — .7 Cash and cash equivalents, and restricted cash at end of period per the statement of cash flows $ 367.9 $ 251.5 $ 373.4

CONSOLIDATED STATEMENTS OF CHAN

CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' DEFICIT - USD ($) shares in Millions, $ in Millions		Total	Cumulative Effect, Period of Adoption, Adjustment	Common Stock	Additional Paid-In Capital	Retained Earnings	Retained Earnings Cumulative Effect, Period of Adoption, Adjustment	Accumulated Other Comprehensive Loss	Treasury Stock	Noncontrolling Interests
Beginning balance (in shares) at Dec. 31, 2019				770
Beginning balance at Dec. 31, 2019		$ (983.8)	$ (2)	$ 192.6	$ 2,321.2	$ 2,138.9	$ (2)	$ (1,040)	$ 4,603.3	$ 6.8
Beginning balance , treasury stock (in shares) at Dec. 31, 2019									319.9
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Gain on common control transaction		1.4				1.4
Capitalization of payable	[1]	91.5			91.5
Net loss		(365.5)				(362.8)				(2.7)
Other comprehensive income		(93.6)						(93.8)		0.2
Conversion of Series C convertible preferred stock (in shares)	[2]								(87)
Conversion of Series C convertible preferred stock	[2]	486.8				(710.8)			$ 1,197.6
Exercise/ vesting/ expense of share-based compensation		(2)		$ (0.2)	(1.8)
Repurchase of common stock (in shares)	[3]			(770)					(232.9)
Exchange of common stock	[3]	0		$ (192.4)	(1,788.1)	(1,425.2)			$ 3,405.7
Ending balance (in shares) at Dec. 31, 2020	[4]			0
Ending balance at Dec. 31, 2020	[4]	(867.2)		$ 0	622.8	(360.5)		(1,133.8)	$ 0	4.3
Ending balance , treasury stock (in shares) at Dec. 31, 2020	[4]								0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Sale on Avon Luxembourg	[5]	148.4				148.4
Net loss		(193.5)				(192.1)				(1.4)
Other comprehensive income		50.2						48.3		1.9
Exercise/ vesting/ expense of share-based compensation		8.4			8.4
Purchases and sales of noncontrolling interests		(1)								(1)
Ending balance (in shares) at Dec. 31, 2021	[4]			0
Ending balance at Dec. 31, 2021	[4]	(854.7)		$ 0	631.2	(404.2)		(1,085.5)	$ 0	3.8
Ending balance , treasury stock (in shares) at Dec. 31, 2021	[4]								0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss		(427.9)				(428.1)				0.2
Other comprehensive income		32.8						33.3		(0.5)
Exercise/ vesting/ expense of share-based compensation		8.6			8.6
Ending balance (in shares) at Dec. 31, 2022				0
Ending balance at Dec. 31, 2022		$ (1,241.2)		$ 0	$ 639.8	$ (832.3)		$ (1,052.2)	$ 0	$ 3.5
Ending balance , treasury stock (in shares) at Dec. 31, 2022									0
[1]On March 1, 2016, the Company issued and sold to Cerberus Investor 435,000 shares of newly issued series C preferred stock for an aggregate purchase price of $435 pursuant to an Investment Agreement, dated as of December 17, 2015, between the Company and Cerberus Investor. The series C preferred stock had accrued unpaid dividends of $91.3 at December 31, 2019. In January 2020 Natura &Co Holding paid the accrued dividends on the shares of series C preferred stock in an amount equal to U.S. $91.5 to Cerberus, resulting in a payable due to an affiliate of Natura &Co Holding for the same amount. During 2020, the payable due to Natura &Co was capitalized and recorded as a capital contribution through Additional Paid in Capital.[2]On December 30, 2019, an affiliate of Cerberus Capital Management, L.P. ("Cerberus") elected to convert 435,000 shares of Series C Preferred Stock into 87,000,000 shares of the Company’s common stock, par value U.S.$0.25 per share, pursuant to the holder of the Company’s Series C Preferred Stock’s rights under the Company’s certificate of incorporation. The foregoing election is conditioned upon the filing of the certificates of merger with respect to the First Merger.[3]In January 2020, subsequent to the Transaction, the Company restated its certificate of incorporation to effect a change in capitalization of the Company by changing the number of authorized shares of stock from 1,525,000,000 shares (of which (i) 1,500,000,000 shares, par value $0.25 per share, were common stock and (ii) 25,000,000 shares, par value $1.00 per share, were preferred stock) to 1,000 shares of common stock, par value $0.01 per share. As a result of the Merger, all of the issued and outstanding common stock of the Company, being 550,890,788, were canceled and converted. See Note 20, Merger with Natura Cosméticos S.A.,.[4]The number of shares of Common Stock (par value $0.01 per share) outstanding at December 31, 2022, 2021 and 2020 was 101.34.[5]On July 1, 2021, the Company sold Avon Luxembourg Holdings S.à r.l. and its subsidiaries ("Avon Luxembourg"), including our Mexican business, to a subsidiary of Natura &Co Holding S.A. for $150. The sale was accounted for as a transaction under common control in accordance with ASC805 - Business Combinations, with the resulting gain of $148, representing the difference between the proceeds, the net assets of Avon Luxembourg on the date of sale, and the cumulative foreign currency translation adjustment, taken directly to Retained Earnings

CONSOLIDATED STATEMENTS OF CH_2

CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS’ DEFICIT (Parenthetical) - USD ($) $ in Millions			1 Months Ended
	Dec. 30, 2019	Mar. 01, 2016	Jan. 31, 2020	Dec. 31, 2019
Payment of accrued preferred stock dividends			$ 91.5
Temporary equity, conversion, common stock equivalent (in shares)	87,000,000
Common stock, par value (in dollars per share)	$ 0.25		$ 0.01	$ 0.25
Shares authorized (in shares)				1,525,000,000
Common stock, shares authorized (in shares)			1,000	1,500,000,000
Preferred stock, shares authorized (in shares)				25,000,000
Preferred stock, par value (in USD per share)			$ 0.01	$ 1
Shares canceled (in shares)			550,890,788
Common stock shares outstanding (in shares)			101.34
Series C Preferred Stock
Shares issued (in shares)		435,000
Stock issued during period		$ 435
Payables to affiliates of Natura &Co				$ 91.3
Conversion of stock (in shares)	435,000

Description of the Business and

Description of the Business and Summary of Significant Accounting Policies	12 Months Ended
	Dec. 31, 2022
Description Of The Business And Summary Of Significant Accounting Policies
Description of the Business and Summary of Significant Accounting Policies	Description of the Business and Summary of Significant Accounting Policies Business When used in these notes, the terms "Avon," "Company," "we," "our" or "us" mean Avon Products, Inc. We are a global manufacturer and marketer of beauty and related products. Our business is conducted primarily in one channel, direct selling. Our reportable segments are based on geographic operations in two regions: Avon International and Avon Latin America. Our product categories are Beauty and Fashion & Home. Beauty consists of skincare, fragrance and color (cosmetics). Fashion & Home consists of fashion jewelry, watches, apparel, footwear, accessories, gift and decorative products, housewares, entertainment and leisure products, children’s products and nutritional products. Sales are made to the ultimate consumer principally by independent Representatives. On May 22, 2019, we entered into an Agreement and Plan of Mergers with Natura Cosméticos S.A., a Brazilian corporation (sociedade anônima) ("Natura Cosméticos"), Natura &Co Holding S.A., a Brazilian corporation (sociedade anônima) ("Natura &Co Holding"), and two subsidiaries of Natura &Co Holding ("Natura &Co") pursuant to which, in a series of transactions, Avon and Natura Cosméticos became direct wholly owned subsidiaries of Natura &Co (the "Transaction"). On January 3, 2020, the Company consummated the Transaction and became a fully owned subsidiary of Natura &Co Holding. In connection with the consummation of the Transaction, the Company notified the NYSE that trading of their stock should be suspended, the Company's common stock was subsequently delisted and deregistered. The Company files these financial statements with the SEC, as a voluntary filer, to comply with the terms of certain debt instruments. For additional information, see Note 20, Merger with Natura Cosméticos S.A.,. In December 2019, the Company declared a dividend of $0.016 per share equating to $9, this dividend was subsequently paid in January 2020 by the Company. Principles of Consolidation The consolidated financial statements include the accounts of Avon and our majority and wholly-owned subsidiaries. Intercompany balances and transactions are eliminated. Basis of Presentation and Use of Estimates We prepare our consolidated financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America, or GAAP. In preparing these statements, we are required to use estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ materially from those estimates and assumptions. On an ongoing basis, we review our estimates, including those related to stand-alone selling prices ("SSP") of promised goods or services delivered under sales incentives, allowances for sales returns, allowances for doubtful accounts receivable, provisions for inventory obsolescence, the determination of discount rates and other actuarial assumptions for pension and postretirement benefit expenses, restructuring expense, income taxes and deferred income tax valuation allowances, share-based compensation, loss contingencies and the evaluation of goodwill, property, plant and equipment and capitalized software for potential impairment. Sale of Avon Luxembourg Holdings S.à r.l On July 1, 2021, the Company sold Avon Luxembourg, including our Mexican business, to a subsidiary of Natura &Co Holding for $150, with the proceeds used to repay maturing loans of $150 borrowed under the $250 Revolving Credit Facility with a subsidiary of Natura &Co Holding. The sale was accounted for as a transaction under common control in accordance with ASC805 - Business Combinations, with the resulting gain of $148, representing the difference between the proceeds, the net assets of Avon Luxembourg on the date of sale, and the cumulative foreign currency translation adjustment, taken directly to Retained Earnings. Under the terms of the transaction and the associated Direction and Settlement Agreement, no cash flows in either investing or financing activities arose as a result of the transaction and it has been treated as a non cash flow item in the Consolidated Statements of Cash Flows. For additional information, see the Consolidated Statements of Changes in Shareholders' Deficit and the Consolidated Statements of Cash Flows. COVID-19 pandemic and Russia-Ukraine war Beginning with the first quarter of 2020, there has been a worldwide impact from the COVID-19 pandemic as during 2020, many markets were subject to lockdown restrictions to varying degrees, which limited our ability to recruit and enroll Representatives, operate manufacturing facilities and distribution centers and to process and deliver orders. In 2021 and 2022, the continuing economic disruption caused by the COVID-19 pandemic also resulted in inflationary pressures on the cost of certain raw materials used in the production of essential items due to the increased demand for these inputs worldwide. These inflationary pressures were compounded in 2022 by the ongoing war between Ukraine and Russia which adversely impacted energy prices around the globe and further increased inflationary pressures. As of the date of this report, we are unable to estimate the longer-term economic impact of the ongoing Russia-Ukraine war and of any further impacts of the COVID-19 pandemic on our business. We will continue to review our revenue, investments, expenses and cash outflows, as well as adjusting our relationships with suppliers. Going concern Considering the uncertain nature of any possible future COVID-19 impacts which are beyond the Company’s control and the ongoing war between Ukraine and Russia, we expect these factors to continue to adversely affect our operations, which could in turn result in lower revenues and lower cash generation from activities. If these impacts are deeper or for longer than we anticipate, the Company could take certain further actions to ease the pressure of certain cash outflows, such as reducing discretionary expenditure, selling non-core assets, accessing government pandemic initiatives or arranging borrowing facilities with third-party banks and affiliate companies. The Company has received an irrevocable commitment from Natura &Co Holding that it will provide sufficient financial support if and when needed to enable the Company to meet its obligations as they come due in the normal course of business. This commitment is effective through to March 31, 2024, a period of more than 12 months from the date of issuance of the Consolidated Financial Statements. See Note 7, Debt and Other Financing, and Note 15, Leases and Commitments, respectively, for information on our debt and contractual financial obligations and commitments, including the loans from Natura &Co and its affiliates maturing within one year. Foreign Currency Financial statements of foreign subsidiaries operating in other than highly inflationary economies are translated at year-end exchange rates for assets and liabilities and average exchange rates during the year for income and expense accounts. The resulting translation adjustments are recorded within accumulated other comprehensive income (loss) ("AOCI"). Gains or losses resulting from the impact of changes in foreign currency rates on assets and liabilities denominated in a currency other than the functional currency are recorded in other expense, net. For financial statements of Avon subsidiaries operating in highly inflationary economies, the U.S. dollar is required to be used as the functional currency. Highly inflationary accounting requires monetary assets and liabilities, such as cash, receivables and payables, to be remeasured into U.S. dollars at the current exchange rate at the end of each period with the impact of any changes in exchange rates being recorded in income. We record the impact of changes in exchange rates on monetary assets and liabilities in other expense, net. Similarly, deferred income tax assets and liabilities are remeasured into U.S. dollars at the current exchange rates; however, the impact of changes in exchange rates is recorded in income taxes in our Consolidated Statements of Operations. Non-monetary assets and liabilities, such as inventory, property, plant and equipment and prepaid expenses are carried forward at their historical dollar cost, which was calculated using the exchange rate at the date which hyperinflationary accounting is implemented. Argentina Currency During the quarter ended June 30, 2018, based on published official exchange rates which indicate that Argentina's three-year cumulative inflation rate has exceeded 100%, we concluded that Argentina had become a highly inflationary economy. From July 1, 2018, we have applied highly inflationary accounting for our Argentinian subsidiary. As such, the functional currency for Argentina has changed to the U.S. dollar, which is the consolidated group's reporting currency. As a result of highly inflationary accounting for our Argentinian subsidiary, the most significant impacts in our Consolidated Income Statements are in cost of sales, primarily due to inventory being accounted for at its historical dollar cost, and in other (expense) income, net, primarily associated with the net monetary position of Argentina. However, these impacts are not considered material to our Consolidated Income Statements. Turkish Currency During the quarter ended March 31, 2022, published official exchange rates for Turkey indicated that the three-year cumulative inflation rate has exceeded 100%. As a result, we concluded that Turkey has become a highly inflationary economy. From April 1, 2022, we have applied inflationary accounting for our Turkish subsidiary. As such, the functional currency for Turkey has changed to the U.S. dollar, which is the consolidated group's reporting currency. As a result of highly inflationary accounting for our Turkish subsidiary, the most significant impacts in our Consolidated Statement of Operations, are in cost of sales, primarily due to inventory being accounted for at its historical dollar cost, and in other (expense) income, net, primarily associated with the net monetary position of Turkey. However, these impacts are not considered material to our Consolidated Income Statements. Revenue Recognition Nature of goods and services We are a global manufacturer and marketer of beauty and related products. Our product categories are Beauty and Fashion & Home. Beauty consists of skincare, fragrance and color (cosmetics). Fashion & Home consists of fashion jewelry, watches, apparel, footwear, accessories, gift and decorative products, housewares, entertainment and leisure products, children’s products and nutritional products. Our business is conducted primarily in one channel, direct selling. Our reportable segments are based on geographic operations in two regions: Avon International and Avon Latin America. We primarily sell our products to the ultimate consumer through the direct selling channel principally through Representatives, who are independent contractors and not our employees. Revenue recognition Revenue is recognized when control of a product or service is transferred to a customer, which is generally the Representative. Revenue is measured based on the consideration specified in a contract with a customer and excludes amounts collected on behalf of third parties, such as Value Added Taxes ("VAT") collected for taxing authorities. Principal revenue streams and significant judgments Our principal revenue streams can be distinguished into: i) the sale of Beauty and Fashion & Home products to Representatives (recorded in net sales); ii) Representative fees, primarily for the sale of brochures to Representatives and fulfillment activities related to the contract, which include fees for shipping and handling (recorded in other revenue); and iii) other, which includes the sale of products to New Avon LLC ("New Avon"), which has ceased since the sale of Avon Luxembourg Holdings S.à r.l on July 1, 2021, and royalties from the licensing of our name and products (recorded in other revenue). i) Sale of Beauty and Fashion & Home products to Representatives We generate the majority of our revenue through the sale of Beauty and Fashion & Home products. A Representative contacts her customers directly, selling primarily through our brochure (whether paper or online), which highlights new products and special promotions (or incentives) for each sales campaign. In this sense, the Representative, together with the brochure, are the "store" through which our products are sold. A brochure introducing a new sales campaign is typically generated every three to four weeks. A purchase order is processed, and the products are picked at a distribution center and delivered to the Representative usually through a combination of local and national delivery companies. Generally, the Representative then delivers the merchandise and collects payment from the customer for her or his own account. A Representative generally receives a refund of the price the Representative paid for a product if the Representative chooses to return it. A Representative Agreement, which outlines the basic terms of the agreement between Avon and the Representative, combined with a purchase order, constitutes a contract for the purposes of Accounting Standards Codification Topic ("ASC"), Revenue from Contracts with Customers ("ASC 606"). Revenue from Contracts with Customers We account for individual products and services separately in the contract if they are distinct (i.e., if a product or service is separately identifiable from the other items in the contract and if a Representative can benefit from the product or service on its own or with other resources that are readily available), which is recognized at a point in time, when control of a product is transferred to a Representative. In addition, we offer incentives to Representatives to support sales growth. Certain of these sales incentives are distinct promises to a Representative, and therefore are a separate performance obligation. As a result, revenue is allocated to the performance obligation for sales incentives and is deferred on the balance sheet until the associated performance obligations are satisfied. Typically included within a contract is variable consideration, such as sales returns and late payment fees. Revenue is only recorded to the extent it is probable that it will not be reversed, and therefore revenue is adjusted for variable consideration. Variable consideration is generally estimated using the expected value method, which considers possible outcomes weighted by their probability. Specifically for sales returns, a refund liability will be recorded for the estimated cash to be refunded for the products expected to be returned, and a returns asset will be recorded for the products which we expect to be returned and re-sold, each of these based on historical experience. The estimate of sales returns as well as the measurement of the returns asset and the refund liability is updated at the end of each month for changes in expectations regarding the amount of salvageable returns, reconditioning costs and any additional decreases in the value of the returned products. Late payment fees are recorded when the uncertainty associated with collecting such fees are resolved (i.e., when collected). The Representative generally receives a credit period of one sales campaign if they meet certain criteria; however, the specific credit terms are outlined in the Representative Agreement. Generally, the Representative remits payment during each sales campaign, which relates to the prior campaign cycle. The Representative is generally precluded from submitting an order for the current sales campaign until the accounts receivable balance past due for prior campaigns is paid; however, there are circumstances where the Representative fails to make the required payment. Our contracts with Representatives often include multiple promises to transfer products and/or services to the Representative, and determining which of these products and/or services are considered distinct performance obligations that should be accounted for separately. In addition, in assessing the recognition of revenue for the following performance obligations, management has exercised significant judgment in the following areas: estimation of variable consideration and the stand-alone selling prices ("SSP") of promised goods or services in order to determine and allocate the transaction price. Performance obligation - Avon products and appointment kits The Representative purchases Avon products and appointment kits through a purchase order. Avon offers appointment kits for purchase to Representatives, which may contain various Avon products. We recognize revenue for Avon products and appointment kits in net sales in our Consolidated Statements of Operations when the Representative obtains control of the products, which occurs upon delivery of the product to the Representative. Transaction price is the amount we expect to receive in exchange for those products adjusted for variable consideration as discussed above and the estimated SSP of other performance obligations as discussed below. The cost of these products and appointment kits is recognized in cost of sales in our Consolidated Statements of Operations. Performance obligation - Sales incentives Types of sales incentives include status programs, loyalty points, prospective discounts, and gift with purchase, among others. A Representative is eligible for certain status programs if specified sales levels are met. Status programs offer additional benefits such as free or discounted products and services. Loyalty points offer the option to redeem for additional Avon or other products or services. Prospective discounts are offered in some countries when certain sales levels are reached in a given time period. The revenue attributable to the prospective discount performance obligation is for the option to purchase additional product at a discounted amount. Certain benefits within status programs, loyalty points, prospective discounts and certain other sales incentives constitute a material right and, therefore, a distinct performance obligation in the contract with the Representative. Transaction price is allocated to the material right (performance obligation) based on estimated SSP and is deferred on the balance sheet until the associated performance obligations are satisfied. The cost of incentives is presented in inventories in our Consolidated Balance Sheets. We recognize revenue allocated to the material right in net sales in our Consolidated Statements of Operations at the point in time that the Representative receives the benefits of the material right or obtains control of the products, which occurs upon delivery to the Representative or upon expiration of the material right. For sales incentives that are delivered with the associated products order (such as gift with purchase), no deferral is required. SSP represents the estimated market value, or the estimated amount that could be charged for that material right when the entity sells it separately in similar circumstances to similar customers. Judgment is required to determine the SSP for each distinct performance obligation. In instances where SSP is not directly observable, such as when we do not sell the product or service separately, including for certain sales incentives, we determine the SSP using information that may include market prices and other observable inputs. ii) Representative fees, primarily for the sale of brochures to Representatives and fulfillment activities related to the contract ("Representative fees") The purchase order in the contract with the Representative explicitly identifies activities that we will perform. This includes fees that we charge Representatives, primarily for the sale of brochures to Representatives and fulfillment activities, and also includes late payment fees (discussed above). Brochures represent promotional materials that are given directly by the Representatives to their customers as a marketing activity. Under ASC 606, brochures that are sold by Avon to Representatives through purchase orders represent separate performance obligations in the contract as these are promises made between Avon and the Representative. Although the brochures are used similar to marketing materials, the Representative generally orders and pays for the brochures, and we allocate consideration for purposes of revenue recognition. The revenue associated with brochures that are sold to Representatives is recognized in other revenue and the related cost is recognized in cost of sales in our Consolidated Statements of Operations. We recognize revenue when the Representative obtains control of the brochures, which occurs upon delivery to the Representative. When brochures are given away for free to Representatives as promotional items, the cost is recognized in selling, general and administrative expenses in our Consolidated Statements of Operations. We often charge the Representative for shipping and handling (including order processing) and payment processing activities on the invoice, and such activities are considered to be fulfillment costs. The consideration received represents part of the transaction price in the contract that is allocated to the performance obligations in the contract. We recognize revenue for fulfillment activities in other revenue in our Consolidated Statements of Operations when such services are provided to the Representative. The cost of these activities is recognized in SG&A expenses in our Consolidated Statements of Operations. iii) Other revenue We also recognize revenue from the sale of products to New Avon, as part of a manufacturing and supply agreement, since the separation of the Company's North America business into New Avon on March 1, 2016, which has ceased since the sale of Avon Luxembourg Holdings S.à r.l on July 1, 2021, and royalties from the licensing of our name and products, in other revenue in our Consolidated Statements of Operations. Contract costs Incremental costs to obtain contracts, such as bonuses or commissions, are recognized as an asset if the entity expects to recover them. However, ASC 340-40, Other Assets and Deferred Costs , offers a practical expedient to recognize the incremental costs of obtaining a contract as an expense when incurred if the amortization period of the asset that the entity otherwise would have recognized is one year or less. We elected the practical expedient and expense costs to obtain contracts when incurred because our amortization period is one year or less. Costs to fulfill contracts with Representatives are comprised of shipping and handling (including order processing) and payment processing services, which are expensed as incurred. The fees for these services are included in the transaction price. Cash and Cash Equivalents Cash equivalents are stated at cost plus accrued interest, which approximates fair value. Cash equivalents are generally high-quality, short-term money market instruments with an original maturity of three months or less and consist of time deposits with a number of U.S. and non-U.S. commercial banks and money market fund investments. Inventories Inventories are stated at the lower of cost or net realizable value. Cost is determined using the first-in, first-out method. We classify inventory into various categories based upon its stage in the product life cycle, future marketing sales plans and the disposition process. We assign a degree of obsolescence risk to products based on this classification to estimate the level of obsolescence provision. Brochure Costs Brochures represent promotional materials that are given directly by the Representatives to their customers as a marketing activity. Brochures that are sold by Avon to Representatives through purchase orders represent separate performance obligations in the contract as these are promises made between Avon and the Representative. Although the brochures are used similar to marketing materials, the Representative generally orders and pays for the brochures, and Avon allocates consideration for purposes of revenue recognition. The revenue associated with brochures that are sold to Representatives is recognized in other revenue and the related cost is recognized in cost of sales in our Consolidated Statements of Operations. We recognize revenue when the Representative obtains control of the brochures, which occurs upon delivery to the Representative. When brochures are given away for free to Representatives as promotional items, the cost is recognized in SG&A expenses in our Consolidated Statements of Operations. Brochure costs and associated fees that are presented as inventory were $2.7 at December 31, 2022 and $4.1 at December 31, 2021. Brochure costs and associated fees that are presented as prepaid expenses and other were $3.1 at December 31, 2022 and $4.0 at December 31, 2021. Brochure costs expensed to COGS and SG&A in 2022 amounted to $36.1 and $68.5, respectively. In 2021 brochure costs expensed to COGS and SG&A were $54.8 and $72.6, respectively. In 2020 brochure costs expensed to COGS and SG&A were of $75.8 and $77.1, respectively. The fees charged to Representatives for brochures sold recorded in Other revenue in 2022, 2021 and 2020 amounted to $29.6, $49.3 and $66.8, respectively. Property, Plant and Equipment and Capitalized Software Property, plant and equipment are stated at cost and are depreciated using a straight-line method over the estimated useful lives of the assets. The estimated useful lives generally are as follows: buildings, 45 years; land improvements, 20 years; machinery and equipment, 15 years; and office equipment, 5 to 10 years. Leasehold improvements are depreciated over the shorter of the lease term or the estimated useful life of the asset. Upon disposal of property, plant and equipment, the cost of the assets and the related accumulated depreciation are removed from the accounts and the resulting gain or loss is reflected in earnings. Costs associated with repair and maintenance activities are expensed as incurred. Certain systems development costs related to the purchase, development and installation of computer software, and implementation costs incurred in a hosting arrangement that is a service contract, are capitalized and amortized over the estimated useful life of the related project. Costs incurred prior to the development stage, as well as maintenance, training costs, and general and administrative expenses are expensed as incurred. The other assets balance included unamortized capitalized software costs of $73.5 at December 31, 2022 and $74.9 at December 31, 2021. The amortization expense associated with capitalized software was $19.8, $22.4 and $24.5 for the years ended December 31, 2022, 2021 and 2020, respectively. We evaluate our property, plant and equipment and capitalized software for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset group may not be recoverable. Recoverability of assets to be held and used is measured by a comparison of the carrying amount of an asset to estimated pre-tax undiscounted future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its estimated future cash flows, an impairment charge is recognized for the amount by which the carrying amount of the asset exceeds the fair value of the asset. The fair value of the asset is determined using revenue and cash flow projections, and royalty and discount rates, as appropriate. Leases We determine if an arrangement is a lease at the lease commencement date. In addition to our lease agreements, we review all material new vendor arrangements for potential embedded lease obligations. The asset balance related to operating and finance leases is presented within right-of-use (ROU) asset and property, plant and equipment, respectively, on our Consolidated Balance Sheet. The short-term liability balance related to operating and finance leases is presented within other accrued liabilities on our Consolidated Balance Sheets. The long-term liability balance is presented within long-term operating lease liability and long-term debt on our Consolidated Balance Sheets for operating and finance leases, respectively. The lease liability is recognized based on the present value of the remaining fixed or in-substance fixed lease payments discounted using our incremental borrowing rates. We use a specific incremental borrowing rate for our material leases, which is determined based on the geography, nature of the asset and term of the lease. These rates are determined based on inputs provided by external banks and updated periodically. The lease liability includes the exercise of a purchase option only if we are reasonably certain to exercise as of the commencement date of the lease. The residual value guarantee amount is only included in the lease liability calculation to the extent payment is probable to the lessor as of the commencement of the lease. The ROU asset is calculated based on the lease liability adjusted for any lease payments paid to the lessor at or before the commencement date (i.e. prepaid rent) and initial direct costs incurred by Avon and excluding any lease incentives received from the Lessor. Variable lease payments are payments to the lessor not included in the lease liability calculation. We define variable lease payments as payments made by Avon to the lessor for the right to use a leased asset that vary because of changes in facts or circumstances (such as changes in an index rate, volume, usage, etc.) occurring after the lease commencement date, other than predetermined contractual changes due to the passage of time (for example, predetermined rent increase amounts that are set out in the contract). Variable lease payments or charges are accounted for as incurred. The lease term for purposes of lease accounting may include options to extend or terminate the lease when it is reasonably certain that we will exercise that option as of the commencement date of the lease. For operating leases, the lease expense is recognized on a straight-line basis over the lease term. For finance leases, the Company amortizes the ROU asset on a straight-line basis and records interest expense on the lease liability created at lease commencement over the lease term. We account for our lease and non-lease components as a single component for most of our asset classes, and therefore both are included in the calculation of lease liability recognized on the Consolidated Balance Sheets. However, for certain lease asset classes related to identified embedded leases we account for the lease and non-lease components separately, and therefore, the non-lease component is not included in the lease liability. Leases with an initial term of twelve months or less are not recorded on the Consolidated Balance Sheet; we recognize lease expense for these leases over their lease term. Assets and Liabilities Held for Sale A long-lived asset (or disposal group) is classified as held for sale if its carrying amount will be recovered principally through a sale transaction rather than through continuing use and a sale is considered highly probable within a year. A long-lived asset (or disposal group) classified as held for sale is initially measured at the lower of its carrying amount or fair value less cost to sell. An impairment loss is recognized for any initial or subsequent write-down of the long-lived asset (or disposal group) to fair value less costs to sell. A gain or loss not previously recognized by the date of the sale of the long-lived asset (or disposal group) is recognized at the date of derecognition. Long-lived assets (including those that are part of a disposal group) are not depreciated or amortized while they are classified as held for sale. Long-lived assets classified as held for sale and the assets of a disposal group classified as held for sale are presented separately from the other assets in the balance sheet. The liabilities of a disposal group classified as held for sale are presented separately from other liabilities in the balance sheet. Goodwill Goodwill is not amortized and is assessed for impairment annually d

New Accounting Standards

New Accounting Standards	12 Months Ended
	Dec. 31, 2022
Accounting Standards Update and Change in Accounting Principle [Abstract]
New Accounting Standards	New Accounting Standards New Accounting Standards Implemented Except for the changes below, we have consistently applied the accounting policies to all periods presented in these consolidated financial statements. ASU 2016-13, Financial Instruments - Credit Losses In June 2016, the FASB issued ASU 2016-13, Financial Instruments - Credit Losses, which requires measurement and recognition of expected credit losses for financial assets held. We adopted this new accounting guidance effective January 1, 2020, using a modified retrospective transition approach. The adoption did not have a material impact on our condensed consolidated financial statements and disclosures and did not significantly impact the Company’s accounting policies or estimation methods related to the allowance for doubtful accounts. The adoption resulted in a cumulative effect decrease to retained earnings of approximately $2 to reflect a change in the allowance for doubtful accounts. ASU 2018-14, Compensation - Retirement Benefits - Defined Benefit Plans In August 2018, the FASB issued ASU 2018-14, Compensation - Retirement Benefits - Defined Benefit Plans - General. ASU 2018-14 modifies the disclosure requirements for employers that sponsor defined benefit pension or other postretirement plans. Early adoption is permitted. The amendments in this Update are effective for fiscal years ending after December 15, 2020, therefore we adopted this standard effective December 31, 2020. The adoption did not have a material impact on our Consolidated Financial Statements. ASU 2017-04, Intangibles - Goodwill and other (Topic 350) In January 2017, the FASB issued Accounting Standards Update ("ASU") 2017-04 Intangibles - Goodwill and other, which simplifies the test for goodwill impairment. This Update eliminates Step 2 from the goodwill impairment test. In computing the implied fair value of goodwill under Step 2, an entity had to perform procedures to determine the fair value at the impairment testing date of its assets and liabilities (including unrecognized assets and liabilities) following the procedure that would be required in determining the fair value of the assets acquired and liabilities assumed in a business combination. Instead an entity should perform its annual, or interim, goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount. An entity should recognize an impairment charge for the amount by which the carrying amount exceeds the reporting unit's fair value, however the loss recognized should not exceed the total amount of goodwill allocated to the reporting unit. The guidance requires prospective adoption. We adopted the guidance for the goodwill impairment test that we have conducted since 2020, and adoption of the guidance did not have a material impact on our financial statements. ASU 2019-12, Simplifying the Accounting for Income Taxes In December 2019, the FASB issued ASU 2019-12, Income Taxes , which is intended to simplify the accounting standard and improve the usefulness of information provided in the financial statements. We adopted this new accounting guidance as of January 1, 2021. The adoption did not have a material impact on our Consolidated Financial Statements. ASU 2020-04 and ASU 2022-06, Reference Rate Reform (Topic 848) In March 2020, the FASB issued ASU 2020-04 “Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting,” which provides temporary optional guidance to ease the potential burden in accounting for reference rate reform. The ASU provides optional expedients and exceptions for applying generally accepted accounting principles to contract modifications and hedging relationships, subject to meeting certain criteria, that reference LIBOR or another reference rate expected to be discontinued. In January 2021, the FASB issued ASU 2021-01 which clarifies that certain optional expedients and exceptions in Topic 848 for contract modifications and hedge accounting apply to derivatives that are affected by the discounting transition. The guidance was initially effective for all entities as of March 12, 2020 through December 31, 2022, however, this was extended to December 31, 2024 following the issue of ASU 2022-06 “Reference Rate Reform (Topic 848): Deferral of the Sunset Date of Topic 848" in December 2022. The Company has implemented a transition plan to identify and modify its loans and other financial instruments with attributes that are either directly or indirectly influenced by LIBOR and, as a result, has elected to apply the optional expedient included in ASU 2020-04 to account for modifications of contracts within the scope of Topics 310, Receivables, and 470, Debt, to be accounted for by prospectively adjusting the effective interest rate. ASU 2021-08, Business Combinations (Topic 805) In October 2021, the FASB issued ASU 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers, which requires entities to apply Topic 606 to recognize and measure contract assets and contract liabilities in a business combination. ASU 2021-08 is effective for our fiscal year beginning after December 15, 2022. The adoption is not expected to have a material impact on our Consolidated Financial Statements. Accounting Standards to be Implemented ASU 2022-04, Disclosure supplier finance program (Topic 405-50) In September 2022, the FASB issued ASU 2022-04, Liabilities - Supplier Finance Programs (Subtopic 405-50): Disclosure of Supplier Finance Program Obligations that will require a buyer in a supplier finance program to disclose sufficient information about the program to allow a user of the financial statements to understand the program's nature, activity during the period, changes from period to period, and potential magnitude. Disclosures will include key terms of the program, including payment terms, along with the amount of related obligations, the financial statement caption that includes such obligations, and a rollforward of activity related to the obligations during the period. ASU 2022-04 is effective for Company beginning with the quarter ending March 31, 2023, except for the roll forward requirement which is effective for the Company beginning with the quarter ending March 31, 2024. No impact will arise on the Company's financial condition, results of operations or cash flows as a result of the application of this accounting standard.

Discontinued Operations and Ass

Discontinued Operations and Assets and Liabilities Held for Sale	12 Months Ended
	Dec. 31, 2022
Discontinued Operations and Disposal Groups [Abstract]
Discontinued Operations and Assets and Liabilities Held for Sale	Discontinued Operations and Assets and Liabilities Held for Sale Discontinued Operations On December 17, 2015, the Company entered into definitive agreements with affiliates controlled by Cerberus. The agreements resulted in the separation of the Company's North America business, which represented the Company's operations in the United States, Canada and Puerto Rico, from the Company into The Avon Company, formerly New Avon, ("New Avon") a privately-held company majority-owned and managed by Cerberus NA Investor LLC (an affiliate of Cerberus). The Company retained an investment of 19.9% ownership interest in New Avon. These transactions closed on March 1, 2016; from that date, resolution of contingent liabilities relating to Avon's ownership and operation of the North America business prior to its separation from the Company into New Avon have been treated as discontinued operations. In April 2019, we signed an agreement with LG Household & Health Care Ltd. to sell our 19.9% ownership interest in New Avon, which was completed during August 2019. Refer to the Divestitures section below for information relating to the sale of New Avon. The Company incurred costs and recognized contingent liabilities during the years ended December 31, 2022, 2021 and 2020 related to its ownership and operation of the North America business prior to its separation into New Avon, including talc- related and environmental related litigation as well as other costs as detailed in Note 17, Contingencies, to the Consolidated Financial Statements. The major classes of financial statement components comprising the loss on discontinued operations, net of tax for New Avon are shown below: Year Ended December 31, 2022 Year Ended December 31, 2021 Year Ended December 31, 2020 Selling, general and administrative expenses $ (73.2) $ (18.5) $ (27.9) Operating loss $ (73.2) $ (18.5) $ (27.9) Loss from discontinued operations, net of tax $ (73.2) $ (18.5) $ (27.9) Assets and Liabilities Held for Sale The major classes of assets and liabilities comprising held for sale assets and held for sale liabilities on the Consolidated Balance Sheet at December 31, 2022 and December 31, 2021 are shown in the following table. Year ended December 31, 2022 2021 Current held for sale assets Property, Plant & Equipment (net) — 2.8 $ — $ 2.8 Current held for sale liabilities Accounts payable $ — $ — Other liabilities — — $ — $ — At December 31, 2021, assets held for sale included one property in the Avon Latin America Segment. At December 31, 2022, there were no assets held for sale. Divestitures Sale of Poland Freehold Administrative Office In December 2022, we completed the sale of our Polish freehold administrative office for a total selling price of $12.5, the proceeds of which are presented as investing activities in the Consolidated Statement of Cash Flows. In the fourth quarter of 2022 we recognized a gain of $1.8 before and $1.5 after tax, which is reported separately in the Consolidated Statements of Operations representing the difference between the proceeds, the carrying value of the Poland Freehold Office on the date of sale, and associated disposal costs. Disposal of Avon Beauty Arabia in Saudi Arabia On December 23, 2021, the Company completed the sale of its 51% share of the business and assets of Avon Beauty Arabia in exchange for converting the business to a distributorship model together with the write off of a $3.9 loan balance. In the fourth quarter of 2021 we recognized a loss of $1.1 before and after tax, which is reported separately in the Consolidated Statements of Operations representing the difference between the write off of the loan balance, the carrying value of the business and assets of the Avon Beauty Arabia on the date of sale, and associated disposal costs. Disposal of Cosmetics Manufacturing Operations in India On November 17, 2021, the Company completed the sale of the business and assets of the Cosmetics Manufacturing Operation in India for a total selling price of $2.9, the proceeds of which are presented as investing activities in the Consolidated Statement of Cash Flows. In the fourth quarter of 2021 we recognized a gain of $1.1 before and after tax, which is reported separately in the Consolidated Statements of Operations representing the difference between the proceeds, the carrying value of the business and assets of the Cosmetics Manufacturing Operation in India on the date of sale, and associated disposal costs. Sale of Spanish Distribution Center In September 2021, we completed the sale of our Spanish Distribution Center for a total selling price of $14.7, the proceeds of which are presented as investing activities in the Consolidated Statement of Cash Flows. In the third quarter of 2021 we recognized a gain of $8.3 before and $6.2 after tax, which is reported separately in the Consolidated Statements of Operations representing the difference between the proceeds, the carrying value of the branch of the Spanish Distribution Center on the date of sale, and associated disposal costs. Sale of Avon Luxembourg Holdings S.à r.l On July 1, 2021, the Company sold Avon Luxembourg, including our Mexican business, to a subsidiary of Natura &Co Holding for $150, with the proceeds used to repay maturing loans of $150 borrowed under the $250 Revolving Credit Facility with a subsidiary of Natura &Co Holding. The sale was accounted for as a transaction under common control in accordance with ASC805 - Business Combinations, with the resulting gain of $148, representing the difference between the proceeds, the net assets of Avon Luxembourg on the date of sale and the cumulative foreign currency translation adjustment, taken directly to Retained Earnings. For additional information, see the Consolidated Statements of Changes in Shareholders' Deficit. Italy Branch In June 2021, we completed the sale of a branch of our Italian business for a total selling price of $1.7, the proceeds of which will be received in installments between October 2021 and December 2026, and will be presented as investing activities in the Consolidated Statement of Cash Flows. In the second quarter of 2021, we recorded a gain of $1.4 before and after tax, which is reported separately in the Consolidated Statements of Operations representing the difference between the proceeds and the carrying value of the branch of the Italian business on the date of sale. Avon Shanghai In August 2020, we signed an agreement to sell Avon Management Shanghai ("Avon Shanghai") to an affiliate of Natura &Co for a selling price of $2.9. In August 2020, we completed the sale of the entity and received proceeds of $2.9. These proceeds are presented as investing activities in the Consolidated Statement of Cash Flows as the sale was to an affiliate under common control by Natura &Co. The gain on sale of $1.4 was recorded directly to Retained earnings. Hungary Distribution Center in Gödöllő In April 2020, we signed an agreement to sell the Hungary Distribution Center in Gödöllő for a selling price of $3.4 and received a deposit of $.3. In June 2020, we completed the sale of the asset and the remaining proceeds of $3.1 were received. These proceeds are presented as investing activities in the Consolidated Statement of Cash Flows. In the second quarter of 2020, we recorded a gain of $.1 before and after tax, which is reported separately in the Consolidated Statements of Operations. The gain represents the difference between the proceeds and the carrying value of the Hungary Distribution Center on the date of sale. China Wellness Plant In March 2020, we signed an agreement to sell the China Wellness Plant for a total selling price of $6.6 before expenses. In the six-month period ended June 30, 2020, we received a cash deposit for the selling price of $6.6, which included $3.3 of restricted cash held in escrow. In August 2020, we completed the sale of the China Wellness Plant and $3.3 of restricted cash in escrow was transferred to Avon. In the third quarter of 2020, we recorded a gain of $1.4 before and after tax, which is reported separately in the Consolidated Statements of Operations. The gain represents the difference between the net proceeds (after associated expenses) and the carrying value of the China Wellness Plant on the date of sale. On May 22, 2019, the Company entered into the Agreement and Plan of Mergers (as amended by Amendment Number One to Agreement and Plant of Mergers, dated as of October 3, 2019, and as further amended by Amendment Number Two to Agreement and Plan of Mergers, dated as of November 5, 2019, the "Merger Agreement") among the Company, Natura Cosméticos S.A., a Brazilian corporation (sociedade anônima) ("Natura Cosméticos"), Natura &Co Holding S.A., a Brazilian corporation (sociedade anônima), Nectarine Merger Sub I, Inc., a Delaware corporation and a direct wholly owned subsidiary of Natura &Co Holding ("Merger Sub I"), and Nectarine Merger Sub II, Inc., a Delaware corporation and a direct wholly owned subsidiary of Merger Sub I ("Merger Sub II"), pursuant to which (i) Natura &Co Holding, after the completion of certain restructuring steps, holds all issued and outstanding shares of Natura Cosméticos, (ii) Merger Sub II merged with and into the Company, with the Company surviving the merger (the "First Merger") and (iii) Merger Sub I merged with and into Natura &Co Holding (the "Second Merger"), with Natura &Co Holding surviving the merger and as a result of which the Company and Natura Cosméticos became wholly owned direct subsidiaries of Natura &Co Holding (collectively, the "Transaction"). The Transaction was consummated on January 3, 2020, and at this time, the Company became a wholly owned direct subsidiary of Natura &Co Holding. In connection with the Transaction, trading of the Company’s stock was suspended by the NYSE, and the Company’s common stock was subsequently delisted and deregistered. On completion of the Transaction, each share of t he Company’s common stock issued and outstanding immediately prior to the consummation of the Transaction was converted into the ultimate right to receive, (i) 0.300 validly issued and allotted, fully paid-up American Depositary Shares of Natura &Co Holding, ("Natura &Co Holding ADSs") against the deposit of two shares of common stock of Natura &Co Holding ("Natura &Co Holding Shares", subject to adjustment in accordance with the terms of the Merger Agreement, and any cash in lieu of fractional Natura &Co Holding ADSs or (ii) 0.600 validly issued and allotted, fully paid-up Natura &Co Holding Shares, subject to adjustment in accordance with the terms of the Merger Agreement, and any cash in lieu of fractional Natura &Co Holding Shares. The Company’s Series C Preferred Stock held by Cerberus Investor were converted to common stock prior to consummation of the Transaction and were therefore automatically converted into common stock of Natura &Co. Natura &Co Holding Shares are listed on the B3 S.A. - Brasil, Bolsa, Balcão stock exchange, and Natura &Co Holding ADSs are listed on the NYSE. Additionally, upon the consummation of the Transaction, Avon common stock ceased to be traded on the NYSE. In January 2020, subsequent to the Transaction, the Company restated the certificate of incorporation. The certificate of incorporation was restated to effect a change in capitalization of the Company by changing the number of authorized shares of stock from 1,525,000,000 shares (of which (i) 1,500,000,000 shares, par value $0.25 per share, are common stock and (ii) 25,000,000 shares, par value $1.00 per share, are preferred stock) to 1,000 shares of common stock, par value $0.01 per share. As a result, all of the issued and outstanding common stock of the Company, being 550,890,788 were canceled and converted into 101.34 common stock, par value $0.01 per share, and all outstanding treasury shares were canceled. The Company incurred costs of $46 and $44 in relation to the Transaction, primarily professional fees during the years ended December 31, 2020 and 2019, respectively. During January 2020, it was announced that the employment of certain senior officers of the Company would be terminated, in connection with the Transaction. The Company incurred severance of approximately $25 and acceleration of share based compensation of approximately $10 relating to these terminations triggered by change in control provisions. As a result of the Transaction, the Company made payments of approximately $26 related to the settlement of stock options. In addition, any remaining restricted stock units and performance restricted stock units were exchanged for awards of Natura &Co Holding. The replacement awards contain substantially the same terms and conditions of the original awards except for the removal of the performance conditions. As such, the replacement awards contain only a service vesting condition. On consummation of the Transaction, a deferred compensation scheme relating to former employees of the Company became payable which resulted in extinguishing the liability and a cash outflow of approximately $12. In January 2020, upon completion of the Transaction, the Company’s revolving credit facility was canceled, triggered by change in control provisions. As a result, debt issuance costs of $7.8 were written off. As a result of the Transaction, the Company will no longer have access to certain tax attributes of approximately $546 to approximately $616 in certain taxing jurisdictions. These tax attributes had been formerly reflected as deferred tax assets which were subject to a full valuation allowance and as a result, there was no impact to net income in 2020 from the write-off of the deferred tax asset and the associated valuation allowances.

Related Party Transactions

Related Party Transactions	12 Months Ended
	Dec. 31, 2022
Related Party Transactions [Abstract]
Related Party Transactions	Related Party Transactions On January 3, 2020, the Company became a wholly owned subsidiary of Natura &Co Holding. From this point, Natura &Co Holding, its subsidiaries and affiliates became related parties of the Company. On July 1, 2021, the Company sold Avon Luxembourg, including our Mexican business, to a subsidiary of Natura &Co Holding. As a result, beginning on July 1, 2021, transactions and balances between Avon International and Avon Luxembourg are no longer eliminated on consolidation and instead are treated as transactions and balances with Related Parties. The following tables present the related party transactions with Natura &Co and its affiliates and the Instituto Avon in Brazil, all of which were on an arm's-length basis. There are no other related party transactions. Year Ended December 31, Year Ended December 31, Year Ended December 31, 2022 2021 2020 Statement of Operations Data Revenue from affiliates of Natura &Co (2)(3) $ 21.7 $ 25.2 $ 6.7 Cost of sales from affiliates of Natura &Co (2)(3) $ (20.4) $ (22.4) $ (5.9) Gross profit from affiliates of Natura &Co (2)(3) $ 1.3 $ 2.8 $ .8 Interest income from Instituto Avon (1) $ — $ — $ .1 Interest expense on Loan from affiliates of Natura &Co (5) $ (93.8) $ (50.6) $ (7.5) Interest income on Loan to affiliates of Natura &Co (5) $ 3.9 $ 1.6 $ — Year Ended December 31,2022 Year Ended December 31,2021 Balance Sheet Data Trade Receivables due from affiliates of Natura &Co (2) $ 30.7 $ 32.7 Derivative Receivables due from affiliates of Natura &Co (8) $ 9.5 $ — Other receivables due from affiliates of Natura &Co (7) $ 32.7 $ 1.4 Loans to affiliates of Natura &Co maturing within one year (7) $ 72.2 $ 46.6 Loans to affiliates of Natura &Co maturing after one year (7) $ 54.8 $ 46.7 Right-of-use asset from affiliates of Natura &Co (9) $ 6.0 $ — Trade Payables due to affiliates of Natura &Co (7) $ (33.7) $ (24.5) Derivative Payables due to affiliates of Natura &Co (8) $ (12.9) $ — Other payables due to affiliates of Natura &Co (4) $ (11.5) $ (4.9) Loans from affiliates of Natura &Co maturing within one year (5) $ (537.2) $ (371.7) Loans from affiliates of Natura &Co maturing after one year (5) $ (1,427.2) $ (736.3) Lease liability to affiliates of Natura &Co (9) $ (6.0) $ — Investments in affiliates of Natura &Co (6) $ .1 $ .1 (1) During the second quarter of 2018, the Company entered into an agreement to loan the Instituto Avon, an independent non-government charitable organization in Brazil, R$12 (Brazilian real) for an unsecured 5-year term at a fixed interest rate of 7% per annum, to be paid back in five equal annual installments. The Instituto Avon was created by an Avon subsidiary in Brazil, with the board and executive team comprised of Avon Brazil management. The purpose of the loan was to provide the Instituto Avon with the means to donate funds to Fundação Pio XII (a leading cancer prevention and treatment organization in Brazil and owner of the Hospital do Câncer de Barretos), in order to invest in equipment with the objective of expanding breast cancer prevention and treatment. During the fourth quarter of 2021, the loan was repaid in full. (2) During the second quarter of 2020, the Company entered into manufacturing agreements with affiliates of Natura &Co Holding. The Company recorded revenue from related party of $21.7, $25.2 and $6.7 associated with these agreements during the years ended December 31, 2022, 2021 and 2020, respectively. The Company recorded gross profit from related party of $1.3, $2.8 and $.8 associated with these agreements during the years ended December 31, 2022, 2021 and 2020, respectively. Trade receivables due from affiliates of Natura &Co primarily relate to these manufacturing agreements. (3) The Company is party to a license agreement with Avon Mexico, whereby Avon Mexico pays the Company a variable royalty. The Company recorded revenue and gross profit from related party of nil associated with these agreements during the year ended December 31, 2022, respectively. The Company recorded revenue and gross profit of $1 and $1, respectively, from related party associated with these agreements during the year ended December 31, 2021. (4) T he payable to Natura &Co relates to the vesting and settlement of share based compensation awards denominated in Natura &Co American Depository Receipts including the 2018 and 2019 long-term employee incentive program which vested and were automatically exercised in March 2021 and March 2022, respectively. (5) Loans from affiliates of Natura &Co Holding at December 31, 2022 of $1,964.4 include $692.2 outstanding under a Promissory Note with Avon Beauty Limited with a maturity date of December 6, 2028, $405 outstanding under a Promissory Note with Avon Products, Inc. with a maturity date of May 17, 2029 and $330 outstanding under two Promissory Notes with Avon Cosmetics Limited with maturity dates of May 17, 2029 and June 28, 2029. In addition loans from affiliates of Natura &Co Holding at December 31, 2022 of $537.2 include of intercompany loans between Avon Luxembourg and Avon Products, Inc. affiliates that, following the sale of Avon Luxembourg to a subsidiary of Natura &Co Holding on July 1, 2021, were redesignated as loans from affiliates of Natura & Co Holding. Loans from affiliates of Natura &Co Holding at December 31, 2021 of $1,108.0 include $736.3 outstanding under a Promissory Note between Avon Beauty Limited and a subsidiary of Natura &Co Holding, and $207.3 outstanding under a Promissory Note with a subsidiary of Natura &Co Holding and an affiliate of the Company. In addition loans from affiliates of Natura &Co Holding at December 31, 2021 include $164.4 of intercompany loans between Avon Luxembourg and Avon Products, Inc. affiliates that, following the sale of Avon Luxembourg to a subsidiary of Natura &Co Holding on July 1, 2021, were redesignated as loans from affiliates of Natura & Co Holding. See Note 7, Debt and Other Financing, for further information relating to these loans. (6) During the second quarter of 2021, Avon Cosméticos LTDA., made an investment of R$.5 in Natura &Co Pay Holding Financeira S.A., representing a 10% holding in the company. This is presented in other assets in our Consolidated Balance Sheets. (7) On July 1, 2021, the Company sold Avon Luxembourg, including our Mexican business, to a subsidiary of Natura &Co Holding. As a result, transactions and balances between Avon International and Avon Luxembourg are no longer eliminated on consolidation and instead are treated as transactions and balances with Related Parties. (8) During the first quarter of 2022, the Company entered into foreign exchange forward contracts with Natura &Co Luxembourg, a subsidiary of Natura &Co Holding, to manage a portion of its foreign currency exchange rate exposures. At December 31, 2022, we had outstanding related party foreign exchange forward contracts with notional amounts totaling approximately $546 for various currencies for up to 12 months, of which $290 were designated as cash flow hedges. In addition we had $9.5 of Accounts Receivable and $12.9 of Accounts Payable recorded in our Consolidated Balance Sheets associated with these transactions, all of which are expected to be reclassified into earnings within the next 12 months.

Revenue

Revenue	12 Months Ended
	Dec. 31, 2022
Revenue from Contract with Customer [Abstract]
Revenue	Revenue Disaggregation of revenue In the following tables, revenue is disaggregated by product or service type. All revenue is recognized at a point in time, when control of a product is transferred to a customer: Twelve Months Ended December 31, 2022 Reportable segments Avon International Avon LATAM Total reportable segments Affiliates of Natura Total Beauty: Skincare $ 458.7 $ 415.4 $ 874.1 $ — $ 874.1 Fragrance 442.7 352.3 795.0 — 795.0 Color 187.9 184.6 372.5 — 372.5 Total Beauty 1,089.3 952.3 2,041.6 — 2,041.6 Fashion & Home: Fashion 197.2 93.5 290.7 — 290.7 Home 51.3 226.9 278.2 — 278.2 Total Fashion & Home 248.5 320.4 568.9 — 568.9 Certain Brazil indirect taxes* — (10.0) (10.0) — (10.0) Product sales 1,337.8 1,262.7 2,600.5 — 2,600.5 Representative fees** 78.0 68.4 146.4 — 146.4 Other .1 0.5 0.6 21.7 22.3 Other revenue 78.1 68.9 147.0 21.7 168.7 Total revenue $ 1,415.9 $ 1,331.6 $ 2,747.5 $ 21.7 $ 2,769.2 Twelve Months Ended December 31, 2021 Reportable segments Avon International Avon LATAM Total reportable segments Affiliates of Natura Total Beauty: Skincare $ 577.6 $ 465.8 $ 1,043.4 $ — $ 1,043.4 Fragrance 514.2 375.8 890.0 — 890.0 Color 238.0 181.9 419.9 — 419.9 Total Beauty 1,329.8 1,023.5 2,353.3 — 2,353.3 Fashion & Home: Fashion 258.3 159.8 418.1 — 418.1 Home 69.6 340.4 410.0 — 410.0 Total Fashion & Home 327.9 500.2 828.1 — 828.1 Certain Brazil indirect taxes* — 21.5 21.5 — 21.5 Product sales 1,657.7 1,545.2 3,202.9 — 3,202.9 Representative fees 66.4 107.8 174.2 — 174.2 Other .5 1.7 2.2 25.2 27.4 Other revenue 66.9 109.5 176.4 25.2 201.6 Total revenue $ 1,724.6 $ 1,654.7 $ 3,379.3 $ 25.2 $ 3,404.5 Twelve Months Ended December 31, 2020 Reportable segments Avon International Avon LATAM Total reportable segments Affiliates of Natura Total Beauty: Skincare $ 594.7 $ 515.9 $ 1,110.6 $ — $ 1,110.6 Fragrance 516.0 456.4 972.4 — 972.4 Color 265.8 197.5 463.3 — 463.3 Total Beauty 1,376.5 1,169.8 2,546.3 — 2,546.3 Fashion & Home: Fashion 267.4 192.5 459.9 — 459.9 Home 55.6 369.4 425.0 — 425.0 Total Fashion & Home 323.0 561.9 884.9 — 884.9 Product sales 1,699.5 1,731.7 3,431.2 — 3,431.2 Representative fees 66.7 108.4 175.1 — 175.1 Other 6.4 5.8 12.2 6.7 18.9 Other revenue 73.1 114.2 187.3 6.7 194.0 Total revenue $ 1,772.6 $ 1,845.9 $ 3,618.5 $ 6.7 $ 3,625.2 * The years ended December 31, 2022 and 2021 include impact of certain Brazil indirect taxes which resulted in an approximate cost of $10 and benefit of $22, respectively. See Note 19 Supplemental Balance Sheet Information. ** In June 2022, an Avon subsidiary concluded the negotiation of a settlement agreement to resolve a breach of contract dispute in Japan. As a result, Avon received cash compensation of $27, $3.3 of which related to the settlement of historically recognized revenues. The remaining $23.7 was recognized as revenue in the quarter ended June 30, 2022. Contract balances The timing of revenue recognition generally is different from the timing of a promise made to a Representative. As a result, we have contract liabilities, which primarily relate to the advance consideration received from Representatives prior to transfer of the related good or service for material rights, such as loyalty points and status programs, and are primarily classified within other accrued liabilities (with the long-term portion in other liabilities) in our Consolidated Balance Sheets. Generally, we record accounts receivable when we invoice a Representative. In addition, we record an estimate of an allowance for doubtful accounts on receivable balances based on an analysis of historical data and, as applicable, current conditions and reasonable and supportable forecasts that affect collectability, including seasonality and changing trends, economic and geopolitical environment and the impact of COVID-19. The allowance for doubtful accounts is reviewed for adequacy, at a minimum, on a quarterly basis. We generally have no detailed information concerning, or any communication with, any ultimate consumer of our products beyond the Representative. We have no legal recourse against the ultimate consumer for the collection of any accounts receivable balances due from the Representative to us. If the financial condition of the Representatives were to deteriorate, resulting in their inability to make payments, additional allowances may be required. The following table provides information about receivables and contract liabilities from contracts with customers at December 31, 2022 and 2021: December 31, 2022 December 31, 2021 Accounts receivable, net of allowances of $35.4 and $37.1 $ 183.4 $ 198.7 Contract liabilities $ 31.6 $ 37.1 The contract liability balances relate to certain material rights (loyalty points, status program and prospective discounts). During the twelve months ended December 31, 2022, we recognized $28.3 of revenue related to the contract liability balance at December 31, 2021, as the result of performance obligations satisfied. In addition, we deferred an additional $25.6 related to

Inventories

Inventories	12 Months Ended
	Dec. 31, 2022
Inventory, Net [Abstract]
Inventories	Inventories Inventories at December 31 consisted of the following: 2022 2021 Raw materials $ 91.2 $ 103.4 Finished goods 241.0 280.7 Total $ 332.2 $ 384.1

Debt and Other Financing

Debt and Other Financing	12 Months Ended
	Dec. 31, 2022
Debt Disclosure [Abstract]
Debt and Other Financing	Debt and Other Financing Debt Debt at December 31 consisted of the following: 2022 2021 Debt maturing within one year: Short term debt $ 5.7 $ 32.6 Loans from affiliates of Natura &Co 537.2 371.7 Total $ 542.9 $ 404.3 Long-term debt: Finance lease liabilities 0.8 1.3 5.00% Notes, due March 2023 — 460.8 6.95% Notes, due March 2043 214.0 213.9 Loans from affiliates of Natura &Co, due 2028 and 2029 1,427.2 736.3 Total 1,642.0 1,412.3 The carrying value of long-term debt is presented net of debt issuance costs and includes any related discount or premium, as applicable. Unsecured Notes In March 2013, we issued, in a public offering, $500.0 principal amount of 5.00% Notes due March 15, 2023 (the "5.00% Notes") and $250.0 principal amount of 6.95% Notes due March 15, 2043 (the "6.95% Notes") (collectively, the "2013 Notes"). Interest on the 2013 Notes is payable semi-annually on March 15 and September 15 of each year. The indenture governing the 2013 Notes contains interest rate adjustment provisions depending on the credit ratings assigned to the 2013 Notes with S&P and Moody's. As described in the indenture, the interest rates on the 2013 Notes increase or decrease by .25% for each one-notch movement below investment grade on each of the credit ratings assigned to the 2013 Notes by S&P or Moody's. These adjustments are limited to a total increase of 2% above the respective interest rates in effect on the date of issuance of the 2013 Notes. In the fourth quarter of 2016, we repurchased $11.1 of our 5.00% Notes and $6.2 of our 6.95% Notes and in the fourth quarter of 2018, we repurchased $27.0 of our 5.00% Notes. In September 2020, we repurchased $27.8 of our 6.95% Notes due March 15, 2043. The aggregate repurchase price was equal to the principal amount of the notes, plus a premium of $3.8 and accrued interest of $1.2. In connection with the repurchase, we incurred a loss on extinguishment of debt of $4.1 before tax in the third quarter of 2020 consisting of the $3.8 premium paid for the repurchases, and $.3 for the write-off of debt issuance costs and discounts related to the initial issuance of the notes that were repurchased. In May 2022, we repurchased $461.9 of our 5% Notes due 15 March, 2023, financed by long-term related party loans (see below). The aggregate repurchase price was equal to the principal amount of the notes, plus a premium of $15.0 and accrued interest of $5.4. In connection with the repurchase, we incurred a loss on extinguishment of debt of $15.7 before tax in the second quarter of 2022 consisting of the $15.0 premium paid for the repurchase and $.7 for the write-off of debt issuance costs and discounts related to the initial issuance of the notes that were repurchased. At December 31, 2022 and 2021, the carrying values of our unsecured notes were comprised of the following: 2022 2021 Remaining Principal Unamortized Discounts Unamortized Debt Issuance Costs Total Remaining Principal Unamortized Discounts Unamortized Debt Issuance Costs Total 5.00% Notes, due March 2023 — — — — 461.9 (.5) (.6) 460.8 6.95% Notes, due March 2043 216.1 (1.6) (.5) 214.0 216.1 (1.7) (.5) 213.9 The indentures governing our outstanding notes described above contain certain customary covenants, customary events of default, cross-default provisions and change in control provisions. In July and September 2019, bondholder consents for the 5% Notes and the 6.95% Notes, respectively, were obtained to amend the definition of "change of control" to permit the acquisition of Avon by Natura. No repayment of notes was triggered by the Transaction with Natura &Co. At December 31, 2022 and 2021, we had recorded accrued interest on our unsecured notes of $5.8 and $14.7, respectively, which is classified within other accrued liabilities in our Consolidated Balance Sheets. Senior Secured Notes In August 2016, Avon International Operations, Inc. ("AIO"), a wholly-owned subsidiary of the Company, issued, in a private placement exempt from registration under the Securities Act of 1933, as amended, $500.0 in aggregate principal amount of 7.875% Senior Secured Notes, with a maturity date of August 15, 2022 (the "2016 Notes"). In July 2019, Avon International Capital, p.l.c. ("AIC"), a wholly-owned subsidiary of the Company, issued, in a private placement exempt from registration under the Securities Act of 1933, as amended, $400.0 in aggregate principal amount of 6.5% Senior Secured Notes, with a maturity date August 15, 2022 (the "2019 Notes"). In November 2020, in connection with the Natura & Co Promissory Note, we redeemed the outstanding principal amount of our 2016 Notes due August 15, 2022 and the outstanding principal amount of our 2019 Notes due August 15, 2022. With respect to the 2016 Notes, the aggregate redemption amount paid was equal to the outstanding principal amount of $500, plus a premium of $9.8 and accrued interest of $8.4. With respect to the 2019 Notes, the aggregate redemption amount paid was equal to the outstanding principal amount of $400, plus a premium of $7.9 and accrued interest of $5.6. In connection with the redemption, we incurred a loss on extinguishment of debt of $25.6 before tax in the fourth quarter of 2020 consisting of the $17.7 premiums, and the write-off of $7.9 of debt issuance costs related to the initial issuances of the notes that were redeemed. Certain hedging and cash management obligations of the Company and certain subsidiaries are secured by first priority security interests in substantially all of its assets, subject to certain exceptions. At December 31, 2022 and 2021, the carrying values of our senior secured notes was nil. Maturities of Long-Term Debt Annual maturities of long-term debt, which includes our notes, loans from affiliates of Natura &Co and capital leases outstanding at December 31, 2022, are as follows: 2023 2024 2025 2026 2027 2028 and Beyond Total Maturities $ — $ .5 $ .3 $ .2 $ — $ 1,643.3 $ 1,644.3 Other Financing Natura Revolving Credit Facility In May 2020, the Company’s subsidiary, Avon Luxembourg entered into a Revolving Credit Facility Agreement with Natura &Co International S.à r.l., a subsidiary of Natura &Co Holding and an affiliate of the Company, in the initial amount of $100, increased to $250 in March 2021, which may be used for working capital and other general corporate purposes (the "Facility"). Borrowings under the Facility bear interest at a rate per annum of LIBOR plus a margin determined on an arm's length basis, and the Facility is to mature on May 31, 2022. On July 1, 2021, the Company sold Avon Luxembourg to a subsidiary of Natura &Co Holding and the Company no longer has access to this facility. On November 7, 2022, the Company’s subsidiary, Avon Cosmetics Limited entered into a two-year committed intercompany multi-currency revolving credit facility with Natura &Co Luxembourg Holdings S.à r.l, a subsidiary of Natura &Co Holding and an affiliate of the Company, in the amount of $300, of which $226 was drawn down at December 31, 2022. Borrowings under this facility will be used to reduce short-term financing from third-party banks and will bear interest at a rate per annum of 3% plus applicable currency benchmark rate. Related Party loans In November 2020, AIO entered into a Promissory Note with a subsidiary of Natura &Co Holding S.A. and an affiliate of the Company in the amount of $960. The Promissory Note bears interest at a rate per annum of 3.13% with a maturity date of November 2, 2022 (“the Natura &Co Loan”). On July 1, 2021, as part of the sale of Avon Luxembourg to a subsidiary of Natura &Co Holding the $960 loan was partially repaid with the proceeds from a loan maturing in 2028. The loan was fully repaid in the second of quarter of 2022 as part of a refinancing and the subsequent repurchase of Unsecured Notes (see above). As at December 31, 2022, $692 was outstanding under the loan maturing in 2028 which is between Avon Beauty Limited, and Natura &Co Luxembourg Holdings S.à r.l. ("Natura &Co Lux Loan"). Avon Beauty Limited is a subsidiary of Avon Cosmetics Limited. In May 2022, Avon Products, Inc and Avon Cosmetics Limited entered into Promissory Notes with a subsidiary of Natura &Co Holding in the amount of $405 and $215 respectively. The Promissory Notes bear interest at a rate per annum of 6.71% and mature on May 17, 2029. In addition, in June 2022 Avon Cosmetics Limited entered into an additional Promissory Note with a subsidiary of Natura &Co Holding in the amount of $115. This Promissory Note bears interest at a rate per annum of 6.51% and matures on June 28, 2029. At December 31, 2022, our debt and other financing maturing within one year of include $537 of intercompany loans between Natura &Co Luxembourg Holdings S.à r.l. and Avon Products, Inc. affiliates, including $226 drawn down under a $300 committed intercompany multi-currency revolving credit facility from an affiliate of Natura &Co expiring in November 2024. In addition, our short term contractual financial obligations and commitments include approximately $101.8 relating to purchase obligations and approximately $39 relating to operating lease repayments. We also expect to make contributions in the range of $5 to $10 to our defined benefit pension and postretirement plans. These commitments and repayments are expected to be fulfilled through a combination of operating cash flows and where necessary, further financial support from Natura &Co Holding. Other short-term financing At December 31, 2022, we utilized approximately $5.7 of short-term financing from third-party banks across multiple markets bearing an average interest rate of per annum of 7.5%. Letters of Credit At December 31, 2022 and 2021, we also had letters of credit outstanding totaling $5.6 and $11.3, respectively. These balances primarily relate to a letter of credit issued to a lessor of certain equipment, a lease which was transferred to New Avon in connection with the separation of the Company's North America business, and letters of credit which guarantee various insurance activities. Long-Term Credit Ratings Our long-term credit ratings are: Moody’s ratings of Stable Outlook with Ba3 for corporate family debt; S&P ratings of Stable Outlook with BB- for corporate family debt and senior unsecured debt; and Fitch rating of Positive Outlook with BB for corporate family and unsecured debt. Our credit ratings remain below investment grade which may impact our ability to access financing transactions on favorable terms.

Accumulated Other Comprehensive

Accumulated Other Comprehensive Income (Loss)	12 Months Ended
	Dec. 31, 2022
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Accumulated Other Comprehensive Income (Loss)	Accumulated Other Comprehensive Income (Loss) The tables below present the changes in AOCI by component and the reclassifications out of AOCI during 2022 and 2021: Foreign Currency Translation Adjustments Net Investment Hedges Cash Flow Hedges Pension and Postretirement Benefits Total Balance at December 31, 2021 $ (1,062.2) $ (4.3) $ — $ (19.0) $ (1,085.5) Other comprehensive income other than reclassifications 44.1 — 0.3 (16.0) 28.4 Reclassifications into earnings: Amortization of net actuarial loss and prior service cost, net of tax of $.8 (1) — — — 4.9 4.9 Total reclassifications into earnings — — — 4.9 4.9 Balance at December 31, 2022 $ (1,018.1) $ (4.3) $ 0.3 $ (30.1) $ (1,052.2) Foreign Currency Translation Adjustments Net Investment Hedges Pension and Postretirement Benefits Total Balance at December 31, 2020 $ (1,038.2) $ (4.3) $ (91.3) $ (1,133.8) Other comprehensive income (loss) other than reclassifications (24.1) — 67.3 43.2 Sale of Avon Luxembourg .1 (.1) — Reclassifications into earnings: Amortization of net actuarial loss and prior service cost, net of tax of $.8 (1) — — 5.1 5.1 Total reclassifications into earnings — — 5.1 5.1 Balance at December 31, 2021 $ (1,062.2) $ (4.3) $ (19.0) $ (1,085.5) (1) Gross amount reclassified to other expense, net, and related taxes reclassified to income taxes.

Income Taxes

Income Taxes	12 Months Ended
	Dec. 31, 2022
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes Income from continuing operations, before taxes for the years ended December 31 was as follows: 2022 2021 2020 United States $ (23.8) $ 19.3 $ (89.6) Foreign (293.5) (178.1) (214.0) Total $ (317.3) $ (158.8) $ (303.6) The provision for income taxes for the years ended December 31 was as follows: 2022 2021 2020 Federal: Current $ — $ 0.2 $ (9.5) Deferred — — 8.9 Total Federal — .2 (0.6) Foreign: Current 25.6 35.5 31.4 Deferred 11.8 (20.0) 2.6 Total Foreign 37.4 15.5 34.0 State and Local: Current — .5 .6 Deferred — — — Total State and other — .5 .6 Total $ 37.4 $ 16.2 $ 34.0 The continuing operations effective tax rate for the years ended December 31 was as follows: 2022 2021 2020 Statutory federal rate 21.0 % 21.0 % 21.0 % State and local taxes, net of federal tax benefit — (.3) (.2) Tax on foreign income 10.8 67.1 (1.8) Tax on uncertain tax positions .6 3.7 1.1 Reorganizations — — (10.0) Net change in valuation allowances (44.6) (103.1) (21.4) Other .4 1.4 .1 Effective tax rate (11.8) % (10.2) % (11.2) % In 2022, the Company’s effective tax rate continues to be impacted by the country mix of earnings. The country mix includes losses in certain jurisdictions that cannot be benefited and income tax expense in certain jurisdictions where taxable income is generated. In 2022, the Company increased its reserves for uncertain tax positions associated with current year activity and reduced reserves due to events, including settlements and the expiration of statutes of limitation. Included in Tax on Foreign Income is the effect of the Colombia Goodwill impairment which could not be benefitted. In 2022, the Net Change in Valuation Allowances line in the rate reconciliation above includes $141.4 of net benefits that could not be recognized. The $141.4 of benefits which were not recognized consisted of the following key items: 1) $115.0 of increased Valuation Allowances due to additional Deferred Tax Assets generated during 2022 which cannot be benefitted; and 2) $26.4 of increased Valuation Allowances due to changes in judgment regarding the ability to use certain Deferred Tax Assets which existed at the beginning of 2022. In 2021, the Company’s effective tax rate continued to be impacted by the country mix of earnings. The country mix includes losses in certain jurisdictions that cannot be benefited and income tax expense in certain jurisdictions where taxable income is generated. In 2021, the Company increased its reserves for uncertain tax positions associated with current year activity and reduced reserves due to events, primarily restructuring and the expiration of statutes of limitation. Included in Tax on Foreign Income is the effect of tax rate changes including the increase in the United Kingdom tax rate from 19% to 25% which resulted in a deferred tax benefit of $89.1. In 2021, the Net Change in Valuation Allowances line in the rate reconciliation above includes $163.7 of net benefits that could not be recognized. The $163.7 of benefits which were not recognized consisted of the following key items: 1) $70.9 of increased Valuation Allowances due to additional Deferred Tax Assets generated during 2021 which cannot be benefitted; 2) $89.1 of increased Valuation Allowances on Deferred Tax Assets due to a tax rate change offsetting equivalent and associated accruals of deferred tax benefits reflected in the “Tax on Foreign Income” line above; and 3) $3.7 of increased Valuation Allowances due to changes in judgment regarding the ability to use certain Deferred Tax Assets which existed at the beginning of 2021. In 2020, the Company’s effective tax rate continues to be impacted by the country mix of earnings. The country mix includes losses in certain jurisdictions that cannot be benefited and income tax expense in certain jurisdictions where taxable income is generated. In 2020, the Company increased its reserves for uncertain tax positions associated with current year activity and reduced reserves due to events, primarily the expiration of statutes of limitation. Included in Tax on Foreign Income is the effect of tax rate changes including the increase in the United Kingdom tax rate from 17% to 19% which resulted in a deferred tax benefit of $21.0. Included in the Re-organizations line is the effect of a true-up for a change in estimate of $30.5 regarding the amount of net operating losses generated as part of the 2018 restructuring transactions. In 2020, the Net Change in Valuation Allowances line in the rate reconciliation above includes $65.1 of net benefits that could not be recognized. The $65.1 of benefits which were not recognized consisted of the following key items: 1) $69.9 of increased Valuation Allowances due to additional Deferred Tax Assets generated during 2020 which cannot be benefitted; 2) $21.0 of increased Valuation Allowances on Deferred Tax Assets due to a tax rate change offsetting equivalent and associated accruals of deferred tax benefits reflected in the “Tax on Foreign Income” line above; 3) $4.7 of increased Valuation Allowances due to changes in judgment regarding the ability to use certain Deferred Tax Assets which existed at the beginning of 2020; and 4) $30.5 decrease which offsets the true-up effect for the change in estimate of the benefit of net operating losses generated as part of the 2018 restructuring transactions. Deferred tax assets (liabilities) at December 31 consisted of the following: 2022 2021 Deferred tax assets: Tax loss and deduction carryforwards $ 478.5 $ 425.0 Intangibles 187.6 218.5 Tax credit carryforwards 120.3 119.7 Interest carryforwards 93.6 76.3 All other future deductions 168.4 199.8 Valuation allowance (941.4) (815.4) Total deferred tax assets 107.0 223.9 Deferred tax liabilities $ (59.2) $ (105.0) Net deferred tax assets $ 47.8 $ 118.9 Deferred tax assets (liabilities) at December 31 were classified as follows: 2022 2021 Deferred tax assets: Other assets $ 52.1 $ 121.4 Total deferred tax assets 52.1 121.4 Deferred tax liabilities: Long-term income taxes $ (4.3) $ (2.5) Total deferred tax liabilities (4.3) (2.5) Net deferred tax assets $ 47.8 $ 118.9 We monitor the realizability of our deferred tax assets on a continuous basis. Should macroeconomic and socio-political conditions change or our business operations do not improve, some or all of our remaining deferred tax assets could potentially need to be offset with the recording of a valuation allowance during the next 12 months. At December 31, 2022, the valuation allowance primarily represents amounts for certain foreign tax loss carryforwards, substantially all U.S. deferred tax assets and certain other foreign deferred tax assets. The recognition of deferred tax assets was based on the evaluation of current and estimated future profitability of the operations, reversal of deferred tax liabilities and the likelihood of utilizing tax credit and/or loss carryforwards. Tax planning strategies were also considered and evaluated as support for the realization of deferred tax assets. Where these sources of income existed along with sufficient positive evidence that indicated it was more likely than not that such sources of income could be relied upon, then the deferred tax assets were not reduced by a valuation allowance. At December 31, 2022, we had deferred tax assets of $120.3 relating to tax credit carryforwards (U.S. foreign tax credits, research and experimentation credits and other tax credits) for which a valuation allowance of $120.3 has been provided. The tax credit carryforwards consist of U.S. foreign tax credits of $87.6 which are substantially all subject to expiration between 2023 and 2027; U.S. research and experimentation credits of $24.8 which are subject to expiration between 2027 and 2042 and other tax credits of $7.9 which are subject to expiration between 2023 and 2036. At December 31, 2022, we had deferred tax assets of $432.2 relating to foreign loss carryforwards. The $432.2 of recognized deferred tax assets includes a $77.5 reduction for unrecognized tax benefits in accordance with ASU2013-11. The $432.2 of recognized deferred tax assets are further reduced by a valuation allowance of $414.2 resulting in a net deferred tax asset of $18.0 for foreign loss carryforwards. At December 31, 2022, we had recognized deferred tax assets of $46.3 relating to federal loss carryforwards for which a valuation allowance of $46.3 has been provided. At December 31, 2022 we had foreign tax loss carryforwards of $2,480.8, of which $924.9 are not subject to expiration and $1,555.9 are subject to expiration between 2023 and 2052. At December 31, 2022, we had federal tax loss carryforwards of $220.4 which are not subject to expiration. In prior years, we had previously recorded valuation allowances against certain deferred tax assets associated with the U.S. and various foreign jurisdictions. We intend to continue maintaining these valuation allowances on our deferred tax assets until there is sufficient evidence to support the reversal of all or some portion of these allowances. Release of the valuation allowance would result in the recognition of certain deferred tax assets and a decrease to income tax expense for the period the release is recorded. However, the exact timing and amount of any such valuation allowance release is subject to change depending on the level of profitability that we are able to achieve. The Company continuously monitors its operational and capital structure changes, business performance, tax planning actions and tax planning strategies that could potentially allow for the recognition of deferred tax assets which are currently subject to a valuation allowance. There is the possibility that, in the foreseeable future, certain deferred tax asset could be recognized related to improvements in actual and/or expected operating results. The ultimate realization of deferred tax assets depends upon generating sufficient taxable income of the right character during the periods in which the temporary differences become deductible, or before net operating loss and tax credit carryforwards expire. Evaluating the need for and quantifying the valuation allowance often requires significant judgment and extensive analysis of all the weighted positive and negative evidence available to the Company in order to determine whether all or some portion of the deferred tax assets will not be realized. Management continuously monitors the performance of entities and assesses the need for any further valuation allowances based on market performance and executability of tax planning actions and opportunities (including corporate restructuring). Should macroeconomic and sociopolitical conditions change, or our business operations not improve, or tax planning actions and opportunities not be implemented, up to approximately $52.1 of the Company's recognized deferred tax assets could potentially need to be offset with the recording of a valuation allowance in the future. At December 31, 2022, we continue to assert that substantially all of our foreign earnings are indefinitely reinvested. At December 31, 2022 the company’s undistributed foreign earnings of approximately $1.2 billion and would generate an approximate $10.2 of income tax if repatriated from the local subsidiaries. Uncertain Tax Positions At December 31, 2022, we had $249.8 of total gross unrecognized tax benefits of which approximately $14.1 would favorably impact the provision for income taxes, if recognized. A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows: Balance at December 31, 2019 331.7 Additions based on tax positions related to the current year 90.6 Additions for tax positions of prior years .6 Reductions for tax positions of prior years (34.1) Reductions due to lapse of statute of limitations (16.5) Reductions due to settlements with tax authorities (.2) Balance at December 31, 2020 372.1 Additions based on tax positions related to the current year 6.8 Additions for tax positions of prior years 24.1 Reductions for tax positions of prior years (136.8) Reductions due to lapse of statute of limitations (11.2) Reductions due to settlements with tax authorities (3.3) Balance at December 31, 2021 251.7 Additions based on tax positions related to the current year 3.3 Additions for tax positions of prior years — Reductions for tax positions of prior years (1.8) Reductions due to lapse of statute of limitations (1.1) Reductions due to settlements with tax authorities (2.3) Balance at December 31, 2022 $ 249.8 We accrue interest and penalties related to unrecognized tax benefits in the provision for income taxes. We reversed previously recorded expenses for interest and penalties, net of tax of $0.2 for the year ended December 31, 2022 and accrued interest and penalties, net of taxes of $0.5 and $1.0, for the years ended December 31, 2021 and 2020, respectively. At December 31, 2022 and 2021 we had $6.3 and $7.1, respectively, recorded for interest and penalties, net of tax benefit. The unrecognized tax benefits, including interest and penalties, were classified within long-term income taxes in our Consolidated Balance Sheets. We file income tax returns in the U.S. and foreign jurisdictions. As of December 31, 2022, the tax years that remained subject to examination by major tax jurisdiction for our most significant subsidiaries were as follows: Jurisdiction Open Years Brazil 2017-2022 Philippines 2017, 2019-2022 Poland 2014-2022 Russia 2020-2022 United Kingdom 2020-2022 United States (Federal) 2017-2022

Financial Instruments and Risk

Financial Instruments and Risk Management	12 Months Ended
	Dec. 31, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Financial Instruments and Risk Management	Financial Instruments and Risk Management We operate globally, with manufacturing and distribution facilities in various countries around the world. We may reduce our exposure to fluctuations in the fair value and cash flows associated with changes in interest rates and foreign exchange rates by creating offsetting positions, including through the use of derivative financial instruments. If we use foreign currency-rate sensitive and interest-rate sensitive instruments to hedge a certain portion of our existing and forecasted transactions, we would expect that any gain or loss in value of the hedge instruments generally would be offset by decreases or increases in the value of the underlying forecasted transactions. We do not enter into derivative financial instruments for trading or speculative purposes, nor are we a party to leveraged derivatives. The master agreements governing our derivative contracts generally contain standard provisions that could trigger early termination of the contracts in certain circumstances. Derivatives are recognized in the Consolidated Balance Sheets at their fair values. The following table presents the fair value of derivative instruments at December 31, 2022: Asset Liability Balance Sheet Fair Balance Sheet Fair Derivatives designated as hedges: Foreign exchange forward contracts Prepaid expenses and other $ 9.2 Accounts payable $ 9.1 Derivatives not designated as hedges: Foreign exchange forward contracts Prepaid expenses and other $ .6 Accounts payable $ 4.6 Total derivatives $ 9.8 $ 13.7 Derivatives are recognized in the Consolidated Balance Sheets at their fair values. The following table presents the fair value of derivative instruments at December 31, 2021: Asset Liability Balance Sheet Fair Balance Sheet Fair Derivatives not designated as hedges: Foreign exchange forward contracts Prepaid expenses and other $ — Accounts payable $ 2.7 Total derivatives $ — $ 2.7 Interest Rate Risk Approximately 3% and 5% of our debt portfolio at December 31, 2022 and 2021, respectively, was exposed to floating interest rates, which relates to our short term debt portfolio. Foreign Currency Risk We may use foreign exchange forward contracts to manage a portion of our foreign currency exchange rate exposures. At December 31, 2022, we had outstanding third-party foreign exchange forward contracts with notional amounts totaling approximately $38.1 for various currencies, all of which were designated as cash flow hedges. During the year ended December 31, 2022, the Company entered into foreign exchange forward contracts with Natura &Co Luxembourg, a subsidiary of Natura &Co Holding, to manage a portion of its foreign currency exchange rate exposures. At December 31, 2022, we had outstanding related party foreign exchange forward contracts with notional amounts totaling approximately $546.3 for various currencies for up to 12 months, of which $289.7 were designated as cash flow hedges. In addition we had $9.5 Accounts Receivable and $12.9 Accounts Payable recorded in our Consolidated Balance Sheets associated with these transactions, all of which are expected to be reclassified into earnings within the next 12 months. We may use foreign exchange forward contracts to manage foreign currency exposure of certain balance sheet items. The change in fair value of these items is immediately recognized in earnings and substantially offsets the foreign currency translation impact recognized in earnings relating to the associated balance sheet items. During the years ended December 31, 2022 and 2021, we recorded gains of $12.1 and losses of $.3, respectively, in other expense, net in our Consolidated Statements of Operations related to these undesignated foreign exchange forward contracts. Credit Risk of Financial Instruments Our foreign currency derivatives are typically comprised of over-the-counter forward contracts, swaps or options with major international financial institutions. Although our theoretical credit risk is the replacement cost at the then estimated fair value of these instruments, we believe that the risk of incurring credit risk losses is remote and that such losses, if any, would not be material. Non-performance of the counterparties on the balance of all the foreign exchange agreements would not have resulted in any write-off at December 31, 2022. In addition, in the event of non-performance by such counterparties, we would be exposed to market risk on the underlying items being hedged as a result of changes in foreign exchange rates.

Fair Value

Fair Value	12 Months Ended
	Dec. 31, 2022
Fair Value Disclosures [Abstract]
Fair Value	Fair Value Assets and Liabilities Recorded at Fair Value The fair value measurement provisions required by GAAP establish a fair value hierarchy, which prioritizes the inputs used in measuring fair value into three broad levels as follows: • Level 1 - Quoted prices in active markets for identical assets or liabilities. • Level 2 - Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly. • Level 3 - Unobservable inputs based on our own assumptions. Assets and Liabilities Recorded at Fair Value on a Recurring Basis The following table presents the fair value hierarchy for those assets and liabilities measured at fair value on a recurring basis at December 31, 2022: Level 1 Level 2 Total Assets: Foreign exchange forward contracts $ — $ .3 $ .3 Total $ — $ .3 $ .3 Liabilities: Foreign exchange forward contracts $ — $ — $ — Total $ — $ — $ — The following table presents the fair value hierarchy for those assets and liabilities measured at fair value on a recurring basis at December 31, 2021: Level 1 Level 2 Total Liabilities: Foreign exchange forward contracts $ — $ 2.7 $ 2.7 Total $ — $ 2.7 $ 2.7 Other than our defined benefit pension and postretirement plan assets, the assets and liabilities measured at fair value on a recurring basis are comprised of foreign exchange forward contracts (see Note 10, Financial Instruments and Risk Management) and available-for-sale securities, which were immaterial at December 31, 2022 and 2021. See Note 13, Employee Benefit Plans, for the fair value hierarchy for our plan assets. The available-for-sale securities include securities held in a trust in order to fund future benefit payments for non-qualified retirement plans (see Note 13, Employee Benefit Plans). Fair Value of Financial Instruments Our financial instruments include cash and cash equivalents, available-for-sale securities, short-term investments, accounts receivable, debt maturing within one year, accounts payable, long-term debt and foreign exchange forward contracts. The carrying value for cash and cash equivalents, accounts receivable, accounts payable and short-term investments approximate fair value because of the short-term nature of these instruments. The net asset (liability) amounts recorded in the balance sheet (carrying amount) and the estimated fair values of our remaining financial instruments at December 31 consisted of the following: 2022 2021 Carrying Fair Value Carrying Fair Value Available-for-sale securities $ — $ — $ — $ — Loans to affiliates of Natura &Co maturing within one year 72.2 72.2 46.6 46.6 Loans to affiliates of Natura &Co maturing after one year 54.8 54.8 46.7 46.7 Debt maturing within one year (5.7) (5.7) (32.6) (32.6) Loans from affiliates of Natura &Co maturing within one year (537.2) (537.2) (371.7) (371.7) Long-term debt (1) (214.8) (206.8) (676.0) (754.2) Loans from affiliates of Natura &Co maturing after one year (1,427.2) (1,427.2) (736.3) (736.3) Foreign exchange forward contracts .3 .3 (2.7) (2.7) (1) The carrying value of long-term debt is presented net of debt issuance costs and includes any related discount or premium, as applicable. The methods and assumptions used to estimate fair value are as follows: • Available-for-sale securities - The fair values of these investments were the quoted market prices for issues listed on securities exchanges. • Long-term debt - The fair values of our debt and other financing were determined using Level 2 inputs based on indicative market prices. • Foreign exchange forward contracts - The fair values of forward contracts were estimated based on quoted forward foreign exchange prices at the reporting date.

Share-Based Compensation Plans

Share-Based Compensation Plans	12 Months Ended
	Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]
Share-Based Compensation Plans	Share-Based Compensation PlansThe Avon Products, Inc. 2013 Stock Incentive Plan, as amended and restated (the "2013 Plan") and the Avon Products, Inc. 2016 Omnibus Incentive Plan (the "2016 Plan"), which are shareholder-approved plans, provide for several types of share-based incentive compensation awards including stock options, restricted stock, restricted stock units and performance restricted stock units. Following shareholder approval of the 2016 Plan in May 2016, there were no further awards made under the 2013 Plan. The 2016 Plan was amended and restated (the “Amended and Restated 2016 Plan”) following shareholder approval in May 2019. Under the Amended and Restated 2016 Plan, the maximum number of shares was amended to 20,451,976 shares of common stock, which includes 5,000,000 additional shares and 15,451,976 unused shares under the 2016 Plan as of March 15, 2019, where the maximum number of shares are reduced as follows: (i) in the case of the grant of an award of an option or SAR, by each share subject to such an award and (ii) in the case of the grant of an award payable in shares other than an option or SAR by 1.35 multiplied by each share subject to such an award. Shares issued under share-based awards will be primarily funded with issuance of new shares. We issued stock options and restricted stock under the 2016 Plan (including under the Amended and Restated 2016 Plan), and restricted stock units and performance restricted stock units under the 2013 Plan and the 2016 Plan (including under the Amended and Restated 2016 Plan). We also have outstanding stock options under our prior shareholder-approved plans. Stock option awards were granted with an exercise price generally at a premium to the closing market price of our stock at the date of grant. Stock options generally vest in thirds over the three-year period following each option grant date and have ten-year contractual terms. Restricted stock units granted to Associates generally vest and settle after three years. Restricted stock units awarded to non-management directors vest in approximately one year and settle upon a director's departure from the Board of Directors. Performance restricted stock units generally vest after three years only upon the satisfaction of certain market or performance conditions. On January 3, 2020, upon the completion of the Transaction with Natura &Co, our share-based compensation awards were either cancelled in exchange for the right to receive an amount in cash or converted into an award denominated in Natura &Co shares. Subsequent to the Transaction, the 2013 Plan and the 2016 Plan (including under the Amended and Restated 2016 Plan) were replaced by the Natura &Co Stock-Based Compensation Plan. Under the Natura &Co Stock-Based Compensation Plan, Natura has issued nominal cost options and performance share units ("performance shares" or "PSUs"). Nominal cost options were granted in exchange for Avon restricted stock units and performance restricted stock units and vest as a single tranche in line with the vesting date of the original Avon awards. Nominal cost options will automatically exercise on vest date. Performance share units generally vest after three years only upon the satisfaction of certain market and/or performance conditions. For the years ended December 31: 2022 2021 2020 Compensation cost for stock-based compensation $ 13.1 $ 13.4 $ 24.9 Total income tax (cost)/ benefit recognized for share-based arrangements .7 (.2) 1.9 All of the compensation cost for share based compensation for 2022, 2021 and 2020 was recorded in SG&A expenses in our Consolidated Statements of Operations. Stock Options During 2019 we granted premium-priced stock options, in which the exercise price was equal to a 25% premium from the closing market price of our stock price at the date of grant. The premium-priced stock options vest on a three-year graded vesting schedule. The fair value of each premium-priced stock option is estimated on the date of grant using a Monte-Carlo simulation. When estimating the fair value of each option, we used the following weighted-average assumptions for options granted during the year ended December 31, 2019: 2019 Risk-free rate (1) 2.4% Expected term (2) 7 years Expected Avon volatility (3) 45% Expected dividends —% (1) The risk-free rate was based upon the rate on a zero coupon U.S. Treasury bill, for periods within the contractual life of the option, in effect at the time of grant. (2) The expected term of the option was based on the vesting terms of the respective option and a contractual life of 10 years. (3) Expected Avon volatility was based on the daily historical volatility of our stock price, over a period similar to the expected life of the option. The weighted-average grant-date fair value per share of options granted was $1.13. On January 3, 2020, upon the completion of the Transaction with Natura &Co, each of the approximately 14.9 million outstanding stock options, whether or not then vested or exercisable, was automatically canceled in exchange for the right to receive an amount in cash, without interest, equal to the number of Avon Common Shares underlying such stock option immediately prior to the effective time of the Transaction multiplied by the excess, if any, of the per share cash-out price over the exercise price per share. The “per share cash out price” was the closing price of an Avon Common Share on the NYSE on the closing date of the Transaction. No amount was payable upon cancellation of stock option with an exercise price per share that is greater than the per share cash-out price. In accordance with ASC 718, Stock-based compensation, we have accounted for the cash settlement as a repurchase of an equity instrument concurrent with the acceleration of vesting of the award. Options that were cancelled without compensation were treated as a repurchase of equity for no consideration. The cash settlement value of $20.5 was recognized through equity and $3.5 of unrecognized compensation expense of the unvested options was accelerated and recorded in SG&A expenses in our Consolidated Statements of Operations. We recognized expense on stock options using a graded vesting method, which recognizes the associated expense based on the timing of option vesting dates. At December 31, 2022 and 2021, there were no outstanding stock options as they were cancelled as per above. Restricted Stock Units and Performance Restricted Stock Units During 2019 we granted performance restricted stock units that would vest and settle after three years based on the relative total shareholder return of our common stock against companies included in the S&P 400 index as of the date of grant over a three year performance period ("2019 PRSUs"). The grant date fair value per share of these awards already reflects the estimated probability of achieving the market condition, and therefore we record the expense ratably over the performance period. The fair value of the PRSUs was estimated on the date of grant using a Monte-Carlo simulation that estimates the fair value based on the Company's share price activity, expected term of the award, risk-free interest rate, expected dividends and the expected volatility of the stock of the Company. When estimating the fair value of the PRSUs, we used the following weighted-average assumptions: 2019 PRSUs Risk-free rate (1) 2.4% Expected Avon volatility (2) 54.8% Expected average volatility (3) 29.9% Expected dividends —% (1) The risk-free rate was based upon the rate on a zero coupon U.S. Treasury bill, for periods within the three year performance period, in effect at the time of grant. (2) Expected Avon volatility was based on the weekly historical volatility of our stock price, over a period similar to the three year performance period of the 2019 PRSUs. (3) Expected average volatility was based on the weekly historical volatility of the stock prices of each member of companies included in the S&P 400 index as of the date of the grant, over a period similar to the three year performance period of the 2019 PRSUs. The weighted-average grant-date fair value per share of the 2019 PRSUs was $2.63. On January 3, 2020, upon the completion of the Transaction with Natura &Co, each of the approximately 4.4 million outstanding Restricted Stock Units ("RSU") was converted into Natura &Co Holding nominal cost options equal to the number of Avon Common Shares subject to each RSU immediately prior to the Transaction multiplied by the Exchange Ratio of 0.30. In addition, each of the approximately 3.0 million outstanding PRSUs was converted into an award denominated in Natura &Co Holding Shares, that is subject only to time-based vesting, equal to the number of Avon Common Shares subject to each PRSU immediately prior to the Transaction, giving effect to market conditions that are deemed to be attained, multiplied by the Exchange Ratios of 0.30. The terms and conditions, including service conditions but excluding market conditions, applicable to each RSU and PRSU will continue in full force and effect with respect to the nominal cost options as described below. In accordance with ASC 718, Stock-based compensation , we accounted for the modification as a Type I (probable-to-probable) modification and the incremental fair value of approximately $3.4 will be recognized over the remaining service period of the awards. At December 31, 2022 and 2021, there were no outstanding RSUs and PRUs as they were exchanged for Natura &Co Holding Nominal Cost Options. Natura &Co Holding options As discussed above, each outstanding Avon RSU and PRSU at the time of the Transaction was exchanged for Natura &Co Holding Options. These options vest in a single tranche in line with the original vesting schedule of three years and will automatically exercise on the vest date. We accounted for the exchange as a Type I (probable-to-probable) modification where the cumulative amount of the compensation cost that should be recognized over the vesting period is the original grant-date fair value plus incremental fair value of $3.4 resulting from the modification. During 2022, Natura &Co granted employees of the Company and its subsidiaries a further 355,000 cost options with a weighted-average grant date fair value of $3.38 per unit. These 2022 options normally vest in two tranches of three A summary of options at December 31, 2022 and changes during 2022, is as follows: Nominal cost options Weighted-Average January 1, 2022 2,326 $ 10.00 Granted 355 3.38 Exercised (902) (12.36) Forfeited (77) (9.13) Modified from option to restricted units 1 (550) $ (8.73) Outstanding at December 31, 2022 1,152 $ 6.78 We recognize expense over the requisite service period. At December 31, 2022, there was $4.1 of unrecognized compensation cost related to options outstanding. That cost is expected to be recognized over a weighted-average period of 2.25 years. Natura &Co Holding Performance Share Units (PSUs) and Restricted Share Units (RSUs) On March 27, 2020, Natura &Co’s Board of Directors approved the new long-term stock-based incentive plan (the “Long-Term Incentive Plan”) for 2020. The Long-Term Incentive Plan consists of the granting of PSUs, the rights of participants in relation to the PSUs will only be fully acquired to the extent that (i) the participant remains continuously linked as an employee of the Company and its subsidiaries until the 3rd anniversary of the grant date; and (ii) performance conditions are met. For certain participants, there is a different condition for item (i) above, in which 50% of the PSUs granted will be acquired on the 3rd anniversary of the grant date and the remaining 50% will be acquired on the 4th anniversary of the grant date. In 2022, stock options, restricted shares and performance shares were granted pursuant to the “Co-Investment Plan” or “Long Term Incentive Plan”. Under the “Co-Investment Plan”, eligible employees may invest part of their payout from the Profit Share Program in the purchase of Natura &Co Holding’s shares. Natura &Co Holding will then grant awards ("Matching Awards”) to match such purchased shares on a 1:1 ratio. The Matching Awards vest in 3 equal installments over three years, subject to remaining in employment. Under the “Long-Term Incentive Plan”, Natura &Co Holding’s shares are awarded to eligible employees. Certain “Long-Term Incentive Plan” awards are only subject to a requirement to remain in employment over the vesting period, whereas the awards referred to as “Performance Shares” are subject to both a requirement to remain employed over the vesting period and meeting certain performance conditions. During 2022 and 2021, Natura &Co granted 1,226,298 and 627,983 PSUs respectively with a weighted-average grant date fair value of $9.96 and $17.32 per unit respectively. A summary of performance share units at December 31, 2022 and changes during 2022, is as follows: Performance Share Units Weighted-Average January 1, 2022 1,854 $ 19.78 Granted 1,226 9.96 Exercised (2) (16.99) Forfeited (563) (16.31) Modified from option to restricted units (refer footnote 1) 550 $ 5.82 Outstanding at December 31, 2022 3,065 $ 15.03 We recognize expense over the requisite service period to the extent that it is expected that the performance conditions are probable of being achieved. At December 31, 2022, there was $25.9 of unrecognized compensation cost related to the PSUs outstanding. That cost is expected to be recognized over a weighted-average period of 1.5 years. Restricted Stock In December 2019, 2,083,872 RSUs and 3,276,774 PRSUs were exchanged for 4,808,534 Restricted Stock. The exchange was done in advance of the Transaction with Natura &Co Holding. The Company accounted for the modification as a Type I (probable-to-probable) modification and the incremental fair value of approximately $1.5 will be recognized over the remaining service period of the awards. The Restricted Stock would vest and settle after three years from the grant date of the original award. The Company retained and cancelled 1,400,010 Restricted Stock to satisfy withholding tax obligations of the grantees. The cancellation resulted in the acceleration and recognition of $1.7 of compensation cost for the year ended December 31, 2019 and was included as part of the $44 of Transaction related costs. On January 3, 2020, upon the completion of the Transaction with Natura & Co, the 3,408,524 Restricted Stock outstanding was converted at the exchange ratio of 0.30 into an award denominated in Natura &Co Holding equity. The terms and conditions, including service-based vesting conditions, continue in full force and effect with respect to such award of Natura &Co Holding Restricted Stock. During January 2020, it was announced that the employment of certain senior officers of the Company would be terminated, in connection with the Transaction. As a result, Restricted Stock held by these senior officers immediately vested and we recognized approximately $10 relating to the acceleration of unamortized expense. Restricted Stock Units and Performance Restricted Stock Units Funded With Treasury Shares In March 2019 and March 2018, we granted 200,000 and 200,000 performance restricted stock units, respectively, that will be funded with treasury shares, outside of the 2016 Plan, in reliance upon the NYSE rules. These performance restricted stock units have a weighted-average grant-date fair value of $2.98 and $2.79 for the 2019 and 2018 grants respectively, and would vest and settle at the end of 2020 only upon the satisfaction of certain performance conditions over a one year performance period. During 2019 none of these performance restricted stock units vested, and 400,000 performance restricted stock units were outstanding at December 31, 2019. During 2019 we recognized compensation cost of $.5, for these performance restricted stock units. In February 2018 we granted 600,000 restricted stock units that will be funded from treasury shares, outside of our shareholder-approved plans, in reliance upon the NYSE rules. The restricted stock units granted in February 2018 have a weighted-average grant-date fair value of $2.25 and vest and settle in full after three years. During 2019 none of these restricted stock units vested, and there were 600,000 restricted stock units outstanding at December 31, 2019. During 2019 we recognized compensation cost of $.4 for these restricted stock units. As at December 31, 2019, there were no outstanding RSUs or PRSUs funded with Treasury Shares as they were all exchanged for Avon Restricted Stock. During 2020 all Avon Restricted Stock was exchanged for Natura Restricted Stock, as described above.

Employee Benefit Plans

Employee Benefit Plans	12 Months Ended
	Dec. 31, 2022
Retirement Benefits, Description [Abstract]
Employee Benefit Plans	Employee Benefit Plans Defined Contribution Plans We offer a defined contribution plan for employees in the United Kingdom ("UK"), which allows eligible participants to contribute eligible compensation through payroll deductions. We double employee contributions up to the first 5% of eligible compensation and therefore the maximum level provided by Avon is 10% of eligible compensation. We made matching contributions in cash to the UK defined contribution plan of $6.5 in 2022, $8.1 in 2021 and $7.6 in 2020, which follow the same investment allocation that the participant has selected for his or her own contributions. We also offer a qualified defined contribution plan for U.S.-based employees, the Avon Personal Savings Account Plan (the "PSA"), which allows eligible participants to contribute up to 25% of eligible compensation through payroll deductions. We match employee contributions dollar for dollar up to the first 3% of eligible compensation and fifty cents for each dollar contributed from 4% to 6% of eligible compensation. We made matching contributions in cash to the PSA of $.8 in 2022, $0.9 in 2021 and $1.0 in 2020, which follow the same investment allocation that the participant has selected for his or her own contributions. Prior to the separation of the North America business, the costs associated with the contributions to the PSA were allocated between Discontinued Operations and Global as the plan included both North America and U.S. Corporate Avon associates. See Note 3, Discontinued Operations and Assets and Liabilities Held for Sale. For U.S.-based employees hired on or after January 1, 2015, we made additional contributions to a Retirement Savings Account ("RSA") within the PSA. Such contributions will range from 3% to 6% of a participant's eligible compensation depending on the sum of the participant's age and length of service (as of December 31 of the prior year). Investment of such contributions will follow the same investment allocation that the participant has selected for his or her own contributions to the PSA. A participant will be vested in the RSA generally after three Defined Benefit Pension and Postretirement Plans Avon and certain subsidiaries have contributory and noncontributory defined benefit retirement plans for substantially all employees of those subsidiaries. Benefits under these plans are generally based on an employee’s length of service and average compensation near retirement, and certain plans have vesting requirements. Plans are funded based on legal requirements and cash flow. Our largest non-U.S. defined benefit pension plan is in the UK. The UK defined benefit pension plan was frozen for future accruals as of April 1, 2013. The U.S. defined benefit pension plan, the Avon Products, Inc. Personal Retirement Account Plan (the "PRA"), is closed to employees hired on or after January 1, 2015. Qualified retirement benefits for U.S.-based employees hired on or after January 1, 2015 will be provided solely through the PSA, as described above. Following the separation of the North America business (see further Note 3, Discontinued Operations and Assets and Liabilities Held for Sale), we continue to retain certain U.S. pension and other postretirement liabilities primarily associated with employees who are actively employed by Avon in the U.S. providing services other than with respect to the North America business. We recognize the funded status of defined benefit pension and other postretirement benefit plans on the balance sheet. Each overfunded plan is recognized as an asset and each underfunded plan is recognized as a liability. The recognition of prior service costs or credits and net actuarial gains or losses, as well as subsequent changes in the funded status, are recognized as components of AOCI, net of tax, in shareholders’ equity, until they are amortized as a component of net periodic benefit cost. We recognize prior service costs or credits and actuarial gains and losses beyond a 10% corridor to earnings based on the estimated future service period of the participants. The determination of the 10% corridor utilizes a calculated value of plan assets for our more significant plans, whereby gains and losses are smoothed over three Reconciliation of Benefit Obligations, Plan Assets and Funded Status The following table summarizes changes in the benefit obligation, plan assets and the funded status of our significant defined benefit pension and postretirement plans. We use a December 31 measurement date for all of our employee benefit plans. Pension Plans U.S. Plans Non-U.S. Plans Postretirement Benefits 2022 2021 2022 2021 2022 2021 Change in Benefit Obligation: Beginning balance $ (60.3) $ (67.9) $ (671.2) $ (767.5) $ (9.7) $ (7.7) Service cost (.8) (.9) (2.9) (4.3) — — Interest cost (1.7) (1.0) (11.0) (8.7) (.3) (.3) Actuarial gain (loss) 9.5 1.8 185.1 54.6 .8 .4 Benefits paid 6.7 7.7 22.2 25.7 2.3 .6 Actual expenses and taxes — — .4 .4 — — Curtailments (.4) — — .2 — — Settlements — — .4 1.8 — — Special termination benefits — — — — — (3.0) Foreign currency changes and other — — 58.2 13.5 (.3) .3 Sale of Avon Luxembourg — — — 13.1 — — Ending balance $ (47.0) $ (60.3) $ (418.8) $ (671.2) $ (7.2) $ (9.7) Change in Plan Assets: Beginning balance $ 54.3 $ 59.7 $ 764.4 $ 762.0 $ — $ — Actual return on plan assets (11.6) 1.6 (177.7) 29.3 — — Company contributions .7 0.7 (3.1) 10.1 2.3 .6 Benefits paid (6.7) (7.7) (22.2) (25.7) (2.3) (.6) Actual expenses and taxes — — (.4) (0.4) — — Settlements — — (0.4) (1.8) — — Transfers — — — — — — Foreign currency changes and other — — (70.6) (9.1) — — Ending balance $ 36.7 $ 54.3 $ 490.0 $ 764.4 $ — $ — Funded Status: Funded status at end of year $ (10.3) $ (6.0) $ 71.2 $ 93.2 $ (7.2) $ (9.7) Amount Recognized in Balance Sheet: Other assets $ — $ — $ 110.8 $ 162.4 $ — $ — Accrued compensation (.8) (.7) (1.2) (1.2) (4.2) (6.3) Employee benefit plans liability (9.5) (5.3) (38.4) (68.0) (3.0) (3.4) Net amount recognized $ (10.3) $ (6.0) $ 71.2 $ 93.2 $ (7.2) $ (9.7) Pretax Amounts Recognized in Accumulated Other Comprehensive Loss: Net actuarial loss $ 16.8 $ 14.7 $ 115.3 $ 122.8 — $ 0.8 Prior service (credit) cost — — 1.7 2.0 (.7) (0.8) Total pretax amount recognized $ 16.8 $ 14.7 $ 117.0 $ 124.8 $ (.7) $ — Supplemental Information: Accumulated benefit obligation $ 46.6 $ 59.5 $ 108.2 $ 159.4 N/A N/A Plans with Projected Benefit Obligation in Excess of Plan Assets: Projected benefit obligation $ 47.1 $ 60.3 $ 115.9 $ 170.0 N/A N/A Fair value plan assets 36.7 54.3 76.3 100.8 N/A N/A Plans with Accumulated Benefit Obligation in Excess of Plan Assets: Accumulated benefit obligation 46.6 59.5 103.4 153.6 N/A N/A Fair value plan assets 36.7 54.3 68.5 91.7 N/A N/A For the years ended December 31, 2022 and 2021, actuarial gains on benefit obligations were primarily due to an increase in discount rates for all plans. For the year ended December 31, 2020, actuarial losses on the benefit obligations were primarily due to a decrease in discount rates for all plans. The U.S. pension plans include a funded qualified plan (the PRA) and unfunded non-qualified plans. At December 31, 2022, the PRA had benefit obligations of $41.5 and plan assets of $36.7. At December 31, 2021, the PRA had benefit obligations of $53.6 and plan assets of $54.3. We believe we have adequate investments and cash flows to fund the liabilities associated with the unfunded non-qualified plans. The Non-U.S. pension plans include a funded qualified pension plan in the UK. At December 31, 2022, the UK qualified pension plan had benefit obligations of $295.6 and plan assets of $404.3. At December 31, 2021, the UK qualified pension plan had benefit obligations of $492.0 and plan assets of $653.6. Components of Net Periodic Benefit Cost and Other Amounts Recognized in Other Comprehensive Loss Pension Benefits U.S. Plans Non-U.S. Plans Postretirement Benefits 2022 2021 2020 2022 2021 2020 2022 2021 2020 Net Periodic Benefit Cost: Service cost $ .8 $ .9 $ 1.2 $ 2.9 $ 4.3 $ 4.3 $ — $ — $ — Interest cost 1.7 1.0 1.4 11.0 8.7 11.7 .3 .3 .7 Expected return on plan assets (2.1) (2.0) (2.6) (14.2) (16.0) (16.0) — — — Amortization of prior service credit — — — .1 — (.1) (.1) (4.5) (.2) Amortization of net actuarial losses 1.1 2.4 2.9 4.1 7.5 6.3 .1 .7 — Amortization of transition obligation — — — — — — — — — Settlements/curtailments 1.5 1.0 2.6 — .1 .1 — — — Special termination benefits — — — — — — — 3.0 (4.2) Net periodic benefit cost $ 3.0 $ 3.3 $ 5.5 $ 3.9 $ 4.6 $ 6.3 $ .3 $ (.5) $ (3.7) Other Changes in Plan Assets and Benefit Obligations Recognized in Other Comprehensive (Loss) Income: Actuarial losses (gains) $ 4.6 $ (1.4) $ .8 $ 6.8 $ (68.1) $ 15.9 $ (.7) $ (.4) $ 1.5 Prior service cost (credit) — — — (.1) — — .1 4.5 (4.1) Amortization of prior service credit — — — — — — — — .2 Amortization of net actuarial losses (2.6) (3.4) (5.5) (4.1) (7.6) (6.4) (.1) (.7) (1.6) Foreign currency changes — — — (10.5) (5.9) 11.6 — — — Total recognized in other comprehensive loss* $ 2.0 $ (4.8) $ (4.7) $ (7.9) $ (81.6) $ 21.1 $ (.7) $ 3.4 $ (4.0) Total recognized in net periodic benefit cost and other comprehensive loss $ 5.0 $ (1.5) $ .8 $ (4.0) $ (77.0) $ 27.4 $ (.4) $ 2.9 $ (7.7) * Amounts represent the pre-tax effect classified within other comprehensive loss. The net of tax amounts are classified within our Consolidated Statements of Comprehensive Loss. Assumptions Weighted-average assumptions used to determine benefit obligations recorded in our Consolidated Balance Sheets as of December 31 were as follows: Pension Benefits Postretirement U.S. Plans Non-U.S. Plans Benefits 2022 2021 2022 2021 2022 2021 Discount rate 5.19 % 2.81 % 4.79 % 2.09 % 7.67 % 3.61 % Rate of compensation increase 4.00 % 4.00 % 3.16 % 2.56 % N/A N/A Interest crediting rate 3.99 % 1.78 % 2.74 % 2.75 % N/A N/A The discount rate used for determining the present value of future pension obligations for each individual defined benefit pension plan is based on a review of bonds that receive a high-quality rating from a recognized rating agency. The discount rates for our more significant plans, including the UK defined benefit pension plan and the PRA, were based on the internal rates of return for a portfolio of high-quality bonds with maturities that are consistent with the projected future benefit payment obligations of each plan. The weighted-average discount rate for U.S. and non-U.S. defined benefit pension plans determined on this basis has increased to 4.83% at December 31, 2022, from 2.15% at December 31, 2021. Weighted-average assumptions used to determine net benefit cost recorded in our Consolidated Statements of Operations for the years ended December 31 were as follows: Pension Benefits U.S. Plans Non-U.S. Plans Postretirement Benefits 2022 2021 2020 2022 2021 2020 2022 2021 2020 Discount rate 2.81 % 2.42 % 3.16 % 1.97 % 1.45 % 2.05 % 3.61 % 3.95 % 3.66 % Rate of compensation increase 4.00 % 4.00 % 4.00 % 2.38 % 2.51 % 2.54 % N/A N/A N/A Rate of return on assets 4.60 % 4.15 % 4.90 % 2.19 % 2.32 % 2.55 % N/A N/A N/A Interest crediting rate 1.94 % 1.49 % 2.49 % 2.75 % 2.74 % 2.69 % N/A N/A N/A In determining the long-term rates of return, we consider the nature of each plan’s investments, an expectation for each plan’s investment strategies, historical rates of return and current economic forecasts, among other factors. We generally evaluate the expected rate of return on plan assets annually and adjust as necessary. In determining the net cost for the year ended December 31, 2022, the assumed rate of return on assets globally was 2.35%, which represents the weighted-average rate of return on all plan assets. A significant portion of our pension plan assets relate to the UK defined benefit pension plan. The assumed rate of return for determining 2022 net periodic benefit cost for the UK defined benefit pension plan was 1.90%. In addition, the 2022 rate of return assumption for the UK defined benefit pension plan was based on an asset allocation of approximately 94% in liability driven investments, and approximately 6% in equity securities, emerging market debt and high yield securities. In addition to the physical assets, the asset portfolio for the UK defined benefit pension plan has derivative instruments which increase our exposure to fixed income (in order to better match liabilities). Similar assessments were performed in determining rates of return on other non-U.S. defined benefit pension plan assets, to arrive at our weighted-average assumed rate of return of 2.19% for determining 2022 net cost for all non-US defined benefit pension plan assets. Plan Assets Our U.S. and non-U.S. funded defined benefit pension plans target and weighted-average asset allocations at December 31, 2022 and 2021, by asset category were as follows: U.S. Pension Plan Non-U.S. Pension Plans % of Plan Assets % of Plan Assets Target at Year-End Target at Year-End Asset Category 2023 2022 2021 2023 2022 2021 Equity securities 30 % 31 % 30 % 17 % 18 % 23 % Debt securities 70 69 70 60 86 72 Other — — — 23 (4) 5 Total 100 % 100 % 100 % 100 % 100 % 100 % The following tables present the fair value hierarchy for pension assets measured at fair value on a recurring basis at December 31, 2022 : U.S. Pension Plan Asset Category Level 1 Level 2 Total Equity Securities: Domestic equity $ — $ 5.6 $ 5.6 International equity — 5.7 5.7 Emerging markets — — — — 11.3 11.3 Fixed Income Securities: Corporate bonds — 15.2 15.2 Government securities — 5.1 5.1 Other — 5.1 5.1 — 25.4 25.4 Other Cash — — — — — — Total $ — $ 36.7 $ 36.7 Non-U.S. Pension Plans Asset Category Level 1 Level 2 Level 3 Total Equity Securities: Domestic equity $ — $ 20.6 $ — $ 20.6 International equity — 67.9 — 67.9 — 88.5 — 88.5 Fixed Income Securities: Corporate bonds — 140.0 — 140.0 Government securities — 189.2 — 189.2 Other — 92.1 — 92.1 — 421.3 — 421.3 Other Cash 1.4 — — 1.4 Derivatives — (23.4) — (23.4) Real estate — — 2.1 2.1 Other — — .1 .1 1.4 (23.4) 2.2 (19.8) Total $ 1.4 $ 486.4 $ 2.2 $ 490.0 The following tables present the fair value hierarchy for pension assets measured at fair value on a recurring basis at December 31, 2021: U.S. Pension Plan Asset Category Level 1 Level 2 Total Equity Securities: Domestic equity $ — $ 8.3 $ 8.3 International equity — 6.6 6.6 Emerging markets — 1.6 1.6 — 16.5 16.5 Fixed Income Securities: Corporate bonds — 21.6 21.6 Government securities — 8.8 8.8 Other — 7.3 7.3 — 37.7 37.7 Cash — .1 .1 Total $ — $ 54.3 $ 54.3 Non-U.S. Pension Plans Asset Category Level 1 Level 2 Level 3 Total Equity Securities: Domestic equity $ — $ 29.4 $ — $ 29.4 International equity — 145.2 — 145.2 — 174.6 — 174.6 Fixed Income Securities: Corporate bonds — 257.6 — 257.6 Government securities — 256.9 — 256.9 Other — 36.5 — 36.5 — 551.0 — 551.0 Other: Cash 34.3 — — 34.3 Derivatives — 2.2 — 2.2 Real estate — — 2.3 2.3 34.3 2.2 2.3 38.8 Total $ 34.3 $ 727.8 $ 2.3 $ 764.4 A reconciliation of the beginning and ending balances for our Level 3 investments is provided in the table below: Amount Balance at January 1, 2021 $ 1.6 Balance at December 31, 2021 2.3 Actual return on plan assets held (.2) Balance at December 31, 2022 2.1 Investments in equity securities classified as Level 1 in the fair value hierarchy are valued at quoted market prices. Investments in equity securities classified as Level 2 in the fair value hierarchy include collective funds that are valued at quoted market prices for non-active securities. Fixed income securities are based on broker quotes for non-active securities. Mutual funds are valued at quoted market prices. Real estate is valued by reference to investment and leasing transactions at similar types of property, supplemented by third party appraisals. Derivative instruments are not publicly traded, and each derivative contract is specifically negotiated with a unique financial counterparty. The derivative instruments are valued based upon valuation statements received from the financial counterparties, which use underlying yield curves or market indices. The overall objective of the plan assets associated with the PRA and the UK defined benefit pension plan is to provide the means to pay benefits to participants and their beneficiaries in the amounts and at the times called for by the plan. This is expected to be achieved through the investment of our contributions and other trust assets and by utilizing investment policies designed to achieve adequate funding over a reasonable period of time. In some of our defined benefit pension plans, we have adopted investment strategies which are designed to match the movements in the pension liability through an increased allocation towards debt securities. In addition, we also utilize derivative instruments in our UK defined benefit pension plans to hedge certain risks. Derivative instruments may include, but are not limited to, futures, options, swaps or swaptions. Investment types, including the use of derivatives are based on written guidelines established for each investment manager and monitored by the plan's investment committee. Pension trust assets are invested so as to achieve a return on investment, based on levels of liquidity and investment risk that are prudent and reasonable as circumstances change from time to time. While we recognize the importance of the preservation of capital, we also adhere to the theory of capital market pricing which maintains that varying degrees of investment risk should be rewarded with compensating returns. Consequently, prudent risk-taking is justifiable. The asset allocation decision includes consideration of the non-investment aspects of the PRA and the UK defined benefit pension plan, including future retirements, lump-sum elections, growth in the number of participants, company contributions, and cash flow. These characteristics of the plan place certain demands upon the level, risk, and required growth of trust assets. We regularly conduct analyses of the plan’s current and likely future financial status by forecasting assets, liabilities, benefits and company contributions over time. In so doing, the impact of alternative investment policies upon the plan’s financial status is measured and an asset mix which balances asset returns and risk is selected. Our decision with regard to asset mix is reviewed periodically. Asset mix guidelines include target allocations and permissible ranges for each asset category. Assets are monitored on an ongoing basis and rebalanced as required to maintain an asset mix within the permissible ranges. The guidelines will change from time to time, based on an ongoing evaluation of the factors discussed above. Cash flows We expect to make contributions related to continuing operations in the range of $5 to $10 to our defined benefit pension and postretirement plans during 2023. Total benefit payments expected to be paid from the plans are as follows: Pension Benefits U.S. Plans Non-U.S. Plans Total Postretirement 2023 $ 7.1 $ 23.2 $ 30.3 $ 4.2 2024 8.9 25.2 34.1 0.3 2025 3.7 162.0 165.7 0.3 2026 2.5 25.5 28.0 0.3 2027 2.4 27.1 29.5 0.3 2028-2032 14.0 135.3 149.3 1.4 Postemployment Benefits We provide postemployment benefits, which include salary continuation, severance benefits, disability benefits and continuation of health care benefits to eligible former employees. The accrued cost for such postemployment benefits was $2.2 at December 31, 2022 and $6.5 at December 31, 2021 and was included in employee benefit plans in our Consolidated Balance Sheets. Supplemental Retirement Programs In the U.S., in addition to qualified retirement plans (i.e., the PSA and the PRA), we also maintain unfunded non-qualified plans. We offer a non-qualified deferred compensation plan, the Avon Products, Inc. Deferred Compensation Plan (the "DCP"), for certain higher paid key employees. The DCP is an unfunded, unsecured plan for which obligations are paid to participants out of our general assets. The DCP allows for the deferral of up to 50% of a participant’s base salary, the deferral of up to 100% of incentive compensation bonuses, and the deferral of contributions that would normally have been made to the PSA but are not deferred because the amount was in excess of U.S. Internal Revenue Code limits on contributions to the PSA. Participants may elect to have their deferred compensation invested in one or more of three permitted investment alternatives. Expense associated with the DCP was zero in 2022, zero in 2021 and $.1 in 2020. The benefit obligation under the DCP was $.6 at December 31, 2022, $.7 at December 31, 2021 and $.8 at December 31, 2020 and was included in other liabilities and accrued compensation in our Consolidated Balance Sheets. The Transaction triggered a change of control provision in the DCP, resulting in the settlement of the majority of the obligation in 2020. We maintain supplemental retirement programs consisting of the Supplemental Executive Retirement Plan of Avon Products, Inc. ("SERP") and the Benefit Restoration Pension Plan of Avon Products, Inc. ("BRP") under which non-qualified supplemental pension benefits are paid to higher paid key employees in addition to amounts received under our qualified defined benefit retirement plan, which is subject to IRS limitations on covered compensation. The SERP has not been offered to new employees in the last ten years, and the BRP is closed to employees hired on or after January 1, 2015 in conjunction with the closure of the PRA. The annual cost of these programs has been included in the determination of the net periodic benefit cost shown previously and amounted to $.9 in 2022, $1.0 in 2021 and $1.2 in 2020. The benefit obligation under these programs was $5.6 at December 31, 2022 and $6.7 at December 31, 2021 and was included in employee benefit plans and accrued compensation in our Consolidated Balance Sheets. We also maintain a Supplemental Life Plan ("SLIP") under which additional death benefits are provided to certain active and retired officers. The SLIP has not been offered to new officers in over ten years. We established a grantor trust to provide assets that may be used for the benefits payable under the SERP and SLIP. The trust is irrevocable and, although subject to creditors’ claims, assets contributed to the trust can only be used to pay such benefits with certain exceptions. The assets held in the trust are included in other assets and at December 31 consisted of the following: 2022 2021 Corporate-owned life insurance policies $ 23.1 $ 24.6 Cash and cash equivalents 5.4 5.8 Total $ 28.5 $ 30.4 The assets are recorded at fair market value, except for investments in corporate-owned life insurance policies which are recorded at their cash surrender values as of each balance sheet date, which is a proxy of fair value. Changes in the cash surrender value during the period are recorded as a gain or loss within SG&A expenses in our Consolidated Statements of Operations.

Segment Information

Segment Information	12 Months Ended
	Dec. 31, 2022
Segment Reporting [Abstract]
Segment Information	Segment InformationWe determine segment profit by deducting the related costs and expenses from segment revenue. Segment profit includes an allocation of central expenses to the extent they support the operating activity of the segment. Segment profit excludes certain CTI restructuring initiatives, certain significant asset impairment charges, and other expenses, which are not allocated to a particular segment, if applicable. This is consistent with the manner in which we assess our performance and allocate resources. Summarized financial information concerning our reportable segments as of December 31 is shown in the following tables: Total Revenue 2022 2021 2020 Avon International (1) $ 1,415.9 $ 1,724.6 $ 1,772.6 Avon Latin America (2) 1,331.6 1,654.7 1,845.9 Total revenue from reportable segments (3) 2,747.5 3,379.3 3,618.5 Revenue from affiliates to Natura &Co 21.7 25.2 6.7 Total revenue $ 2,769.2 $ 3,404.5 $ 3,625.2 Operating (Loss) Profit 2022 2021 2020 Segment Profit Avon International (1) $ 60.4 $ 49.9 $ 27.4 Avon Latin America (2) (111.4) (10.9) (39.1) Total (loss) profit from reportable segments (4) (8) (51.0) 39.0 (11.7) Unallocated global expenses (5) (23.2) (27.0) (11.6) Certain Brazil Indirect taxes (6) — (1.7) 10.6 CTI restructuring initiatives (68.6) (68.7) (23.7) Costs related to the Transaction (7) — — (85.8) Impairment of goodwill (9) (35.8) — — Operating (loss) profit $ (178.6) $ (58.4) $ (122.2) (1) In June 2022, an Avon subsidiary concluded the negotiation of a settlement agreement to resolve a breach of contract dispute in Japan. As a result, Avon received cash compensation of $27, $3.3 of which related to the settlement of historically recognized revenues. The remaining $23.7 was recognized as revenue in the second quarter of 2022. (2) 2022 includes the impact of certain Brazil indirect taxes, which was recorded in product sales in the amount of approximately $10 in our Consolidated Income Statements. 2021 includes the impact of certain Brazil indirect taxes, which was recorded in product sales in the amount of approximately $21 in our Consolidated Income Statements. See Note 19 Supplemental Balance Sheet Information. (3) Total revenue from reportable segments also includes revenue from other business activities of $0.5, $4.7 and $14.5 for the years ended December 31, 2022, 2021 and 2020, respectively, allocated to Avon International and Avon Latin America segments. Other business activities include revenue from the sale of products to New Avon since the separation of the Company’s North America business into New Avon on March 1, 2016 and ongoing royalties from the licensing of our name and products. Previously reported amounts have been allocated to Avon International and Avon Latin America segments to conform to the current year presentation. (4) Total profit from reportable segments also includes profit from other business activities and central expenses allocated to Avon International and Avon Latin America segments. Other business activities of $0.5, $1.5 and $7.3 for the years ended December 31, 2022, 2021 and 2020, respectively, include profit from the sale of products to New Avon since the separation of the Company’s North America business into New Avon on March 1, 2016 and ongoing royalties from the licensing of our name and products. Central expenses of $96.7, $206.7 and $197.6 for the years ended December 31, 2022, 2021 and 2020, respectively, include corporate general and administrative expenses allocated to Avon International and Avon Latin America to the extent they support the operating activity of the segment. Previously reported amounts have been allocated to segments to conform to the current year presentation. (5) For the years ended December 31, 2022, 2021 and 2020, unallocated global expenses primarily include stewardship and other expenses not directly attributable to reportable segments. (6) The year ended December 31, 2022 includes the impact of certain Brazil indirect taxes in the amount of nil. The year ended December 31, 2021 includes the impact of certain Brazil indirect taxes, which were recorded in selling, general and administrative expenses, net in the amounts of approximately $2. (7) For the year ended December 31, 2020, costs related to the Transaction primarily include professional fees of approximately $46, severance payments of approximately $25 and acceleration of share based compensation of approximately $10 relating to these terminations triggered by change in control provisions. Refer to Note 20, Merger with Natura Cosméticos S.A. for more information relating to the Natura transaction. (8) On July 1, 2021, the Company sold Avon Luxembourg, including our Mexican business, to a subsidiary of Natura &Co Holding. As a result, from the same date, the results of Avon Luxembourg are no longer included within Avon's consolidated results. The year ended December 31, 2021 includes the results of Avon Luxembourg for the period from January 1 to June 30, 2021. The years ended December 31, 2020 include the results of Avon Luxembourg. (9) During the 2022 year-end close process, our analysis of the Colombia business indicated an impairment as the carrying value of the business exceeded the estimated fair value. This was primarily the result of reducing our long-term projections of the business as it continued to experience challenging trading and economic conditions as a result of the continuing economic disruption caused by the COVID-19 pandemic and subsequent inflationary pressures compounded by the ongoing war between Ukraine and Russia. Accordingly, a non-cash impairment charge of $35.8 was recorded to reduce the carrying amount of goodwill. Total Assets 2022 2021 2020 Avon International $ 1,308.2 $ 1,362.0 $ 1,364.4 Avon Latin America (1) 853.5 945.8 1,199.9 Total assets $ 2,161.7 $ 2,307.8 $ 2,564.3 (1) On July 1, 2021, the Company sold Avon Luxembourg, including our Mexican business, to a subsidiary of Natura &Co Holding. As a result, balances at December 31, 2021 do not include the assets of Avon Luxembourg. Balances at December 31, 2020 include the assets of Avon Luxembourg. Capital Expenditures 2022 2021 2020 Avon International $ 39.5 $ 53.3 $ 36.0 Avon Latin America (1) 14.0 15.0 8.6 Total capital expenditures $ 53.5 $ 68.3 $ 44.6 (1) On July 1, 2021, the Company sold Avon Luxembourg, including our Mexican business, to a subsidiary of Natura &Co Holding. As a result, from the same date, the results of Avon Luxembourg are no longer included within Avon's consolidated results. The year ended December 31, 2021 includes the results of Avon Luxembourg for the period from January 1 to June 30, 2021. The years ended December 31, 2020 include the results of Avon Luxembourg. Depreciation and Amortization 2022 2021 2020 Avon International $ 44.6 $ 48.1 $ 49.5 Avon Latin America (1) 19.9 24.7 32.3 Total depreciation and amortization $ 64.5 $ 72.8 $ 81.8 (1) On July 1, 2021, the Company sold Avon Luxembourg, including our Mexican business, to a subsidiary of Natura &Co Holding. As a result, from the same date, the results of Avon Luxembourg are no longer included within Avon's consolidated results. The year ended December 31, 2021 includes the results of Avon Luxembourg for the period from January 1 to June 30, 2021. The years ended December 31, 2020 include the results of Avon Luxembourg. Total Revenue by Major Country A major country is defined as one with total revenues greater than 10% of consolidated total revenues. 2022 2021 2020 Brazil $ 587.0 $ 627.0 $ 729.9 Mexico (1) — 249.2 420.2 All other 2,182.2 2,528.3 2,475.1 Total $ 2,769.2 $ 3,404.5 $ 3,625.2 (1) On July 1, 2021, the Company sold Avon Luxembourg, including our Mexican business, to a subsidiary of Natura &Co Holding. As a result, from the same date, the results of Avon Luxembourg are no longer included within Avon's consolidated results. The year ended December 31, 2021 includes the results of Avon Luxembourg for the period from January 1 to June 30, 2021. The years ended December 31, 2020 include the results of Avon Luxembourg. Long-Lived Assets by Major Country A major country is defined as one with long-lived assets greater than 10% of consolidated long-lived assets, and also includes our country of domicile (the U.S.). Long-lived assets primarily include property, plant and equipment associated with our continuing operations. Long-lived assets in Brazil, Poland and Mexico consist primarily of property, plant and equipment related to manufacturing and distribution facilities, long-lived assets in the U.S. consist primarily of property, plant and equipment, including our global research and development facility and right-of-use assets related to equipment. 2022 2021 2020 U.S. $ 106.4 $ 122.7 $ 135.3 Brazil 76.8 75.4 86.4 Poland 81.0 95.0 96.8 Mexico (1) — — 55.2 All other 162.5 183.9 220.8 Total $ 426.7 $ 477.0 $ 594.5 (1) On July 1, 2021, the Company sold Avon Luxembourg, including our Mexican business, to a subsidiary of Natura &Co Holding. As a result, balances at December 31, 2021 do not include the assets of Avon Luxembourg. Balances at December 31, 2020 include the assets of Avon Luxembourg.

Leases and Commitments

Leases and Commitments	12 Months Ended
	Dec. 31, 2022
Leases [Abstract]
Leases and Commitments	Leases and Commitments In February 2016, the FASB issued ASU 2016-02, Leases, which requires all assets and liabilities arising from leases to be recognized in our Consolidated Balance Sheets. We adopted this new accounting guidance effective January 1, 2019. We have operating and finance leases for corporate and market offices, warehouses, automotive and other equipment. Some of our leases may include options to extend or terminate the lease. Certain leases also include options to purchase the leased property. The depreciable life of assets and leasehold improvements are limited by the expected lease term, unless there is a transfer of title or purchase option reasonably certain of exercise. Classification 2022 2021 Assets Operating right-of-use assets Right-of-use asset $ 92.1 $ 111.1 Finance right-of-use assets Property, Plant and Equipment 1.6 2.2 Total right-of-use assets 93.7 113.3 Liabilities Current Operating lease liabilities Other accrued liabilities $ 31.5 $ 37.1 Finance lease liabilities Other accrued liabilities 0.9 1.2 Total current lease liabilities 32.4 38.3 Noncurrent Operating lease liabilities Long-term operating lease liability 71.5 87.5 Finance lease liabilities Long-term debt 0.8 1.3 Total noncurrent lease liabilities $ 72.3 $ 88.8 Total lease liability $ 104.7 $ 127.1 The table below shows the lease income and expenses recorded in the Consolidated Statement of Operations incurred during the years ended December 31: Lease Costs Classification 2022 2021 2020 Operating lease cost (1) Selling, general and administrative expenses $ 44.5 $ 51.7 $ 63.6 Finance lease cost Amortization of right-of-use assets Selling, general and administrative expenses 1.1 1.3 1.2 Interest on lease liabilities Interest Expense .2 .2 .3 Short-term leases costs Selling, general and administrative expenses 7.1 11.0 2.3 Sublease income (2) Selling, general and administrative expenses (14.9) (14.5) (15.3) Net lease cost $ 38.0 $ 49.7 $ 52.1 (1) Includes variable lease costs which are immaterial. These are presented in selling, general and administrative expenses in our Consolidated Statements of Operations. (2) Sublease portfolio consists of the sublease of our previous principal executive office located at 777 Third Avenue, New York, NY. The maturity analysis of the finance and operating lease liabilities is reflected below. This table also reflects the reconciliation of the undiscounted cash flows to the discounted finance and operating lease liabilities as recognized in the December 31, 2022 Consolidated Balance Sheet: Maturity of Lease Liabilities Operating Leases Finance Leases Total 2023 39.4 1.0 40.4 2024 31.0 .5 31.5 2025 25.6 .3 25.9 2026 14.3 .2 14.5 2027 2.8 — 2.8 Thereafter 13.7 — 13.7 Total lease payments $ 126.8 $ 2.0 $ 128.8 Less: Interest 23.8 .3 24.1 Present value of lease liabilities $ 103.0 $ 1.7 $ 104.7 The Company has calculated the weighted-average remaining lease term, presented in years below, and the weighted-average discount rate for our operating and finance lease population. As noted in our lease accounting policy (See Note 1, Description of the Business and Summary of Significant Accounting Policies), the Company uses the incremental borrowing rate as the lease discount rate. Lease Term and Discount Rate 2022 2021 Weighted-average remaining lease term (years) Operating leases 4.3 4 Finance leases 2.6 2.7 Weighted-average discount rate Operating leases 9.1 % 8.3 % Finance leases 10.5 % 9.6 % The table below sets out the classification of lease payments in the Consolidated Statement of Cash Flows. The ROU assets obtained in exchange for new finance and operating lease liabilities represent the new operating and finance leases entered into during the years ended December 31. Other Information 2022 2021 2020 Operating Cash Flows From Operating Leases $ 47.3 $ 54.0 $ 63.7 Operating Cash Flows From Finance Leases .2 .2 .3 Financing Cash Flows From Finance Leases 1.2 1.3 1.3 Cash Paid For Amounts Included In Measurement of Liabilities $ 48.7 $ 55.5 $ 65.3 Right-of-use Assets Obtained In Exchange For New Finance Liabilities $ .7 $ 1.4 $ .9 Right-of-use Assets Obtained In Exchange For New Operating Liabilities $ 17.4 $ 8.8 $ 24.9 Purchase obligations include commitments to purchase paper, inventory and other services. At December 31, 2022, our purchase obligations by due date were as follows: Year Purchase Obligations 2023 $ 101.8 2024 51 2025 28.9 2026 26.2 2027 14.4 Later years 1.3 Total $ 223.6

Restructuring Initiatives

Restructuring Initiatives	12 Months Ended
	Dec. 31, 2022
Restructuring and Related Activities [Abstract]
Restructuring Initiatives	Restructuring Initiatives Transformation Plan and Open Up Avon Natura &Co - Avon Integration Subsequent to the merger of Natura and Avon in January 2020, an integration plan (the "Avon Integration") was established to create the right global infrastructure to support the future ambitions of the Natura &Co Group while also identifying synergies and opportunities to leverage our combined strength, scale and reach. Synergies will be derived mainly from procurement, manufacturing/distribution and administrative, as well as top line synergies, primarily between Avon LATAM and Natura &Co Latin America. Open Up Avon, Open Up & Grow and Transformation Plan In January 2016, we initiated a transformation plan (the "Transformation Plan"), which was completed in 2018. In September 2018, we initiated a new strategy in order to return Avon to growth ( " Open Up Avon"). The Open Up Avon strategy is integral to our ability to return Avon to growth, built around the necessity of incorporating new approaches to various elements of our business, including increased utilization of third-party providers in manufacturing and technology, a more fit for purpose asset base, and a focus on enabling our Representatives to more easily interact with the company and achieve relevant earnings. These savings have been and are expected to continue to be achieved through restructuring actions (that have may continue to result in charges related to severance, contract terminations and inventory and other asset write-offs), as well as other cost-savings strategies that would not result in restructuring charges. In January 2019, we announced significant advancements in this strategy, including a structural reset of inventory processes and a reduction in global workforce. In May 2020, the new leadership of Avon International refreshed our strategy ("Open Up & Grow") which aims to return Avon International to growth over the next three years. Open Up & Grow replaces and builds on the success of the Open Up Avon strategy, launched in 2018 to strengthen competitiveness through enhancing the representative experience, improving brand position and relevance, accelerating digital expansion and improving costs. Over the next three years, savings are expected to continue to be achieved through restructuring actions (that may continue to result in charges related to severance, contract terminations and asset write-offs), as well as other cost-savings strategies that would not result in restructuring charges. Costs to Implement Restructuring Initiatives - Twelve Months Ended December 31, 2022 , 2021 and 2020 During the twelve months ended December 31, 2022, we recorded net costs to implement of $68.6, of which $25.5 related to Avon Integration, $44.1 related to Open Up & Grow, and a net benefit of $1.0 related to the Transformation Plan and other restructuring initiatives, in our Consolidated Statements of Operations. During the twelve months ended December 31, 2021, we recorded net costs to implement of $58.8, of which $15.4 related to Avon Integration, $44.0 related to Open Up & Grow, and a net benefit of $0.6 related to the Transformation Plan and other restructuring initiatives, in our Consolidated Statements of Operations. During the twelve months ended December 31, 2020, we recorded costs to implement of $22.2 of which $16.1 related to Avon Integration, $10.9 related to Open Up Avon, and a net benefit of $4.8 related to the Transformation Plan and other restructuring initiatives, in our Consolidated Statements of Operations. The costs during the twelve months ended December 31, 2022, 2021 and 2020 consisted of the following: Year ended December 31, 2022 2021 2020 CTI recorded in operating profit - COGS Inventory write-off 1.3 — (1.8) 1.3 — (1.8) CTI recorded in operating profit - SG&A Net charges for employee-related costs, including severance benefits 39.2 36.7 5.2 Implementation costs, primarily related to professional service fees 16.8 17.5 10.3 Dual running costs 2.3 1.1 3.1 Contract termination and other net costs 5.9 10.5 3.9 Impairment of other assets — 1.0 .8 Accelerated depreciation 3.1 .3 .4 Variable lease charges — 1.6 1.8 Foreign Currency Translation Adjustment Write-offs — — — 67.3 68.7 25.5 CTI recorded in operating profit 68.6 68.7 23.7 CTI recorded in other (income) expense Gain on sale of business / assets — (9.9) (1.5) Total CTI $ 68.6 $ 58.8 $ 22.2 Avon Integration $ 25.5 $ 15.4 $ 16.1 Open Up & Grow $ 44.1 $ 44.0 $ 10.9 Transformation Plan & Other $ (1.0) $ (.6) $ (4.8) The tables below include restructuring costs such as employee-related costs, inventory and asset write-offs, foreign currency translation write-offs and contract terminations, and do not include other costs to implement restructuring initiatives such as professional services fees, dual running costs which are clearly identifiable and directly associated with exit activity such as people cost to perform knowledge transfer or rental costs for building being exited once the new building has become fully operational , accelerated depreciation and gain on sale of business. The liability balance included in other accrued liabilities in our Consolidated Balance Sheet for the restructuring actions associated with Avon Integration at December 31, 2022 and 2021 is $1.5 and $1.6, respectively, related to employee related costs. The liability balance included in other accrued liabilities in our Consolidated Balance Sheet for the restructuring actions associated with Open Up & Grow at December 31, 2022 is as follows: Employee-Related Costs Inventory/ Asset Write-offs Contract Terminations/Other Total Balance at December 31, 2020 $ 9.0 $ — $ 2.8 $ 11.8 2021 charges 33.8 1.0 3.4 38.2 Adjustments (1.3) — — (1.3) Cash payments (26.8) — (5.0) (31.8) Non-cash write-offs — (1.0) — (1.0) Foreign exchange (.7) — — (.7) Balance at December 31, 2021 $ 14.0 $ — $ 1.2 $ 15.2 2022 charges 27.0 1.3 3.0 31.3 Adjustments — — — — Cash payments (20.7) — (2.5) (23.2) Non-cash write-offs — (1.3) — (1.3) Foreign exchange (.7) — (.1) (.8) Balance at December 31, 2022 $ 19.6 $ — $ 1.6 $ 21.2 The liability balance included in other accrued liabilities in our Consolidated Balance Sheet for the restructuring actions associated with our Transformation Plan at December 31, 2022 and 2021 is $1.3 and $1.5, respectively, related to employee related costs. The majority of cash payments, if applicable, associated with the year-end liability are expected to be made during 2023. The following table presents the restructuring charges incurred to date, under the Avon Integration , Open Up & Grow and the Transformation Plan, along with the estimated charges expected to be incurred on approved initiatives under the plans: Employee- Related Costs Inventory/ Asset Write-offs Contract Foreign Currency Translation Adjustment Write-offs Total Avon Integration Charges incurred to-date $ 24.5 $ 3.1 $ 27.6 Estimated charges to be incurred on approved initiatives — — — — — Total expected charges on approved initiatives $ 24.5 $ — $ 3.1 $ — $ 27.6 Open Up & Grow Charges incurred to-date $ 142.8 $ 108.7 $ 18.9 $ (10.9) $ 259.5 Estimated charges to be incurred on approved initiatives $ .4 — — — $ .4 Total expected charges on approved initiatives $ 143.2 $ 108.7 $ 18.9 $ (10.9) $ 259.9 Transformation Plan Charges incurred to-date $ 122.7 $ 2.5 $ 40.9 $ 3.4 $ 169.5 Estimated charges to be incurred on approved initiatives — — — — — Total expected charges on approved initiatives $ 122.7 $ 2.5 $ 40.9 $ 3.4 $ 169.5 The charges, net of adjustments, of initiatives under the Open Up & Grow and the Transformation Plan, along with the estimated charges expected to be incurred on approved initiatives under the plans, by reportable segment are as follows: Avon International Avon LATAM Total Avon Integration 2020 6.2 4.6 $ 10.8 2021 (1.2) 3.0 $ 1.8 2022 .6 14.4 15.0 Charges incurred to-date 5.6 22.0 27.6 Estimated charges to be incurred on approved initiatives — — — Total expected charges on approved initiatives $ 5.6 $ 22.0 $ 27.6 Open Up & Grow 2018 52.8 64.3 $ 117.1 2019 34.7 36.9 71.6 2020 3.2 (.8) 2.4 2021 36.9 .2 37.1 2022 31.3 31.3 Charges incurred to-date 158.9 100.6 259.5 Estimated charges to be incurred on approved initiatives .4 — .4 Total expected charges on approved initiatives $ 159.3 $ 100.6 $ 259.9 The charges above are not included in segment profit, as this excludes costs to implement restructuring initiatives. The amounts shown in the tables above as charges recorded to-date relate to initiatives that have been approved and recorded in the consolidated financial statements, as the costs are probable and estimable. The amounts shown in the tables above as total expected charges on approved initiatives represent charges recorded to-date plus charges yet to be recorded for approved initiatives as the relevant accounting criteria for recording an expense have not yet been met. On November 3, 2022, the board of directors of Avon Products, Inc. approved a plan to relocate its research and development facilities to Brazil and Poland, two of its largest markets, by the end of its fiscal quarter ending June 30, 2024, in order to further deliver its Global Innovation Program and realize cost efficiencies. As a result, Avon will close its research and development facility in Suffern, New York. The closure of the Suffern facility is expected to be completed by the end of Avon’s fiscal quarter ending June 30, 2024. Avon is currently assessing the costs associated with the closure of its research and development facility in Suffern and the relocation of research and development activities to Brazil and Poland. Avon expects to incur total non-recurring restructuring costs in connection with the closure and relocation in the amount of approximately $37, of which approximately $10 was incurred in the fiscal year ending December 31, 2022 and the remainder to be incurred in the fiscal year ending 31, 2023, 2024 and 2025. Avon also expects to incur capital expenditures relating to the infrastructure and facilities in Brazil and Poland totaling approximately $10, to be incurred in the fiscal years ending December 31, 2023. Following the announcement of the above plan, the remaining useful life and estimated residual value of facility fixed assets were reassessed and on the basis that the facility fixed assets continued to be held in use as a corporate asset, accelerated depreciation of approximately $3.1 was recognized in the fiscal year ending December 31, 2022. If the facility fixed assets were to become classified as held for sale, Avon would expect record a potential impairment charge in the range of $15 and $20. The restructuring costs described above are preliminary estimates and actual amounts may be materially different from these estimates. Avon may also incur additional charges, non-cash costs, future cash expenditures or impairments not currently contemplated due to events that may occur as a result of, or that are associated with, the Suffern facility closure and the relocation of its research and development facilities to Brazil and Poland.

Contingencies

Contingencies	12 Months Ended
	Dec. 31, 2022
Loss Contingency [Abstract]
Contingencies	Contingencies Brazilian Tax Assessments Tax on Manufactured Products – minimum pricing rules In December 2012, October 2017 and June 2022, our Brazilian subsidiary, Avon Industrial LTDA (Avon Brazil Manufacturing) received excise tax ("IPI") assessments for the years 2008, 2014 and 2018. As in prior IPI cases that have been resolved in Avon’s favor, the assessments assert that the establishment in 1995 of separate manufacturing and distribution companies in Brazil was done without a valid business purpose, and that Avon Brazil Manufacturing did not observe minimum pricing rules to define the taxable basis of the tax on manufactured products. The structure adopted in 1995 is comparable to that used by many other companies in Brazil. We believe that our Brazilian corporate structure is appropriate, both operationally and legally, and that the assessments are unfounded. These matters are being contested at the administrative level, where proceedings are currently in progress. As of December 31, 2022, the total disputed amount classified as a remote risk of loss was $483. As of December 31, 2021, the total disputed amount of $360 was classified as a reasonably possible risk of loss. The change in classification was a result of enactment of new legislation in Brazil in July 2022 which defined the legal term 'Place of Business', this enactment was in alignment with Avon's argument and resulted as a favorable assessment, whilst the change in the total amount was largely due to the new assessment received in June 2022 and movements in foreign exchange rates. Tax on Manufactured Products – Decree equated certain commercial companies (not subject to IPI taxation) to industrial companies (IPI taxpayers) In May 2015, an executive decree established the levy of IPI on the sales of cosmetic products by Avon Brazil. Avon Brazil filed an objection to this levy on the basis that it is not constitutional since this tax is already paid by Avon Brazil Manufacturing. In December 2016, Avon Brazil received a favorable decision from the Federal District Court regarding this objection. This decision has been appealed by the Brazilian federal tax authority. At December 31, 2022 and 2021, the total amount under discussion classified as a reasonably possible risk of loss was $301 and $243, respectively, with the increase being largely a result of higher interest and taxes due, and movements in foreign exchange rates. Brazilian Financial Indemnities As of December 31, 2022 and 2021, the Company has issued a number of guarantees totaling $181 and $157, respectively, which it could be required to make in the event of adverse judgments in a number of lawsuits in Brazil. Talc-Related Litigation The Company has been named a defendant in numerous personal injury lawsuits filed in U.S. courts, alleging that certain talc products the Company sold in the past were contaminated with asbestos. Many of these actions involve a number of co-defendants from a variety of different industries, including manufacturers of cosmetics and manufacturers of other products that, unlike the Company’s products, were designed to contain asbestos. As of December 31, 2022, there were 227 individual active cases pending against the Company, for which associated costs and estimated liabilities have been included in current liabilities of discontinued operations on the Consolidated Balance Sheet. During the three months ended December 31, 2022, 39 new cases were filed and 23 cases were dismissed, settled or otherwise resolved. During the year ended December 31, 2022, 128 new cases were filed and 52 cases were dismissed, settled or otherwise resolved. In December 2022, one case, captioned Chapman, et al. v. Avon Products, Inc., et al ., No. 22STCV05968, resulted in an adverse jury verdict after a trial, with the jury awarding Plaintiffs a total of $36.0 in compensatory damages and $10.3 in punitive damages against Avon. The Company believes it has strong grounds for seeking to overturn the verdict in this case and in January 2023 began the process of appealing the verdict by seeking relief from the trial court. On March 1, 2023, following post-trial arguments, the trial court issued a conditional order reducing the compensatory damages award against Avon to $29.3. If Plaintiffs reject this reduction, there will be a new trial on the compensatory damages portion of the jury’s verdict. Avon will proceed with its appeal of the jury’s verdict in any event. We account for these claims in accordance with our loss contingency accounting policy as set out in Note 1: Description of the Business and Summary of Significant Accounting Policies. The company believes that the claims asserted against us in all of these cases are without merit and is defending vigorously against these claims and will continue to do so. However, additional similar cases arising out of the use of the Company's talc products are reasonably anticipated. Given the inherent uncertainties of litigation, it is not possible to predict the outcome of all individual cases pending against the Company or potential unasserted claims, and therefore a specific estimate and associated provision is made for a small number of individual cases that have advanced to the later stages of legal proceedings. This estimated liability for claims and associated legal costs incurred to date includes an amount for the Chapman case, however taking into consideration the strong grounds for appeal and seeking to overturn the verdict as noted above, should the Company ultimately lose the case, additional amounts representing a significant portion of the original awarded damages could be incurred. For the remaining filed cases, we record an estimate of exposure loss on an aggregated and ongoing basis, which takes into account the historical outcomes of all cases we have resolved to date. Any adverse outcomes, either in an individual case or in the aggregate, could be material. Future costs to litigate these cases, which we expense as incurred, are not known but may be significant, though some costs will be covered by insurance. Brazilian Labor-Related Litigation On an ongoing basis, the Company is subject to numerous and diverse labor-related lawsuits filed by employees in Brazil. These cases are assessed on an aggregated and ongoing basis based on historical outcomes of similar cases. The claims made are often for significantly larger sums than have historically been paid out by the Company. Our practice continues to be to recognize a liability based on our assessment of historical payments in similar cases. Our best estimate of the probable loss for such cases at December 31, 2022 and 2021 was approximately $10 and $11, respectively. Accordingly, we have recognized a liability for this amount. Other Matters Various other lawsuits and claims, arising in the ordinary course of business or related to businesses previously sold, are pending or threatened against Avon. In management’s opinion, based on its review of the information available at this time, the total cost of resolving such other contingencies at December 31, 2022, is not expected to have a material adverse effect on our consolidated financial position, results of operations or cash flows.

Goodwill

Goodwill	12 Months Ended
	Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill	Goodwill Goodwill During the 2022 year-end close process, our analysis of the Colombia business indicated an impairment as the carrying value of the business exceeded the estimated fair value. This was primarily the result of reducing our long-term projections of the business as it continued to experience challenging trading and economic conditions as a result of the continuing economic disruption caused by the COVID-19 pandemic and subsequent inflationary pressures compounded by the ongoing war between Ukraine and Russia. Accordingly, a non-cash impairment charge of $35.8 was recorded to reduce the carrying amount of goodwill. Avon International Avon LATAM Total Gross balance at December 31, 2021 $ 106.9 $ 54.5 $ 161.4 Accumulated impairments (89.3) — (89.3) Net balance at December 31, 2021 $ 17.6 $ 54.5 $ 72.1 Changes during the period ended December 31, 2022: Impairment — (35.8) (35.8) Foreign exchange (1.0) (9.4) (10.4) Gross balance at December 31, 2022 $ 105.9 $ 45.1 $ 151.0 Accumulated impairments (89.3) (35.8) (125.1) Net balance at December 31, 2022 $ 16.6 $ 9.3 $ 25.9

Supplemental Balance Sheet Info

Supplemental Balance Sheet Information	12 Months Ended
	Dec. 31, 2022
Balance Sheet Related Disclosures [Abstract]
Supplemental Balance Sheet Information	Supplemental Balance Sheet Information At December 31, 2022 and 2021, prepaid expenses and other included the following: Components of Prepaid expenses and other 2022 2021 Prepaid taxes and tax refunds receivable $ 60.9 $ 84.0 Receivables other than trade 18.8 27.8 Prepaid brochure costs, paper and other literature 7.4 8.3 Other 40.8 45.5 Prepaid expenses and other $ 127.9 $ 165.6 At December 31, 2022 and 2021, other assets included the following: Components of Other assets 2022 2021 Capitalized software (Note 1) 73.5 74.9 Judicial deposits 23.4 47.2 Net overfunded pension plans (Note 13) 110.7 162.5 Long-term receivables including taxes 198.3 180.2 Trust assets associated with supplemental benefit plans (Note 13) 28.5 30.4 Other 11.1 14.2 Other assets $ 445.5 $ 509.4

Merger with Natura Cosm_ticos S

Merger with Natura Cosméticos S.A.	12 Months Ended
	Dec. 31, 2022
Business Combinations [Abstract]
Merger with Natura Cosméticos S.A.	Discontinued Operations and Assets and Liabilities Held for Sale Discontinued Operations On December 17, 2015, the Company entered into definitive agreements with affiliates controlled by Cerberus. The agreements resulted in the separation of the Company's North America business, which represented the Company's operations in the United States, Canada and Puerto Rico, from the Company into The Avon Company, formerly New Avon, ("New Avon") a privately-held company majority-owned and managed by Cerberus NA Investor LLC (an affiliate of Cerberus). The Company retained an investment of 19.9% ownership interest in New Avon. These transactions closed on March 1, 2016; from that date, resolution of contingent liabilities relating to Avon's ownership and operation of the North America business prior to its separation from the Company into New Avon have been treated as discontinued operations. In April 2019, we signed an agreement with LG Household & Health Care Ltd. to sell our 19.9% ownership interest in New Avon, which was completed during August 2019. Refer to the Divestitures section below for information relating to the sale of New Avon. The Company incurred costs and recognized contingent liabilities during the years ended December 31, 2022, 2021 and 2020 related to its ownership and operation of the North America business prior to its separation into New Avon, including talc- related and environmental related litigation as well as other costs as detailed in Note 17, Contingencies, to the Consolidated Financial Statements. The major classes of financial statement components comprising the loss on discontinued operations, net of tax for New Avon are shown below: Year Ended December 31, 2022 Year Ended December 31, 2021 Year Ended December 31, 2020 Selling, general and administrative expenses $ (73.2) $ (18.5) $ (27.9) Operating loss $ (73.2) $ (18.5) $ (27.9) Loss from discontinued operations, net of tax $ (73.2) $ (18.5) $ (27.9) Assets and Liabilities Held for Sale The major classes of assets and liabilities comprising held for sale assets and held for sale liabilities on the Consolidated Balance Sheet at December 31, 2022 and December 31, 2021 are shown in the following table. Year ended December 31, 2022 2021 Current held for sale assets Property, Plant & Equipment (net) — 2.8 $ — $ 2.8 Current held for sale liabilities Accounts payable $ — $ — Other liabilities — — $ — $ — At December 31, 2021, assets held for sale included one property in the Avon Latin America Segment. At December 31, 2022, there were no assets held for sale. Divestitures Sale of Poland Freehold Administrative Office In December 2022, we completed the sale of our Polish freehold administrative office for a total selling price of $12.5, the proceeds of which are presented as investing activities in the Consolidated Statement of Cash Flows. In the fourth quarter of 2022 we recognized a gain of $1.8 before and $1.5 after tax, which is reported separately in the Consolidated Statements of Operations representing the difference between the proceeds, the carrying value of the Poland Freehold Office on the date of sale, and associated disposal costs. Disposal of Avon Beauty Arabia in Saudi Arabia On December 23, 2021, the Company completed the sale of its 51% share of the business and assets of Avon Beauty Arabia in exchange for converting the business to a distributorship model together with the write off of a $3.9 loan balance. In the fourth quarter of 2021 we recognized a loss of $1.1 before and after tax, which is reported separately in the Consolidated Statements of Operations representing the difference between the write off of the loan balance, the carrying value of the business and assets of the Avon Beauty Arabia on the date of sale, and associated disposal costs. Disposal of Cosmetics Manufacturing Operations in India On November 17, 2021, the Company completed the sale of the business and assets of the Cosmetics Manufacturing Operation in India for a total selling price of $2.9, the proceeds of which are presented as investing activities in the Consolidated Statement of Cash Flows. In the fourth quarter of 2021 we recognized a gain of $1.1 before and after tax, which is reported separately in the Consolidated Statements of Operations representing the difference between the proceeds, the carrying value of the business and assets of the Cosmetics Manufacturing Operation in India on the date of sale, and associated disposal costs. Sale of Spanish Distribution Center In September 2021, we completed the sale of our Spanish Distribution Center for a total selling price of $14.7, the proceeds of which are presented as investing activities in the Consolidated Statement of Cash Flows. In the third quarter of 2021 we recognized a gain of $8.3 before and $6.2 after tax, which is reported separately in the Consolidated Statements of Operations representing the difference between the proceeds, the carrying value of the branch of the Spanish Distribution Center on the date of sale, and associated disposal costs. Sale of Avon Luxembourg Holdings S.à r.l On July 1, 2021, the Company sold Avon Luxembourg, including our Mexican business, to a subsidiary of Natura &Co Holding for $150, with the proceeds used to repay maturing loans of $150 borrowed under the $250 Revolving Credit Facility with a subsidiary of Natura &Co Holding. The sale was accounted for as a transaction under common control in accordance with ASC805 - Business Combinations, with the resulting gain of $148, representing the difference between the proceeds, the net assets of Avon Luxembourg on the date of sale and the cumulative foreign currency translation adjustment, taken directly to Retained Earnings. For additional information, see the Consolidated Statements of Changes in Shareholders' Deficit. Italy Branch In June 2021, we completed the sale of a branch of our Italian business for a total selling price of $1.7, the proceeds of which will be received in installments between October 2021 and December 2026, and will be presented as investing activities in the Consolidated Statement of Cash Flows. In the second quarter of 2021, we recorded a gain of $1.4 before and after tax, which is reported separately in the Consolidated Statements of Operations representing the difference between the proceeds and the carrying value of the branch of the Italian business on the date of sale. Avon Shanghai In August 2020, we signed an agreement to sell Avon Management Shanghai ("Avon Shanghai") to an affiliate of Natura &Co for a selling price of $2.9. In August 2020, we completed the sale of the entity and received proceeds of $2.9. These proceeds are presented as investing activities in the Consolidated Statement of Cash Flows as the sale was to an affiliate under common control by Natura &Co. The gain on sale of $1.4 was recorded directly to Retained earnings. Hungary Distribution Center in Gödöllő In April 2020, we signed an agreement to sell the Hungary Distribution Center in Gödöllő for a selling price of $3.4 and received a deposit of $.3. In June 2020, we completed the sale of the asset and the remaining proceeds of $3.1 were received. These proceeds are presented as investing activities in the Consolidated Statement of Cash Flows. In the second quarter of 2020, we recorded a gain of $.1 before and after tax, which is reported separately in the Consolidated Statements of Operations. The gain represents the difference between the proceeds and the carrying value of the Hungary Distribution Center on the date of sale. China Wellness Plant In March 2020, we signed an agreement to sell the China Wellness Plant for a total selling price of $6.6 before expenses. In the six-month period ended June 30, 2020, we received a cash deposit for the selling price of $6.6, which included $3.3 of restricted cash held in escrow. In August 2020, we completed the sale of the China Wellness Plant and $3.3 of restricted cash in escrow was transferred to Avon. In the third quarter of 2020, we recorded a gain of $1.4 before and after tax, which is reported separately in the Consolidated Statements of Operations. The gain represents the difference between the net proceeds (after associated expenses) and the carrying value of the China Wellness Plant on the date of sale. On May 22, 2019, the Company entered into the Agreement and Plan of Mergers (as amended by Amendment Number One to Agreement and Plant of Mergers, dated as of October 3, 2019, and as further amended by Amendment Number Two to Agreement and Plan of Mergers, dated as of November 5, 2019, the "Merger Agreement") among the Company, Natura Cosméticos S.A., a Brazilian corporation (sociedade anônima) ("Natura Cosméticos"), Natura &Co Holding S.A., a Brazilian corporation (sociedade anônima), Nectarine Merger Sub I, Inc., a Delaware corporation and a direct wholly owned subsidiary of Natura &Co Holding ("Merger Sub I"), and Nectarine Merger Sub II, Inc., a Delaware corporation and a direct wholly owned subsidiary of Merger Sub I ("Merger Sub II"), pursuant to which (i) Natura &Co Holding, after the completion of certain restructuring steps, holds all issued and outstanding shares of Natura Cosméticos, (ii) Merger Sub II merged with and into the Company, with the Company surviving the merger (the "First Merger") and (iii) Merger Sub I merged with and into Natura &Co Holding (the "Second Merger"), with Natura &Co Holding surviving the merger and as a result of which the Company and Natura Cosméticos became wholly owned direct subsidiaries of Natura &Co Holding (collectively, the "Transaction"). The Transaction was consummated on January 3, 2020, and at this time, the Company became a wholly owned direct subsidiary of Natura &Co Holding. In connection with the Transaction, trading of the Company’s stock was suspended by the NYSE, and the Company’s common stock was subsequently delisted and deregistered. On completion of the Transaction, each share of t he Company’s common stock issued and outstanding immediately prior to the consummation of the Transaction was converted into the ultimate right to receive, (i) 0.300 validly issued and allotted, fully paid-up American Depositary Shares of Natura &Co Holding, ("Natura &Co Holding ADSs") against the deposit of two shares of common stock of Natura &Co Holding ("Natura &Co Holding Shares", subject to adjustment in accordance with the terms of the Merger Agreement, and any cash in lieu of fractional Natura &Co Holding ADSs or (ii) 0.600 validly issued and allotted, fully paid-up Natura &Co Holding Shares, subject to adjustment in accordance with the terms of the Merger Agreement, and any cash in lieu of fractional Natura &Co Holding Shares. The Company’s Series C Preferred Stock held by Cerberus Investor were converted to common stock prior to consummation of the Transaction and were therefore automatically converted into common stock of Natura &Co. Natura &Co Holding Shares are listed on the B3 S.A. - Brasil, Bolsa, Balcão stock exchange, and Natura &Co Holding ADSs are listed on the NYSE. Additionally, upon the consummation of the Transaction, Avon common stock ceased to be traded on the NYSE. In January 2020, subsequent to the Transaction, the Company restated the certificate of incorporation. The certificate of incorporation was restated to effect a change in capitalization of the Company by changing the number of authorized shares of stock from 1,525,000,000 shares (of which (i) 1,500,000,000 shares, par value $0.25 per share, are common stock and (ii) 25,000,000 shares, par value $1.00 per share, are preferred stock) to 1,000 shares of common stock, par value $0.01 per share. As a result, all of the issued and outstanding common stock of the Company, being 550,890,788 were canceled and converted into 101.34 common stock, par value $0.01 per share, and all outstanding treasury shares were canceled. The Company incurred costs of $46 and $44 in relation to the Transaction, primarily professional fees during the years ended December 31, 2020 and 2019, respectively. During January 2020, it was announced that the employment of certain senior officers of the Company would be terminated, in connection with the Transaction. The Company incurred severance of approximately $25 and acceleration of share based compensation of approximately $10 relating to these terminations triggered by change in control provisions. As a result of the Transaction, the Company made payments of approximately $26 related to the settlement of stock options. In addition, any remaining restricted stock units and performance restricted stock units were exchanged for awards of Natura &Co Holding. The replacement awards contain substantially the same terms and conditions of the original awards except for the removal of the performance conditions. As such, the replacement awards contain only a service vesting condition. On consummation of the Transaction, a deferred compensation scheme relating to former employees of the Company became payable which resulted in extinguishing the liability and a cash outflow of approximately $12. In January 2020, upon completion of the Transaction, the Company’s revolving credit facility was canceled, triggered by change in control provisions. As a result, debt issuance costs of $7.8 were written off. As a result of the Transaction, the Company will no longer have access to certain tax attributes of approximately $546 to approximately $616 in certain taxing jurisdictions. These tax attributes had been formerly reflected as deferred tax assets which were subject to a full valuation allowance and as a result, there was no impact to net income in 2020 from the write-off of the deferred tax asset and the associated valuation allowances.

Subsequent Events

Subsequent Events	12 Months Ended
	Dec. 31, 2022
Subsequent Events [Abstract]
Subsequent Events	Subsequent Events On January 12, 2023, the Company filed a surety bond in favor of the Superior Court of the State of California and the County of Los Angeles in the amount of $75.5 in order to begin the process of appealing the verdict in Chapman, et al. v. Avon Products, Inc., et al . With the bond in place, the Company is not obligated to pay any damages to Plaintiffs for the duration of the appeals process. The amount of the bond represents a statutory multiple of the damages that the jury awarded to Plaintiffs. On March 1, 2023, following post-trial arguments, the trial court issued a conditional order reducing the compensatory damages award against Avon to $29.3. If Plaintiffs reject this reduction, there will be a new trial on the compensatory damages portion of the jury’s verdict. Avon will proceed with its appeal of the jury’s verdict in any event. See Note 17, Contingencies for further information.

Schedule II - Valuation and Qua

Schedule II - Valuation and Qualifying Accounts	12 Months Ended
	Dec. 31, 2022
SEC Schedule, 12-09, Valuation and Qualifying Accounts [Abstract]
Schedule II - Valuation and Qualifying Accounts	AVON PRODUCTS, INC. AND SUBSIDIARIES VALUATION AND QUALIFYING ACCOUNTS Years ended December 31, 2022, 2021 and 2020 Additions (In millions) Balance at Charged to Costs and Expenses Charged Deductions Balance 2022 Allowance for doubtful accounts receivable $ 37.1 $ 51.7 $ — $ (53.6) (1) $ 35.2 Refund liability 4.3 — 52.8 (54.1) (2) 3.0 Allowance for inventory obsolescence 54.8 22.6 — (31.3) (3) 46.1 Deferred tax asset valuation allowance 815.4 126.0 — — 941.4 2021 Allowance for doubtful accounts receivable $ 51.1 $ 62.4 $ — $ (76.4) (1) $ 37.1 Refund liability 9.1 — 75.9 (80.7) (2) 4.3 Allowance for inventory obsolescence 70.4 26.8 — (42.4) (3) 54.8 Deferred tax asset valuation allowance 2,327.6 125.7 — (1,637.9) (4) 815.4 2020 Allowance for doubtful accounts receivable $ 66.6 $ 78.3 $ — $ (93.8) (1) $ 51.1 Refund liability 10.7 — 101.4 (103.0) (2) 9.1 Allowance for inventory obsolescence 82.0 37.9 — (49.5) (3) 70.4 Deferred tax asset valuation allowance 2,960.0 (632.4) — — 2,327.6 (1) Accounts written off, net of recoveries and foreign currency translation adjustment. (2) Returned product reused or destroyed and foreign currency translation adjustment. (3) Obsolete inventory destroyed and foreign currency translation adjustment. (4) Deductions associated with divestiture of Luxembourg Holdings and subsidiaries.

Description of the Business a_2

Description of the Business and Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Dec. 31, 2022
Description Of The Business And Summary Of Significant Accounting Policies
Principles of Consolidation	Principles of Consolidation The consolidated financial statements include the accounts of Avon and our majority and wholly-owned subsidiaries. Intercompany balances and transactions are eliminated.
Basis of Presentation and Use of Estimates	Basis of Presentation and Use of Estimates We prepare our consolidated financial statements and related disclosures in conformity with accounting principles generally accepted in the United States of America, or GAAP. In preparing these statements, we are required to use estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ materially from those estimates and assumptions. On an ongoing basis, we review our estimates, including those related to stand-alone selling prices ("SSP") of promised goods or services delivered under sales incentives, allowances for sales returns, allowances for doubtful accounts receivable, provisions for inventory obsolescence, the determination of discount rates and other actuarial assumptions for pension and postretirement benefit expenses, restructuring expense, income taxes and deferred income tax valuation allowances, share-based compensation, loss contingencies and the evaluation of goodwill, property, plant and equipment and capitalized software for potential impairment.
Foreign Currency	Foreign Currency Financial statements of foreign subsidiaries operating in other than highly inflationary economies are translated at year-end exchange rates for assets and liabilities and average exchange rates during the year for income and expense accounts. The resulting translation adjustments are recorded within accumulated other comprehensive income (loss) ("AOCI"). Gains or losses resulting from the impact of changes in foreign currency rates on assets and liabilities denominated in a currency other than the functional currency are recorded in other expense, net. For financial statements of Avon subsidiaries operating in highly inflationary economies, the U.S. dollar is required to be used as the functional currency. Highly inflationary accounting requires monetary assets and liabilities, such as cash, receivables and payables, to be remeasured into U.S. dollars at the current exchange rate at the end of each period with the impact of any changes in exchange rates being recorded in income. We record the impact of changes in exchange rates on monetary assets and liabilities in other expense, net. Similarly, deferred income tax assets and liabilities are remeasured into U.S. dollars at the current exchange rates; however, the impact of changes in exchange rates is recorded in income taxes in our Consolidated Statements of Operations. Non-monetary assets and liabilities, such as inventory, property, plant and equipment and prepaid expenses are carried forward at their historical dollar cost, which was calculated using the exchange rate at the date which hyperinflationary accounting is implemented. Argentina Currency During the quarter ended June 30, 2018, based on published official exchange rates which indicate that Argentina's three-year cumulative inflation rate has exceeded 100%, we concluded that Argentina had become a highly inflationary economy. From July 1, 2018, we have applied highly inflationary accounting for our Argentinian subsidiary. As such, the functional currency for Argentina has changed to the U.S. dollar, which is the consolidated group's reporting currency. As a result of highly inflationary accounting for our Argentinian subsidiary, the most significant impacts in our Consolidated Income Statements are in cost of sales, primarily due to inventory being accounted for at its historical dollar cost, and in other (expense) income, net, primarily associated with the net monetary position of Argentina. However, these impacts are not considered material to our Consolidated Income Statements. Turkish Currency During the quarter ended March 31, 2022, published official exchange rates for Turkey indicated that the three-year cumulative inflation rate has exceeded 100%. As a result, we concluded that Turkey has become a highly inflationary economy. From April 1, 2022, we have applied inflationary accounting for our Turkish subsidiary. As such, the functional currency for Turkey has changed to the U.S. dollar, which is the consolidated group's reporting currency.
Revenue Recognition	Revenue Recognition Nature of goods and services We are a global manufacturer and marketer of beauty and related products. Our product categories are Beauty and Fashion & Home. Beauty consists of skincare, fragrance and color (cosmetics). Fashion & Home consists of fashion jewelry, watches, apparel, footwear, accessories, gift and decorative products, housewares, entertainment and leisure products, children’s products and nutritional products. Our business is conducted primarily in one channel, direct selling. Our reportable segments are based on geographic operations in two regions: Avon International and Avon Latin America. We primarily sell our products to the ultimate consumer through the direct selling channel principally through Representatives, who are independent contractors and not our employees. Revenue recognition Revenue is recognized when control of a product or service is transferred to a customer, which is generally the Representative. Revenue is measured based on the consideration specified in a contract with a customer and excludes amounts collected on behalf of third parties, such as Value Added Taxes ("VAT") collected for taxing authorities. Principal revenue streams and significant judgments Our principal revenue streams can be distinguished into: i) the sale of Beauty and Fashion & Home products to Representatives (recorded in net sales); ii) Representative fees, primarily for the sale of brochures to Representatives and fulfillment activities related to the contract, which include fees for shipping and handling (recorded in other revenue); and iii) other, which includes the sale of products to New Avon LLC ("New Avon"), which has ceased since the sale of Avon Luxembourg Holdings S.à r.l on July 1, 2021, and royalties from the licensing of our name and products (recorded in other revenue). i) Sale of Beauty and Fashion & Home products to Representatives We generate the majority of our revenue through the sale of Beauty and Fashion & Home products. A Representative contacts her customers directly, selling primarily through our brochure (whether paper or online), which highlights new products and special promotions (or incentives) for each sales campaign. In this sense, the Representative, together with the brochure, are the "store" through which our products are sold. A brochure introducing a new sales campaign is typically generated every three to four weeks. A purchase order is processed, and the products are picked at a distribution center and delivered to the Representative usually through a combination of local and national delivery companies. Generally, the Representative then delivers the merchandise and collects payment from the customer for her or his own account. A Representative generally receives a refund of the price the Representative paid for a product if the Representative chooses to return it. A Representative Agreement, which outlines the basic terms of the agreement between Avon and the Representative, combined with a purchase order, constitutes a contract for the purposes of Accounting Standards Codification Topic ("ASC"), Revenue from Contracts with Customers ("ASC 606"). Revenue from Contracts with Customers We account for individual products and services separately in the contract if they are distinct (i.e., if a product or service is separately identifiable from the other items in the contract and if a Representative can benefit from the product or service on its own or with other resources that are readily available), which is recognized at a point in time, when control of a product is transferred to a Representative. In addition, we offer incentives to Representatives to support sales growth. Certain of these sales incentives are distinct promises to a Representative, and therefore are a separate performance obligation. As a result, revenue is allocated to the performance obligation for sales incentives and is deferred on the balance sheet until the associated performance obligations are satisfied. Typically included within a contract is variable consideration, such as sales returns and late payment fees. Revenue is only recorded to the extent it is probable that it will not be reversed, and therefore revenue is adjusted for variable consideration. Variable consideration is generally estimated using the expected value method, which considers possible outcomes weighted by their probability. Specifically for sales returns, a refund liability will be recorded for the estimated cash to be refunded for the products expected to be returned, and a returns asset will be recorded for the products which we expect to be returned and re-sold, each of these based on historical experience. The estimate of sales returns as well as the measurement of the returns asset and the refund liability is updated at the end of each month for changes in expectations regarding the amount of salvageable returns, reconditioning costs and any additional decreases in the value of the returned products. Late payment fees are recorded when the uncertainty associated with collecting such fees are resolved (i.e., when collected). The Representative generally receives a credit period of one sales campaign if they meet certain criteria; however, the specific credit terms are outlined in the Representative Agreement. Generally, the Representative remits payment during each sales campaign, which relates to the prior campaign cycle. The Representative is generally precluded from submitting an order for the current sales campaign until the accounts receivable balance past due for prior campaigns is paid; however, there are circumstances where the Representative fails to make the required payment. Our contracts with Representatives often include multiple promises to transfer products and/or services to the Representative, and determining which of these products and/or services are considered distinct performance obligations that should be accounted for separately. In addition, in assessing the recognition of revenue for the following performance obligations, management has exercised significant judgment in the following areas: estimation of variable consideration and the stand-alone selling prices ("SSP") of promised goods or services in order to determine and allocate the transaction price. Performance obligation - Avon products and appointment kits The Representative purchases Avon products and appointment kits through a purchase order. Avon offers appointment kits for purchase to Representatives, which may contain various Avon products. We recognize revenue for Avon products and appointment kits in net sales in our Consolidated Statements of Operations when the Representative obtains control of the products, which occurs upon delivery of the product to the Representative. Transaction price is the amount we expect to receive in exchange for those products adjusted for variable consideration as discussed above and the estimated SSP of other performance obligations as discussed below. The cost of these products and appointment kits is recognized in cost of sales in our Consolidated Statements of Operations. Performance obligation - Sales incentives Types of sales incentives include status programs, loyalty points, prospective discounts, and gift with purchase, among others. A Representative is eligible for certain status programs if specified sales levels are met. Status programs offer additional benefits such as free or discounted products and services. Loyalty points offer the option to redeem for additional Avon or other products or services. Prospective discounts are offered in some countries when certain sales levels are reached in a given time period. The revenue attributable to the prospective discount performance obligation is for the option to purchase additional product at a discounted amount. Certain benefits within status programs, loyalty points, prospective discounts and certain other sales incentives constitute a material right and, therefore, a distinct performance obligation in the contract with the Representative. Transaction price is allocated to the material right (performance obligation) based on estimated SSP and is deferred on the balance sheet until the associated performance obligations are satisfied. The cost of incentives is presented in inventories in our Consolidated Balance Sheets. We recognize revenue allocated to the material right in net sales in our Consolidated Statements of Operations at the point in time that the Representative receives the benefits of the material right or obtains control of the products, which occurs upon delivery to the Representative or upon expiration of the material right. For sales incentives that are delivered with the associated products order (such as gift with purchase), no deferral is required. SSP represents the estimated market value, or the estimated amount that could be charged for that material right when the entity sells it separately in similar circumstances to similar customers. Judgment is required to determine the SSP for each distinct performance obligation. In instances where SSP is not directly observable, such as when we do not sell the product or service separately, including for certain sales incentives, we determine the SSP using information that may include market prices and other observable inputs. ii) Representative fees, primarily for the sale of brochures to Representatives and fulfillment activities related to the contract ("Representative fees") The purchase order in the contract with the Representative explicitly identifies activities that we will perform. This includes fees that we charge Representatives, primarily for the sale of brochures to Representatives and fulfillment activities, and also includes late payment fees (discussed above). Brochures represent promotional materials that are given directly by the Representatives to their customers as a marketing activity. Under ASC 606, brochures that are sold by Avon to Representatives through purchase orders represent separate performance obligations in the contract as these are promises made between Avon and the Representative. Although the brochures are used similar to marketing materials, the Representative generally orders and pays for the brochures, and we allocate consideration for purposes of revenue recognition. The revenue associated with brochures that are sold to Representatives is recognized in other revenue and the related cost is recognized in cost of sales in our Consolidated Statements of Operations. We recognize revenue when the Representative obtains control of the brochures, which occurs upon delivery to the Representative. When brochures are given away for free to Representatives as promotional items, the cost is recognized in selling, general and administrative expenses in our Consolidated Statements of Operations. We often charge the Representative for shipping and handling (including order processing) and payment processing activities on the invoice, and such activities are considered to be fulfillment costs. The consideration received represents part of the transaction price in the contract that is allocated to the performance obligations in the contract. We recognize revenue for
Other Revenue	Other revenue We also recognize revenue from the sale of products to New Avon, as part of a manufacturing and supply agreement, since the separation of the Company's North America business into New Avon on March 1, 2016, which has ceased since the sale of Avon Luxembourg Holdings S.à r.l on July 1, 2021, and royalties from the licensing of our name and products, in other revenue in our Consolidated Statements of Operations. Contract costs Incremental costs to obtain contracts, such as bonuses or commissions, are recognized as an asset if the entity expects to recover them. However, ASC 340-40, Other Assets and Deferred Costs , offers a practical expedient to recognize the incremental costs of obtaining a contract as an expense when incurred if the amortization period of the asset that the entity otherwise would have recognized is one year or less. We elected the practical expedient and expense costs to obtain contracts when incurred because our amortization period is one year or less. Costs to fulfill contracts with Representatives are comprised of shipping and handling (including order processing) and payment processing services, which are expensed as incurred. The fees for these services are included in the transaction price.
Cash and Cash Equivalents	Cash and Cash Equivalents Cash equivalents are stated at cost plus accrued interest, which approximates fair value. Cash equivalents are generally high-quality, short-term money market instruments with an original maturity of three months or less and consist of time deposits with a number of U.S. and non-U.S. commercial banks and money market fund investments.
Inventories	Inventories Inventories are stated at the lower of cost or net realizable value. Cost is determined using the first-in, first-out method. We classify inventory into various categories based upon its stage in the product life cycle, future marketing sales plans and the disposition process. We assign a degree of obsolescence risk to products based on this classification to estimate the level of obsolescence provision.
Brochure Costs	Brochure Costs Brochures represent promotional materials that are given directly by the Representatives to their customers as a marketing activity. Brochures that are sold by Avon to Representatives through purchase orders represent separate performance obligations in the contract as these are promises made between Avon and the Representative. Although the brochures are used similar to marketing materials, the Representative generally orders and pays for the brochures, and Avon allocates consideration for purposes of revenue recognition. The revenue associated with brochures that are sold to Representatives is recognized in other revenue and the related cost is recognized in cost of sales in our Consolidated Statements of Operations. We recognize revenue when the Representative obtains control of the brochures, which occurs upon delivery to the Representative. When brochures are given away for free to Representatives as promotional items, the cost is recognized in SG&A expenses in our Consolidated Statements of Operations.
Property, Plant and Equipment and Capitalized Software	Property, Plant and Equipment and Capitalized Software Property, plant and equipment are stated at cost and are depreciated using a straight-line method over the estimated useful lives of the assets. The estimated useful lives generally are as follows: buildings, 45 years; land improvements, 20 years; machinery and equipment, 15 years; and office equipment, 5 to 10 years. Leasehold improvements are depreciated over the shorter of the lease term or the estimated useful life of the asset. Upon disposal of property, plant and equipment, the cost of the assets and the related accumulated depreciation are removed from the accounts and the resulting gain or loss is reflected in earnings. Costs associated with repair and maintenance activities are expensed as incurred.
Leases	Leases We determine if an arrangement is a lease at the lease commencement date. In addition to our lease agreements, we review all material new vendor arrangements for potential embedded lease obligations. The asset balance related to operating and finance leases is presented within right-of-use (ROU) asset and property, plant and equipment, respectively, on our Consolidated Balance Sheet. The short-term liability balance related to operating and finance leases is presented within other accrued liabilities on our Consolidated Balance Sheets. The long-term liability balance is presented within long-term operating lease liability and long-term debt on our Consolidated Balance Sheets for operating and finance leases, respectively. The lease liability is recognized based on the present value of the remaining fixed or in-substance fixed lease payments discounted using our incremental borrowing rates. We use a specific incremental borrowing rate for our material leases, which is determined based on the geography, nature of the asset and term of the lease. These rates are determined based on inputs provided by external banks and updated periodically. The lease liability includes the exercise of a purchase option only if we are reasonably certain to exercise as of the commencement date of the lease. The residual value guarantee amount is only included in the lease liability calculation to the extent payment is probable to the lessor as of the commencement of the lease. The ROU asset is calculated based on the lease liability adjusted for any lease payments paid to the lessor at or before the commencement date (i.e. prepaid rent) and initial direct costs incurred by Avon and excluding any lease incentives received from the Lessor. Variable lease payments are payments to the lessor not included in the lease liability calculation. We define variable lease payments as payments made by Avon to the lessor for the right to use a leased asset that vary because of changes in facts or circumstances (such as changes in an index rate, volume, usage, etc.) occurring after the lease commencement date, other than predetermined contractual changes due to the passage of time (for example, predetermined rent increase amounts that are set out in the contract). Variable lease payments or charges are accounted for as incurred. The lease term for purposes of lease accounting may include options to extend or terminate the lease when it is reasonably certain that we will exercise that option as of the commencement date of the lease. For operating leases, the lease expense is recognized on a straight-line basis over the lease term. For finance leases, the Company amortizes the ROU asset on a straight-line basis and records interest expense on the lease liability created at lease commencement over the lease term. We account for our lease and non-lease components as a single component for most of our asset classes, and therefore both are included in the calculation of lease liability recognized on the Consolidated Balance Sheets. However, for certain lease asset classes related to identified embedded leases we account for the lease and non-lease components separately, and therefore, the non-lease component is not included in the lease liability.
Assets and Liabilities Held for Sale	Assets and Liabilities Held for Sale A long-lived asset (or disposal group) is classified as held for sale if its carrying amount will be recovered principally through a sale transaction rather than through continuing use and a sale is considered highly probable within a year. A long-lived asset (or disposal group) classified as held for sale is initially measured at the lower of its carrying amount or fair value less cost to sell. An impairment loss is recognized for any initial or subsequent write-down of the long-lived asset (or disposal group) to fair value less costs to sell. A gain or loss not previously recognized by the date of the sale of the long-lived asset (or disposal group) is recognized at the date of derecognition. Long-lived assets (including those that are part of a disposal group) are not depreciated or amortized while they are classified as held for sale. Long-lived assets classified as held for sale and the assets of a disposal group classified as held for sale are
Goodwill	Goodwill Goodwill is not amortized and is assessed for impairment annually during the fourth quarter or on the occurrence of an event that indicates impairment may have occurred, at the reporting unit level. A reporting unit is the operating segment, or a component, which is one level below that operating segment. Components are aggregated as a single reporting unit if they have similar economic characteristics. When testing goodwill for impairment, we perform either a qualitative or quantitative assessment for each of our reporting units. Factors considered in the qualitative analysis include macroeconomic conditions, industry and market considerations, cost factors and overall financial performance specific to the reporting unit. If the qualitative analysis results in a more likely than not probability of impairment, the quantitative test, as described below, is required. We perform the quantitative test to evaluate goodwill for impairment by comparing the fair value of a reporting unit with its carrying amount. If the carrying amount exceeds the reporting unit’s fair value, that difference represents an impairment; however, the loss recognized should not exceed the total amount of goodwill allocated to that reporting unit. five
Financial Instruments	Financial Instruments We use derivative financial instruments, including forward foreign currency contracts, to manage foreign currency exposures. If applicable, derivatives are recognized in our Consolidated Balance Sheets at their fair values. When we become a party to a derivative instrument and intend to apply hedge accounting, we designate the instrument, for financial reporting purposes, as a fair value hedge, a cash flow hedge, or a net investment hedge. The accounting for changes in fair value (gains or losses) of a derivative instrument depends on whether we had designated it and it qualified as part of a hedging relationship and further, on the type of hedging relationship. We apply the following: • Changes in the fair value of a derivative that is designated as a fair value hedge, along with the loss or gain on the hedged asset or liability that is attributable to the hedged risk are recorded in earnings. • Changes in the fair value of a derivative that is designated as a cash flow hedge are recorded in AOCI and reclassified into earnings in the same period or periods during which the transaction hedged by that derivative also affects earnings. • Changes in the fair value of a derivative that is designated as a hedge of a net investment in a foreign operation are recorded in foreign currency translation adjustments within AOCI. • Changes in the fair value of a derivative that is not designated as a hedging instrument are recognized in earnings in other expense, net in our Consolidated Statements of Operations. We present the earnings effect of the hedging instrument in our Consolidated Statements of Operations in the same income statement line item in which the earnings effect of the hedged item is reported. We classify derivative cash flows as operating, investing or financing consistent with the nature of the underlying hedged item. For derivatives designated as cash flow hedges, if we conclude that the hedging relationship is perfectly effective at inception, a detailed effectiveness assessment in each period is not required as long as (i) the critical terms of the hedging instrument completely match the related terms of the hedged item (ii) it is considered probable that the counterparties to the hedging instrument and the hedged item will not default, and (iii) the hedged cash flows remain probable. If the conditions above are not met, we will assess prospective and retrospective effectiveness using the cumulative dollar-offset method, which compares the change in fair value or present value of cash flows of the hedging instrument to the changes in the fair value or present value of the cash flows of the hedged item. If the result of the quantification demonstrates that the hedge is still highly effective (meaning that cumulative changes in the fair value of the derivative are between 80% and 125% of the
Deferred Income Taxes	Deferred Income Taxes Deferred income taxes have been provided on items recognized for financial reporting purposes in different periods than for income tax purposes using tax rates in effect for the year in which the differences are expected to reverse. A valuation allowance is provided to reduce our deferred tax assets to an amount that is "more likely than not" to be realized. The ultimate realization of deferred tax assets depends upon generating sufficient taxable income of the right character during the periods in which the temporary differences become deductible, or before net operating loss and tax credit carryforwards expire. Evaluating the need for and quantifying the valuation allowance often requires significant judgment and extensive analysis of all the weighted positive and negative evidence available to the Company in order to determine whether all or some portion of the deferred tax assets will not be realized. Management continuously monitors the performance of entities and assesses the need for any further valuation allowances based on market performance and executability of tax planning actions and opportunities (including corporate restructuring). See Note 9, Income Taxes for more information. In accordance with guidance issued by the Financial Accounting Standards Board ("FASB"), we are choosing to treat the U.S. income tax consequences of Global Intangible Low-Taxed Income ("GILTI") as a period cost. As a result, at December 31, 2022, no deferred income taxes have been provided.
Uncertain Tax Positions	Uncertain Tax Positions We recognize the benefit of a tax position, if that position is more likely than not of being sustained on audit, based on the technical merits of the position. We record interest expense and penalties payable to relevant tax authorities in income taxes in our Consolidated Statements of Operations.
SG&A Expenses	SG&A Expenses SG&A expenses include costs associated with selling; marketing; distribution, including shipping and handling costs; advertising; net brochure costs; research and development; information technology; and other administrative costs, including finance, legal and human resource functions.
Shipping and Handling	Shipping and HandlingShipping and handling costs are expensed as incurred
Advertising	AdvertisingAdvertising costs, excluding brochure preparation costs, are expensed as incurred
Research and Development	Research and Development Research and development costs are expensed as incurred and amounted to $40.8 in 2022, $39.3 in 2021 and $36.5 in 2020. Research and development costs include all costs related to the design and development of new products such as salaries and benefits, supplies and materials and facilities costs.
Share-based Compensation	Share-based Compensation Where applicable, share-based payments to employees are recognized in the financial statements based on their fair value at the date of grant. If applicable, we use a Monte-Carlo simulation to calculate the fair value of performance restricted stock units with market conditions and the fair value of premium-priced stock options. We account for forfeitures on share-based payments as they occur. When the terms of an equity-settled award are modified, the minimum expense recognized is the grant date fair value of the unmodified award, provided the original vesting terms of the award are met. An additional expense, measured as at the date of modification, is recognized for any modification that increases the total fair value of the share-based payment. Where an award is cancelled, any unamortized compensation cost is expensed immediately. Subsequent to the Transaction with Natura &Co, our employees are considered employees of the parent company for purposes of applying ASC 718 Compensation—Stock Compensation. S hare-based payments made by Natura &Co to our employees are recognized in the financial statements based on their fair value at the date of grant.
Restructuring Expense	Restructuring ExpenseWe record the estimated expense for our restructuring initiatives, such as our Transformation Plan, Open Up & Grow and Avon Integration, when such costs are deemed probable and estimable, when approved by the appropriate corporate authority and by accumulating detailed estimates of costs for such plans. These expenses include the estimated costs of employee severance and related benefits, inventory write-offs, impairment or accelerated depreciation of property, plant and equipment and capitalized software, and any other qualifying exit costs. Such costs represent our best estimate, but require assumptions about the programs that may change over time, including attrition rates. Estimates are evaluated periodically to determine whether an adjustment is required.
Pension and Postretirement Expense	Pension and Postretirement ExpensePension and postretirement expense is determined based on a number of actuarial assumptions, which are generally reviewed and determined on an annual basis. These assumptions include the discount rate applied to plan obligations, the expected rate of return on plan assets, the rate of compensation increase of plan participants, price inflation, cost-of-living adjustments, mortality rates and certain other demographic assumptions, and other factors. Actual results that differ from assumptions are accumulated and amortized to expense over future periods and, therefore, generally affect recognized expense in future periods. We recognize the funded status of pension and other postretirement benefit plans in our Consolidated Balance Sheets. Each overfunded plan is recognized as an asset and each underfunded plan is recognized as a liability. The recognition of prior service costs or credits and net actuarial gains or losses, as well as subsequent changes in the funded status, are recognized as components of AOCI, net of tax, in shareholders’ equity, until they are amortized as a component of net periodic benefit cost. We recognize prior service costs or credits and actuarial gains and losses beyond a 10% corridor to earnings based on the estimated future service period of the participants. The determination of the 10% corridor utilizes a calculated value of plan assets for our more significant plans, whereby gains and losses are smoothed over three
Contingencies	Contingencies We determine whether to disclose and/or accrue for loss contingencies based on an assessment of the likelihood of a loss as being remote, reasonably possible or probable. We record loss contingencies when it is probable that a liability has been incurred and the amount of loss is reasonably estimable.
New Accounting Standards Implemented	New Accounting Standards Implemented Except for the changes below, we have consistently applied the accounting policies to all periods presented in these consolidated financial statements. ASU 2016-13, Financial Instruments - Credit Losses In June 2016, the FASB issued ASU 2016-13, Financial Instruments - Credit Losses, which requires measurement and recognition of expected credit losses for financial assets held. We adopted this new accounting guidance effective January 1, 2020, using a modified retrospective transition approach. The adoption did not have a material impact on our condensed consolidated financial statements and disclosures and did not significantly impact the Company’s accounting policies or estimation methods related to the allowance for doubtful accounts. The adoption resulted in a cumulative effect decrease to retained earnings of approximately $2 to reflect a change in the allowance for doubtful accounts. ASU 2018-14, Compensation - Retirement Benefits - Defined Benefit Plans In August 2018, the FASB issued ASU 2018-14, Compensation - Retirement Benefits - Defined Benefit Plans - General. ASU 2018-14 modifies the disclosure requirements for employers that sponsor defined benefit pension or other postretirement plans. Early adoption is permitted. The amendments in this Update are effective for fiscal years ending after December 15, 2020, therefore we adopted this standard effective December 31, 2020. The adoption did not have a material impact on our Consolidated Financial Statements. ASU 2017-04, Intangibles - Goodwill and other (Topic 350) In January 2017, the FASB issued Accounting Standards Update ("ASU") 2017-04 Intangibles - Goodwill and other, which simplifies the test for goodwill impairment. This Update eliminates Step 2 from the goodwill impairment test. In computing the implied fair value of goodwill under Step 2, an entity had to perform procedures to determine the fair value at the impairment testing date of its assets and liabilities (including unrecognized assets and liabilities) following the procedure that would be required in determining the fair value of the assets acquired and liabilities assumed in a business combination. Instead an entity should perform its annual, or interim, goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount. An entity should recognize an impairment charge for the amount by which the carrying amount exceeds the reporting unit's fair value, however the loss recognized should not exceed the total amount of goodwill allocated to the reporting unit. The guidance requires prospective adoption. We adopted the guidance for the goodwill impairment test that we have conducted since 2020, and adoption of the guidance did not have a material impact on our financial statements. ASU 2019-12, Simplifying the Accounting for Income Taxes In December 2019, the FASB issued ASU 2019-12, Income Taxes , which is intended to simplify the accounting standard and improve the usefulness of information provided in the financial statements. We adopted this new accounting guidance as of January 1, 2021. The adoption did not have a material impact on our Consolidated Financial Statements. ASU 2020-04 and ASU 2022-06, Reference Rate Reform (Topic 848) In March 2020, the FASB issued ASU 2020-04 “Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting,” which provides temporary optional guidance to ease the potential burden in accounting for reference rate reform. The ASU provides optional expedients and exceptions for applying generally accepted accounting principles to contract modifications and hedging relationships, subject to meeting certain criteria, that reference LIBOR or another reference rate expected to be discontinued. In January 2021, the FASB issued ASU 2021-01 which clarifies that certain optional expedients and exceptions in Topic 848 for contract modifications and hedge accounting apply to derivatives that are affected by the discounting transition. The guidance was initially effective for all entities as of March 12, 2020 through December 31, 2022, however, this was extended to December 31, 2024 following the issue of ASU 2022-06 “Reference Rate Reform (Topic 848): Deferral of the Sunset Date of Topic 848" in December 2022. The Company has implemented a transition plan to identify and modify its loans and other financial instruments with attributes that are either directly or indirectly influenced by LIBOR and, as a result, has elected to apply the optional expedient included in ASU 2020-04 to account for modifications of contracts within the scope of Topics 310, Receivables, and 470, Debt, to be accounted for by prospectively adjusting the effective interest rate. ASU 2021-08, Business Combinations (Topic 805) In October 2021, the FASB issued ASU 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers, which requires entities to apply Topic 606 to recognize and measure contract assets and contract liabilities in a business combination. ASU 2021-08 is effective for our fiscal year beginning after December 15, 2022. The adoption is not expected to have a material impact on our Consolidated Financial Statements. Accounting Standards to be Implemented ASU 2022-04, Disclosure supplier finance program (Topic 405-50) In September 2022, the FASB issued ASU 2022-04, Liabilities - Supplier Finance Programs (Subtopic 405-50): Disclosure of Supplier Finance Program Obligations that will require a buyer in a supplier finance program to disclose sufficient information about the program to allow a user of the financial statements to understand the program's nature, activity during the period, changes from period to period, and potential magnitude. Disclosures will include key terms of the program, including payment terms, along with the amount of related obligations, the financial statement caption that includes such obligations, and a rollforward of activity related to the obligations during the period. ASU 2022-04 is effective for Company beginning with the quarter ending March 31, 2023, except for the roll forward requirement which is effective for the Company beginning with the quarter ending March 31, 2024. No impact will arise on the Company's financial condition, results of operations or cash flows as a result of the application of this accounting standard.

Discontinued Operations and A_2

Discontinued Operations and Assets and Liabilities Held for Sale (Tables)	12 Months Ended
	Dec. 31, 2022
Discontinued Operations and Disposal Groups [Abstract]
Schedule of Discontinued Operations	The major classes of financial statement components comprising the loss on discontinued operations, net of tax for New Avon are shown below: Year Ended December 31, 2022 Year Ended December 31, 2021 Year Ended December 31, 2020 Selling, general and administrative expenses $ (73.2) $ (18.5) $ (27.9) Operating loss $ (73.2) $ (18.5) $ (27.9) Loss from discontinued operations, net of tax $ (73.2) $ (18.5) $ (27.9) The major classes of assets and liabilities comprising held for sale assets and held for sale liabilities on the Consolidated Balance Sheet at December 31, 2022 and December 31, 2021 are shown in the following table. Year ended December 31, 2022 2021 Current held for sale assets Property, Plant & Equipment (net) — 2.8 $ — $ 2.8 Current held for sale liabilities Accounts payable $ — $ — Other liabilities — — $ — $ —

Related Party Transactions (Tab

Related Party Transactions (Tables)	12 Months Ended
	Dec. 31, 2022
Related Party Transactions [Abstract]
Schedule of Related Party Transactions	The following tables present the related party transactions with Natura &Co and its affiliates and the Instituto Avon in Brazil, all of which were on an arm's-length basis. There are no other related party transactions. Year Ended December 31, Year Ended December 31, Year Ended December 31, 2022 2021 2020 Statement of Operations Data Revenue from affiliates of Natura &Co (2)(3) $ 21.7 $ 25.2 $ 6.7 Cost of sales from affiliates of Natura &Co (2)(3) $ (20.4) $ (22.4) $ (5.9) Gross profit from affiliates of Natura &Co (2)(3) $ 1.3 $ 2.8 $ .8 Interest income from Instituto Avon (1) $ — $ — $ .1 Interest expense on Loan from affiliates of Natura &Co (5) $ (93.8) $ (50.6) $ (7.5) Interest income on Loan to affiliates of Natura &Co (5) $ 3.9 $ 1.6 $ — Year Ended December 31,2022 Year Ended December 31,2021 Balance Sheet Data Trade Receivables due from affiliates of Natura &Co (2) $ 30.7 $ 32.7 Derivative Receivables due from affiliates of Natura &Co (8) $ 9.5 $ — Other receivables due from affiliates of Natura &Co (7) $ 32.7 $ 1.4 Loans to affiliates of Natura &Co maturing within one year (7) $ 72.2 $ 46.6 Loans to affiliates of Natura &Co maturing after one year (7) $ 54.8 $ 46.7 Right-of-use asset from affiliates of Natura &Co (9) $ 6.0 $ — Trade Payables due to affiliates of Natura &Co (7) $ (33.7) $ (24.5) Derivative Payables due to affiliates of Natura &Co (8) $ (12.9) $ — Other payables due to affiliates of Natura &Co (4) $ (11.5) $ (4.9) Loans from affiliates of Natura &Co maturing within one year (5) $ (537.2) $ (371.7) Loans from affiliates of Natura &Co maturing after one year (5) $ (1,427.2) $ (736.3) Lease liability to affiliates of Natura &Co (9) $ (6.0) $ — Investments in affiliates of Natura &Co (6) $ .1 $ .1 (1) During the second quarter of 2018, the Company entered into an agreement to loan the Instituto Avon, an independent non-government charitable organization in Brazil, R$12 (Brazilian real) for an unsecured 5-year term at a fixed interest rate of 7% per annum, to be paid back in five equal annual installments. The Instituto Avon was created by an Avon subsidiary in Brazil, with the board and executive team comprised of Avon Brazil management. The purpose of the loan was to provide the Instituto Avon with the means to donate funds to Fundação Pio XII (a leading cancer prevention and treatment organization in Brazil and owner of the Hospital do Câncer de Barretos), in order to invest in equipment with the objective of expanding breast cancer prevention and treatment. During the fourth quarter of 2021, the loan was repaid in full. (2) During the second quarter of 2020, the Company entered into manufacturing agreements with affiliates of Natura &Co Holding. The Company recorded revenue from related party of $21.7, $25.2 and $6.7 associated with these agreements during the years ended December 31, 2022, 2021 and 2020, respectively. The Company recorded gross profit from related party of $1.3, $2.8 and $.8 associated with these agreements during the years ended December 31, 2022, 2021 and 2020, respectively. Trade receivables due from affiliates of Natura &Co primarily relate to these manufacturing agreements. (3) The Company is party to a license agreement with Avon Mexico, whereby Avon Mexico pays the Company a variable royalty. The Company recorded revenue and gross profit from related party of nil associated with these agreements during the year ended December 31, 2022, respectively. The Company recorded revenue and gross profit of $1 and $1, respectively, from related party associated with these agreements during the year ended December 31, 2021. (4) T he payable to Natura &Co relates to the vesting and settlement of share based compensation awards denominated in Natura &Co American Depository Receipts including the 2018 and 2019 long-term employee incentive program which vested and were automatically exercised in March 2021 and March 2022, respectively. (5) Loans from affiliates of Natura &Co Holding at December 31, 2022 of $1,964.4 include $692.2 outstanding under a Promissory Note with Avon Beauty Limited with a maturity date of December 6, 2028, $405 outstanding under a Promissory Note with Avon Products, Inc. with a maturity date of May 17, 2029 and $330 outstanding under two Promissory Notes with Avon Cosmetics Limited with maturity dates of May 17, 2029 and June 28, 2029. In addition loans from affiliates of Natura &Co Holding at December 31, 2022 of $537.2 include of intercompany loans between Avon Luxembourg and Avon Products, Inc. affiliates that, following the sale of Avon Luxembourg to a subsidiary of Natura &Co Holding on July 1, 2021, were redesignated as loans from affiliates of Natura & Co Holding. Loans from affiliates of Natura &Co Holding at December 31, 2021 of $1,108.0 include $736.3 outstanding under a Promissory Note between Avon Beauty Limited and a subsidiary of Natura &Co Holding, and $207.3 outstanding under a Promissory Note with a subsidiary of Natura &Co Holding and an affiliate of the Company. In addition loans from affiliates of Natura &Co Holding at December 31, 2021 include $164.4 of intercompany loans between Avon Luxembourg and Avon Products, Inc. affiliates that, following the sale of Avon Luxembourg to a subsidiary of Natura &Co Holding on July 1, 2021, were redesignated as loans from affiliates of Natura & Co Holding. See Note 7, Debt and Other Financing, for further information relating to these loans. (6) During the second quarter of 2021, Avon Cosméticos LTDA., made an investment of R$.5 in Natura &Co Pay Holding Financeira S.A., representing a 10% holding in the company. This is presented in other assets in our Consolidated Balance Sheets. (7) On July 1, 2021, the Company sold Avon Luxembourg, including our Mexican business, to a subsidiary of Natura &Co Holding. As a result, transactions and balances between Avon International and Avon Luxembourg are no longer eliminated on consolidation and instead are treated as transactions and balances with Related Parties. (8) During the first quarter of 2022, the Company entered into foreign exchange forward contracts with Natura &Co Luxembourg, a subsidiary of Natura &Co Holding, to manage a portion of its foreign currency exchange rate exposures. At December 31, 2022, we had outstanding related party foreign exchange forward contracts with notional amounts totaling approximately $546 for various currencies for up to 12 months, of which $290 were designated as cash flow hedges. In addition we had $9.5 of Accounts Receivable and $12.9 of Accounts Payable recorded in our Consolidated Balance Sheets associated with these transactions, all of which are expected to be reclassified into earnings within the next 12 months.

Revenue (Tables)

Revenue (Tables)	12 Months Ended
	Dec. 31, 2022
Revenue from Contract with Customer [Abstract]
Summary of Disaggregation of Revenue by Product and Service	In the following tables, revenue is disaggregated by product or service type. All revenue is recognized at a point in time, when control of a product is transferred to a customer: Twelve Months Ended December 31, 2022 Reportable segments Avon International Avon LATAM Total reportable segments Affiliates of Natura Total Beauty: Skincare $ 458.7 $ 415.4 $ 874.1 $ — $ 874.1 Fragrance 442.7 352.3 795.0 — 795.0 Color 187.9 184.6 372.5 — 372.5 Total Beauty 1,089.3 952.3 2,041.6 — 2,041.6 Fashion & Home: Fashion 197.2 93.5 290.7 — 290.7 Home 51.3 226.9 278.2 — 278.2 Total Fashion & Home 248.5 320.4 568.9 — 568.9 Certain Brazil indirect taxes* — (10.0) (10.0) — (10.0) Product sales 1,337.8 1,262.7 2,600.5 — 2,600.5 Representative fees** 78.0 68.4 146.4 — 146.4 Other .1 0.5 0.6 21.7 22.3 Other revenue 78.1 68.9 147.0 21.7 168.7 Total revenue $ 1,415.9 $ 1,331.6 $ 2,747.5 $ 21.7 $ 2,769.2 Twelve Months Ended December 31, 2021 Reportable segments Avon International Avon LATAM Total reportable segments Affiliates of Natura Total Beauty: Skincare $ 577.6 $ 465.8 $ 1,043.4 $ — $ 1,043.4 Fragrance 514.2 375.8 890.0 — 890.0 Color 238.0 181.9 419.9 — 419.9 Total Beauty 1,329.8 1,023.5 2,353.3 — 2,353.3 Fashion & Home: Fashion 258.3 159.8 418.1 — 418.1 Home 69.6 340.4 410.0 — 410.0 Total Fashion & Home 327.9 500.2 828.1 — 828.1 Certain Brazil indirect taxes* — 21.5 21.5 — 21.5 Product sales 1,657.7 1,545.2 3,202.9 — 3,202.9 Representative fees 66.4 107.8 174.2 — 174.2 Other .5 1.7 2.2 25.2 27.4 Other revenue 66.9 109.5 176.4 25.2 201.6 Total revenue $ 1,724.6 $ 1,654.7 $ 3,379.3 $ 25.2 $ 3,404.5 Twelve Months Ended December 31, 2020 Reportable segments Avon International Avon LATAM Total reportable segments Affiliates of Natura Total Beauty: Skincare $ 594.7 $ 515.9 $ 1,110.6 $ — $ 1,110.6 Fragrance 516.0 456.4 972.4 — 972.4 Color 265.8 197.5 463.3 — 463.3 Total Beauty 1,376.5 1,169.8 2,546.3 — 2,546.3 Fashion & Home: Fashion 267.4 192.5 459.9 — 459.9 Home 55.6 369.4 425.0 — 425.0 Total Fashion & Home 323.0 561.9 884.9 — 884.9 Product sales 1,699.5 1,731.7 3,431.2 — 3,431.2 Representative fees 66.7 108.4 175.1 — 175.1 Other 6.4 5.8 12.2 6.7 18.9 Other revenue 73.1 114.2 187.3 6.7 194.0 Total revenue $ 1,772.6 $ 1,845.9 $ 3,618.5 $ 6.7 $ 3,625.2 * The years ended December 31, 2022 and 2021 include impact of certain Brazil indirect taxes which resulted in an approximate cost of $10 and benefit of $22, respectively. See Note 19 Supplemental Balance Sheet Information. ** In June 2022, an Avon subsidiary concluded the negotiation of a settlement agreement to resolve a breach of contract dispute in Japan. As a result, Avon received cash compensation of $27, $3.3 of which related to the settlement of historically recognized revenues. The remaining $23.7 was recognized as revenue in the quarter ended June 30, 2022.
Summary of Receivables and Contract Liabilities	The following table provides information about receivables and contract liabilities from contracts with customers at December 31, 2022 and 2021: December 31, 2022 December 31, 2021 Accounts receivable, net of allowances of $35.4 and $37.1 $ 183.4 $ 198.7 Contract liabilities $ 31.6 $ 37.1

Inventories (Tables)

Inventories (Tables)	12 Months Ended
	Dec. 31, 2022
Inventory, Net [Abstract]
Components of Inventories	Inventories at December 31 consisted of the following: 2022 2021 Raw materials $ 91.2 $ 103.4 Finished goods 241.0 280.7 Total $ 332.2 $ 384.1

Debt and Other Financing (Table

Debt and Other Financing (Tables)	12 Months Ended
	Dec. 31, 2022
Debt Disclosure [Abstract]
Schedule of Debt	Debt at December 31 consisted of the following: 2022 2021 Debt maturing within one year: Short term debt $ 5.7 $ 32.6 Loans from affiliates of Natura &Co 537.2 371.7 Total $ 542.9 $ 404.3 Long-term debt: Finance lease liabilities 0.8 1.3 5.00% Notes, due March 2023 — 460.8 6.95% Notes, due March 2043 214.0 213.9 Loans from affiliates of Natura &Co, due 2028 and 2029 1,427.2 736.3 Total 1,642.0 1,412.3
Schedule of Carrying Values of Debt Instrument	At December 31, 2022 and 2021, the carrying values of our unsecured notes were comprised of the following: 2022 2021 Remaining Principal Unamortized Discounts Unamortized Debt Issuance Costs Total Remaining Principal Unamortized Discounts Unamortized Debt Issuance Costs Total 5.00% Notes, due March 2023 — — — — 461.9 (.5) (.6) 460.8 6.95% Notes, due March 2043 216.1 (1.6) (.5) 214.0 216.1 (1.7) (.5) 213.9
Schedule of Maturities of Long-term Debt	Annual maturities of long-term debt, which includes our notes, loans from affiliates of Natura &Co and capital leases outstanding at December 31, 2022, are as follows: 2023 2024 2025 2026 2027 2028 and Beyond Total Maturities $ — $ .5 $ .3 $ .2 $ — $ 1,643.3 $ 1,644.3

Accumulated Other Comprehensi_2

Accumulated Other Comprehensive Income (Loss) (Tables)	12 Months Ended
	Dec. 31, 2022
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Schedule of Accumulated Other Comprehensive Income (Loss)	The tables below present the changes in AOCI by component and the reclassifications out of AOCI during 2022 and 2021: Foreign Currency Translation Adjustments Net Investment Hedges Cash Flow Hedges Pension and Postretirement Benefits Total Balance at December 31, 2021 $ (1,062.2) $ (4.3) $ — $ (19.0) $ (1,085.5) Other comprehensive income other than reclassifications 44.1 — 0.3 (16.0) 28.4 Reclassifications into earnings: Amortization of net actuarial loss and prior service cost, net of tax of $.8 (1) — — — 4.9 4.9 Total reclassifications into earnings — — — 4.9 4.9 Balance at December 31, 2022 $ (1,018.1) $ (4.3) $ 0.3 $ (30.1) $ (1,052.2) Foreign Currency Translation Adjustments Net Investment Hedges Pension and Postretirement Benefits Total Balance at December 31, 2020 $ (1,038.2) $ (4.3) $ (91.3) $ (1,133.8) Other comprehensive income (loss) other than reclassifications (24.1) — 67.3 43.2 Sale of Avon Luxembourg .1 (.1) — Reclassifications into earnings: Amortization of net actuarial loss and prior service cost, net of tax of $.8 (1) — — 5.1 5.1 Total reclassifications into earnings — — 5.1 5.1 Balance at December 31, 2021 $ (1,062.2) $ (4.3) $ (19.0) $ (1,085.5) (1) Gross amount reclassified to other expense, net, and related taxes reclassified to income taxes.

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Dec. 31, 2022
Income Tax Disclosure [Abstract]
Schedule of Income from Continuing Operations before Taxes	Income from continuing operations, before taxes for the years ended December 31 was as follows: 2022 2021 2020 United States $ (23.8) $ 19.3 $ (89.6) Foreign (293.5) (178.1) (214.0) Total $ (317.3) $ (158.8) $ (303.6)
Schedule of Provision for Income Taxes	The provision for income taxes for the years ended December 31 was as follows: 2022 2021 2020 Federal: Current $ — $ 0.2 $ (9.5) Deferred — — 8.9 Total Federal — .2 (0.6) Foreign: Current 25.6 35.5 31.4 Deferred 11.8 (20.0) 2.6 Total Foreign 37.4 15.5 34.0 State and Local: Current — .5 .6 Deferred — — — Total State and other — .5 .6 Total $ 37.4 $ 16.2 $ 34.0
Schedule of Effective Tax Rate	The continuing operations effective tax rate for the years ended December 31 was as follows: 2022 2021 2020 Statutory federal rate 21.0 % 21.0 % 21.0 % State and local taxes, net of federal tax benefit — (.3) (.2) Tax on foreign income 10.8 67.1 (1.8) Tax on uncertain tax positions .6 3.7 1.1 Reorganizations — — (10.0) Net change in valuation allowances (44.6) (103.1) (21.4) Other .4 1.4 .1 Effective tax rate (11.8) % (10.2) % (11.2) %
Schedule of Deferred Tax Assets and Liabilities	Deferred tax assets (liabilities) at December 31 consisted of the following: 2022 2021 Deferred tax assets: Tax loss and deduction carryforwards $ 478.5 $ 425.0 Intangibles 187.6 218.5 Tax credit carryforwards 120.3 119.7 Interest carryforwards 93.6 76.3 All other future deductions 168.4 199.8 Valuation allowance (941.4) (815.4) Total deferred tax assets 107.0 223.9 Deferred tax liabilities $ (59.2) $ (105.0) Net deferred tax assets $ 47.8 $ 118.9 Deferred tax assets (liabilities) at December 31 were classified as follows: 2022 2021 Deferred tax assets: Other assets $ 52.1 $ 121.4 Total deferred tax assets 52.1 121.4 Deferred tax liabilities: Long-term income taxes $ (4.3) $ (2.5) Total deferred tax liabilities (4.3) (2.5) Net deferred tax assets $ 47.8 $ 118.9
Reconciliation of Beginning and Ending Amount of Unrecognized tax benefits	A reconciliation of the beginning and ending amount of unrecognized tax benefits is as follows: Balance at December 31, 2019 331.7 Additions based on tax positions related to the current year 90.6 Additions for tax positions of prior years .6 Reductions for tax positions of prior years (34.1) Reductions due to lapse of statute of limitations (16.5) Reductions due to settlements with tax authorities (.2) Balance at December 31, 2020 372.1 Additions based on tax positions related to the current year 6.8 Additions for tax positions of prior years 24.1 Reductions for tax positions of prior years (136.8) Reductions due to lapse of statute of limitations (11.2) Reductions due to settlements with tax authorities (3.3) Balance at December 31, 2021 251.7 Additions based on tax positions related to the current year 3.3 Additions for tax positions of prior years — Reductions for tax positions of prior years (1.8) Reductions due to lapse of statute of limitations (1.1) Reductions due to settlements with tax authorities (2.3) Balance at December 31, 2022 $ 249.8
Tax Years Remaining	As of December 31, 2022, the tax years that remained subject to examination by major tax jurisdiction for our most significant subsidiaries were as follows: Jurisdiction Open Years Brazil 2017-2022 Philippines 2017, 2019-2022 Poland 2014-2022 Russia 2020-2022 United Kingdom 2020-2022 United States (Federal) 2017-2022

Financial Instruments and Ris_2

Financial Instruments and Risk Management (Tables)	12 Months Ended
	Dec. 31, 2022
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Fair Value of Derivative Instruments	The following table presents the fair value of derivative instruments at December 31, 2022: Asset Liability Balance Sheet Fair Balance Sheet Fair Derivatives designated as hedges: Foreign exchange forward contracts Prepaid expenses and other $ 9.2 Accounts payable $ 9.1 Derivatives not designated as hedges: Foreign exchange forward contracts Prepaid expenses and other $ .6 Accounts payable $ 4.6 Total derivatives $ 9.8 $ 13.7 Derivatives are recognized in the Consolidated Balance Sheets at their fair values. The following table presents the fair value of derivative instruments at December 31, 2021: Asset Liability Balance Sheet Fair Balance Sheet Fair Derivatives not designated as hedges: Foreign exchange forward contracts Prepaid expenses and other $ — Accounts payable $ 2.7 Total derivatives $ — $ 2.7 The following table presents the fair value hierarchy for those assets and liabilities measured at fair value on a recurring basis at December 31, 2022: Level 1 Level 2 Total Assets: Foreign exchange forward contracts $ — $ .3 $ .3 Total $ — $ .3 $ .3 Liabilities: Foreign exchange forward contracts $ — $ — $ — Total $ — $ — $ — The following table presents the fair value hierarchy for those assets and liabilities measured at fair value on a recurring basis at December 31, 2021: Level 1 Level 2 Total Liabilities: Foreign exchange forward contracts $ — $ 2.7 $ 2.7 Total $ — $ 2.7 $ 2.7

Fair Value (Tables)

Fair Value (Tables)	12 Months Ended
	Dec. 31, 2022
Fair Value Disclosures [Abstract]
Fair Value of Hierarchy	The following table presents the fair value of derivative instruments at December 31, 2022: Asset Liability Balance Sheet Fair Balance Sheet Fair Derivatives designated as hedges: Foreign exchange forward contracts Prepaid expenses and other $ 9.2 Accounts payable $ 9.1 Derivatives not designated as hedges: Foreign exchange forward contracts Prepaid expenses and other $ .6 Accounts payable $ 4.6 Total derivatives $ 9.8 $ 13.7 Derivatives are recognized in the Consolidated Balance Sheets at their fair values. The following table presents the fair value of derivative instruments at December 31, 2021: Asset Liability Balance Sheet Fair Balance Sheet Fair Derivatives not designated as hedges: Foreign exchange forward contracts Prepaid expenses and other $ — Accounts payable $ 2.7 Total derivatives $ — $ 2.7 The following table presents the fair value hierarchy for those assets and liabilities measured at fair value on a recurring basis at December 31, 2022: Level 1 Level 2 Total Assets: Foreign exchange forward contracts $ — $ .3 $ .3 Total $ — $ .3 $ .3 Liabilities: Foreign exchange forward contracts $ — $ — $ — Total $ — $ — $ — The following table presents the fair value hierarchy for those assets and liabilities measured at fair value on a recurring basis at December 31, 2021: Level 1 Level 2 Total Liabilities: Foreign exchange forward contracts $ — $ 2.7 $ 2.7 Total $ — $ 2.7 $ 2.7
Fair Value of Financial Instruments	The net asset (liability) amounts recorded in the balance sheet (carrying amount) and the estimated fair values of our remaining financial instruments at December 31 consisted of the following: 2022 2021 Carrying Fair Value Carrying Fair Value Available-for-sale securities $ — $ — $ — $ — Loans to affiliates of Natura &Co maturing within one year 72.2 72.2 46.6 46.6 Loans to affiliates of Natura &Co maturing after one year 54.8 54.8 46.7 46.7 Debt maturing within one year (5.7) (5.7) (32.6) (32.6) Loans from affiliates of Natura &Co maturing within one year (537.2) (537.2) (371.7) (371.7) Long-term debt (1) (214.8) (206.8) (676.0) (754.2) Loans from affiliates of Natura &Co maturing after one year (1,427.2) (1,427.2) (736.3) (736.3) Foreign exchange forward contracts .3 .3 (2.7) (2.7) (1) The carrying value of long-term debt is presented net of debt issuance costs and includes any related discount or premium, as applicable.

Share-Based Compensation Plans

Share-Based Compensation Plans (Tables)	12 Months Ended
	Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]
Schedule of Allocation of Share-based Compensation Costs	For the years ended December 31: 2022 2021 2020 Compensation cost for stock-based compensation $ 13.1 $ 13.4 $ 24.9 Total income tax (cost)/ benefit recognized for share-based arrangements .7 (.2) 1.9
Schedule of Valuation Assumptions	When estimating the fair value of each option, we used the following weighted-average assumptions for options granted during the year ended December 31, 2019: 2019 Risk-free rate (1) 2.4% Expected term (2) 7 years Expected Avon volatility (3) 45% Expected dividends —% (1) The risk-free rate was based upon the rate on a zero coupon U.S. Treasury bill, for periods within the contractual life of the option, in effect at the time of grant. (2) The expected term of the option was based on the vesting terms of the respective option and a contractual life of 10 years. (3) Expected Avon volatility was based on the daily historical volatility of our stock price, over a period similar to the expected life of the option.
Schedule of Share-based Payment Award, Performance Restricted Stock Units, Valuation Assumptions	When estimating the fair value of the PRSUs, we used the following weighted-average assumptions: 2019 PRSUs Risk-free rate (1) 2.4% Expected Avon volatility (2) 54.8% Expected average volatility (3) 29.9% Expected dividends —% (1) The risk-free rate was based upon the rate on a zero coupon U.S. Treasury bill, for periods within the three year performance period, in effect at the time of grant. (2) Expected Avon volatility was based on the weekly historical volatility of our stock price, over a period similar to the three year performance period of the 2019 PRSUs. (3) Expected average volatility was based on the weekly historical volatility of the stock prices of each member of companies included in the S&P 400 index as of the date of the grant, over a period similar to the three year performance period of the 2019 PRSUs.
Schedule of Options Activity During Period	A summary of options at December 31, 2022 and changes during 2022, is as follows: Nominal cost options Weighted-Average January 1, 2022 2,326 $ 10.00 Granted 355 3.38 Exercised (902) (12.36) Forfeited (77) (9.13) Modified from option to restricted units 1 (550) $ (8.73) Outstanding at December 31, 2022 1,152 $ 6.78
Schedule of Share-Based Compensation Performance Restricted Stock Units Activity	A summary of performance share units at December 31, 2022 and changes during 2022, is as follows: Performance Share Units Weighted-Average January 1, 2022 1,854 $ 19.78 Granted 1,226 9.96 Exercised (2) (16.99) Forfeited (563) (16.31) Modified from option to restricted units (refer footnote 1) 550 $ 5.82 Outstanding at December 31, 2022 3,065 $ 15.03

Employee Benefit Plans (Tables)

Employee Benefit Plans (Tables)	12 Months Ended
	Dec. 31, 2022
Retirement Benefits, Description [Abstract]
Summary of Defined Benefit Pension and Postretirement Plans	The following table summarizes changes in the benefit obligation, plan assets and the funded status of our significant defined benefit pension and postretirement plans. We use a December 31 measurement date for all of our employee benefit plans. Pension Plans U.S. Plans Non-U.S. Plans Postretirement Benefits 2022 2021 2022 2021 2022 2021 Change in Benefit Obligation: Beginning balance $ (60.3) $ (67.9) $ (671.2) $ (767.5) $ (9.7) $ (7.7) Service cost (.8) (.9) (2.9) (4.3) — — Interest cost (1.7) (1.0) (11.0) (8.7) (.3) (.3) Actuarial gain (loss) 9.5 1.8 185.1 54.6 .8 .4 Benefits paid 6.7 7.7 22.2 25.7 2.3 .6 Actual expenses and taxes — — .4 .4 — — Curtailments (.4) — — .2 — — Settlements — — .4 1.8 — — Special termination benefits — — — — — (3.0) Foreign currency changes and other — — 58.2 13.5 (.3) .3 Sale of Avon Luxembourg — — — 13.1 — — Ending balance $ (47.0) $ (60.3) $ (418.8) $ (671.2) $ (7.2) $ (9.7) Change in Plan Assets: Beginning balance $ 54.3 $ 59.7 $ 764.4 $ 762.0 $ — $ — Actual return on plan assets (11.6) 1.6 (177.7) 29.3 — — Company contributions .7 0.7 (3.1) 10.1 2.3 .6 Benefits paid (6.7) (7.7) (22.2) (25.7) (2.3) (.6) Actual expenses and taxes — — (.4) (0.4) — — Settlements — — (0.4) (1.8) — — Transfers — — — — — — Foreign currency changes and other — — (70.6) (9.1) — — Ending balance $ 36.7 $ 54.3 $ 490.0 $ 764.4 $ — $ — Funded Status: Funded status at end of year $ (10.3) $ (6.0) $ 71.2 $ 93.2 $ (7.2) $ (9.7) Amount Recognized in Balance Sheet: Other assets $ — $ — $ 110.8 $ 162.4 $ — $ — Accrued compensation (.8) (.7) (1.2) (1.2) (4.2) (6.3) Employee benefit plans liability (9.5) (5.3) (38.4) (68.0) (3.0) (3.4) Net amount recognized $ (10.3) $ (6.0) $ 71.2 $ 93.2 $ (7.2) $ (9.7) Pretax Amounts Recognized in Accumulated Other Comprehensive Loss: Net actuarial loss $ 16.8 $ 14.7 $ 115.3 $ 122.8 — $ 0.8 Prior service (credit) cost — — 1.7 2.0 (.7) (0.8) Total pretax amount recognized $ 16.8 $ 14.7 $ 117.0 $ 124.8 $ (.7) $ — Supplemental Information: Accumulated benefit obligation $ 46.6 $ 59.5 $ 108.2 $ 159.4 N/A N/A Plans with Projected Benefit Obligation in Excess of Plan Assets: Projected benefit obligation $ 47.1 $ 60.3 $ 115.9 $ 170.0 N/A N/A Fair value plan assets 36.7 54.3 76.3 100.8 N/A N/A Plans with Accumulated Benefit Obligation in Excess of Plan Assets: Accumulated benefit obligation 46.6 59.5 103.4 153.6 N/A N/A Fair value plan assets 36.7 54.3 68.5 91.7 N/A N/A
Schedule of Components of Net Periodic Benefit Cost and Other Amounts Recognized in Other Comprehensive Income	Components of Net Periodic Benefit Cost and Other Amounts Recognized in Other Comprehensive Loss Pension Benefits U.S. Plans Non-U.S. Plans Postretirement Benefits 2022 2021 2020 2022 2021 2020 2022 2021 2020 Net Periodic Benefit Cost: Service cost $ .8 $ .9 $ 1.2 $ 2.9 $ 4.3 $ 4.3 $ — $ — $ — Interest cost 1.7 1.0 1.4 11.0 8.7 11.7 .3 .3 .7 Expected return on plan assets (2.1) (2.0) (2.6) (14.2) (16.0) (16.0) — — — Amortization of prior service credit — — — .1 — (.1) (.1) (4.5) (.2) Amortization of net actuarial losses 1.1 2.4 2.9 4.1 7.5 6.3 .1 .7 — Amortization of transition obligation — — — — — — — — — Settlements/curtailments 1.5 1.0 2.6 — .1 .1 — — — Special termination benefits — — — — — — — 3.0 (4.2) Net periodic benefit cost $ 3.0 $ 3.3 $ 5.5 $ 3.9 $ 4.6 $ 6.3 $ .3 $ (.5) $ (3.7) Other Changes in Plan Assets and Benefit Obligations Recognized in Other Comprehensive (Loss) Income: Actuarial losses (gains) $ 4.6 $ (1.4) $ .8 $ 6.8 $ (68.1) $ 15.9 $ (.7) $ (.4) $ 1.5 Prior service cost (credit) — — — (.1) — — .1 4.5 (4.1) Amortization of prior service credit — — — — — — — — .2 Amortization of net actuarial losses (2.6) (3.4) (5.5) (4.1) (7.6) (6.4) (.1) (.7) (1.6) Foreign currency changes — — — (10.5) (5.9) 11.6 — — — Total recognized in other comprehensive loss* $ 2.0 $ (4.8) $ (4.7) $ (7.9) $ (81.6) $ 21.1 $ (.7) $ 3.4 $ (4.0) Total recognized in net periodic benefit cost and other comprehensive loss $ 5.0 $ (1.5) $ .8 $ (4.0) $ (77.0) $ 27.4 $ (.4) $ 2.9 $ (7.7) * Amounts represent the pre-tax effect classified within other comprehensive loss. The net of tax amounts are classified within our Consolidated Statements of Comprehensive Loss.
Weighted-Average Assumptions Used to Determine Benefit Obligations	Weighted-average assumptions used to determine benefit obligations recorded in our Consolidated Balance Sheets as of December 31 were as follows: Pension Benefits Postretirement U.S. Plans Non-U.S. Plans Benefits 2022 2021 2022 2021 2022 2021 Discount rate 5.19 % 2.81 % 4.79 % 2.09 % 7.67 % 3.61 % Rate of compensation increase 4.00 % 4.00 % 3.16 % 2.56 % N/A N/A Interest crediting rate 3.99 % 1.78 % 2.74 % 2.75 % N/A N/A
Weighted-Average Assumptions Used to Determine Net Benefit Cost	Weighted-average assumptions used to determine net benefit cost recorded in our Consolidated Statements of Operations for the years ended December 31 were as follows: Pension Benefits U.S. Plans Non-U.S. Plans Postretirement Benefits 2022 2021 2020 2022 2021 2020 2022 2021 2020 Discount rate 2.81 % 2.42 % 3.16 % 1.97 % 1.45 % 2.05 % 3.61 % 3.95 % 3.66 % Rate of compensation increase 4.00 % 4.00 % 4.00 % 2.38 % 2.51 % 2.54 % N/A N/A N/A Rate of return on assets 4.60 % 4.15 % 4.90 % 2.19 % 2.32 % 2.55 % N/A N/A N/A Interest crediting rate 1.94 % 1.49 % 2.49 % 2.75 % 2.74 % 2.69 % N/A N/A N/A
Pension and Postretirement Plans Target and Weighted-Average Asset Allocations	Our U.S. and non-U.S. funded defined benefit pension plans target and weighted-average asset allocations at December 31, 2022 and 2021, by asset category were as follows: U.S. Pension Plan Non-U.S. Pension Plans % of Plan Assets % of Plan Assets Target at Year-End Target at Year-End Asset Category 2023 2022 2021 2023 2022 2021 Equity securities 30 % 31 % 30 % 17 % 18 % 23 % Debt securities 70 69 70 60 86 72 Other — — — 23 (4) 5 Total 100 % 100 % 100 % 100 % 100 % 100 %
Schedule Of Fair Value Hierarchy For Pension And Postretirement Assets	The following tables present the fair value hierarchy for pension assets measured at fair value on a recurring basis at December 31, 2022 : U.S. Pension Plan Asset Category Level 1 Level 2 Total Equity Securities: Domestic equity $ — $ 5.6 $ 5.6 International equity — 5.7 5.7 Emerging markets — — — — 11.3 11.3 Fixed Income Securities: Corporate bonds — 15.2 15.2 Government securities — 5.1 5.1 Other — 5.1 5.1 — 25.4 25.4 Other Cash — — — — — — Total $ — $ 36.7 $ 36.7 Non-U.S. Pension Plans Asset Category Level 1 Level 2 Level 3 Total Equity Securities: Domestic equity $ — $ 20.6 $ — $ 20.6 International equity — 67.9 — 67.9 — 88.5 — 88.5 Fixed Income Securities: Corporate bonds — 140.0 — 140.0 Government securities — 189.2 — 189.2 Other — 92.1 — 92.1 — 421.3 — 421.3 Other Cash 1.4 — — 1.4 Derivatives — (23.4) — (23.4) Real estate — — 2.1 2.1 Other — — .1 .1 1.4 (23.4) 2.2 (19.8) Total $ 1.4 $ 486.4 $ 2.2 $ 490.0 The following tables present the fair value hierarchy for pension assets measured at fair value on a recurring basis at December 31, 2021: U.S. Pension Plan Asset Category Level 1 Level 2 Total Equity Securities: Domestic equity $ — $ 8.3 $ 8.3 International equity — 6.6 6.6 Emerging markets — 1.6 1.6 — 16.5 16.5 Fixed Income Securities: Corporate bonds — 21.6 21.6 Government securities — 8.8 8.8 Other — 7.3 7.3 — 37.7 37.7 Cash — .1 .1 Total $ — $ 54.3 $ 54.3 Non-U.S. Pension Plans Asset Category Level 1 Level 2 Level 3 Total Equity Securities: Domestic equity $ — $ 29.4 $ — $ 29.4 International equity — 145.2 — 145.2 — 174.6 — 174.6 Fixed Income Securities: Corporate bonds — 257.6 — 257.6 Government securities — 256.9 — 256.9 Other — 36.5 — 36.5 — 551.0 — 551.0 Other: Cash 34.3 — — 34.3 Derivatives — 2.2 — 2.2 Real estate — — 2.3 2.3 34.3 2.2 2.3 38.8 Total $ 34.3 $ 727.8 $ 2.3 $ 764.4
Reconciliation of Beginning and Ending Balance For Our Level 3 Investments	A reconciliation of the beginning and ending balances for our Level 3 investments is provided in the table below: Amount Balance at January 1, 2021 $ 1.6 Balance at December 31, 2021 2.3 Actual return on plan assets held (.2) Balance at December 31, 2022 2.1
Schedule of Expected Benefit Payments	Total benefit payments expected to be paid from the plans are as follows: Pension Benefits U.S. Plans Non-U.S. Plans Total Postretirement 2023 $ 7.1 $ 23.2 $ 30.3 $ 4.2 2024 8.9 25.2 34.1 0.3 2025 3.7 162.0 165.7 0.3 2026 2.5 25.5 28.0 0.3 2027 2.4 27.1 29.5 0.3 2028-2032 14.0 135.3 149.3 1.4
Schedule of Assets Held in Trust	The assets held in the trust are included in other assets and at December 31 consisted of the following: 2022 2021 Corporate-owned life insurance policies $ 23.1 $ 24.6 Cash and cash equivalents 5.4 5.8 Total $ 28.5 $ 30.4

Segment Information (Tables)

Segment Information (Tables)	12 Months Ended
	Dec. 31, 2022
Segment Reporting [Abstract]
Schedule of Total Revenue	Summarized financial information concerning our reportable segments as of December 31 is shown in the following tables: Total Revenue 2022 2021 2020 Avon International (1) $ 1,415.9 $ 1,724.6 $ 1,772.6 Avon Latin America (2) 1,331.6 1,654.7 1,845.9 Total revenue from reportable segments (3) 2,747.5 3,379.3 3,618.5 Revenue from affiliates to Natura &Co 21.7 25.2 6.7 Total revenue $ 2,769.2 $ 3,404.5 $ 3,625.2
Schedule of Operating Profit	Operating (Loss) Profit 2022 2021 2020 Segment Profit Avon International (1) $ 60.4 $ 49.9 $ 27.4 Avon Latin America (2) (111.4) (10.9) (39.1) Total (loss) profit from reportable segments (4) (8) (51.0) 39.0 (11.7) Unallocated global expenses (5) (23.2) (27.0) (11.6) Certain Brazil Indirect taxes (6) — (1.7) 10.6 CTI restructuring initiatives (68.6) (68.7) (23.7) Costs related to the Transaction (7) — — (85.8) Impairment of goodwill (9) (35.8) — — Operating (loss) profit $ (178.6) $ (58.4) $ (122.2) (1) In June 2022, an Avon subsidiary concluded the negotiation of a settlement agreement to resolve a breach of contract dispute in Japan. As a result, Avon received cash compensation of $27, $3.3 of which related to the settlement of historically recognized revenues. The remaining $23.7 was recognized as revenue in the second quarter of 2022. (2) 2022 includes the impact of certain Brazil indirect taxes, which was recorded in product sales in the amount of approximately $10 in our Consolidated Income Statements. 2021 includes the impact of certain Brazil indirect taxes, which was recorded in product sales in the amount of approximately $21 in our Consolidated Income Statements. See Note 19 Supplemental Balance Sheet Information. (3) Total revenue from reportable segments also includes revenue from other business activities of $0.5, $4.7 and $14.5 for the years ended December 31, 2022, 2021 and 2020, respectively, allocated to Avon International and Avon Latin America segments. Other business activities include revenue from the sale of products to New Avon since the separation of the Company’s North America business into New Avon on March 1, 2016 and ongoing royalties from the licensing of our name and products. Previously reported amounts have been allocated to Avon International and Avon Latin America segments to conform to the current year presentation. (4) Total profit from reportable segments also includes profit from other business activities and central expenses allocated to Avon International and Avon Latin America segments. Other business activities of $0.5, $1.5 and $7.3 for the years ended December 31, 2022, 2021 and 2020, respectively, include profit from the sale of products to New Avon since the separation of the Company’s North America business into New Avon on March 1, 2016 and ongoing royalties from the licensing of our name and products. Central expenses of $96.7, $206.7 and $197.6 for the years ended December 31, 2022, 2021 and 2020, respectively, include corporate general and administrative expenses allocated to Avon International and Avon Latin America to the extent they support the operating activity of the segment. Previously reported amounts have been allocated to segments to conform to the current year presentation. (5) For the years ended December 31, 2022, 2021 and 2020, unallocated global expenses primarily include stewardship and other expenses not directly attributable to reportable segments. (6) The year ended December 31, 2022 includes the impact of certain Brazil indirect taxes in the amount of nil. The year ended December 31, 2021 includes the impact of certain Brazil indirect taxes, which were recorded in selling, general and administrative expenses, net in the amounts of approximately $2. (7) For the year ended December 31, 2020, costs related to the Transaction primarily include professional fees of approximately $46, severance payments of approximately $25 and acceleration of share based compensation of approximately $10 relating to these terminations triggered by change in control provisions. Refer to Note 20, Merger with Natura Cosméticos S.A. for more information relating to the Natura transaction. (8) On July 1, 2021, the Company sold Avon Luxembourg, including our Mexican business, to a subsidiary of Natura &Co Holding. As a result, from the same date, the results of Avon Luxembourg are no longer included within Avon's consolidated results. The year ended December 31, 2021 includes the results of Avon Luxembourg for the period from January 1 to June 30, 2021. The years ended December 31, 2020 include the results of Avon Luxembourg. (9) During the 2022 year-end close process, our analysis of the Colombia business indicated an impairment as the carrying value of the business exceeded the estimated fair value. This was primarily the result of reducing our long-term projections of the business as it continued to experience challenging trading and economic conditions as a result of the continuing economic disruption caused by the COVID-19 pandemic and subsequent inflationary pressures compounded by the ongoing war between Ukraine and Russia. Accordingly, a non-cash impairment charge of $35.8 was recorded to reduce the carrying amount of goodwill.
Schedule of Total Assets	Total Assets 2022 2021 2020 Avon International $ 1,308.2 $ 1,362.0 $ 1,364.4 Avon Latin America (1) 853.5 945.8 1,199.9 Total assets $ 2,161.7 $ 2,307.8 $ 2,564.3 (1) On July 1, 2021, the Company sold Avon Luxembourg, including our Mexican business, to a subsidiary of Natura &Co Holding. As a result, balances at December 31, 2021 do not include the assets of Avon Luxembourg. Balances at December 31, 2020 include the assets of Avon Luxembourg. Capital Expenditures 2022 2021 2020 Avon International $ 39.5 $ 53.3 $ 36.0 Avon Latin America (1) 14.0 15.0 8.6 Total capital expenditures $ 53.5 $ 68.3 $ 44.6
Schedule of Depreciation and Amortization	Depreciation and Amortization 2022 2021 2020 Avon International $ 44.6 $ 48.1 $ 49.5 Avon Latin America (1) 19.9 24.7 32.3 Total depreciation and amortization $ 64.5 $ 72.8 $ 81.8 (1) On July 1, 2021, the Company sold Avon Luxembourg, including our Mexican business, to a subsidiary of Natura &Co Holding. As a result, from the same date, the results of Avon Luxembourg are no longer included within Avon's consolidated results. The year ended December 31, 2021 includes the results of Avon Luxembourg for the period from January 1 to June 30, 2021. The years ended December 31, 2020 include the results of Avon Luxembourg.
Schedule of Total Revenue by Major Country	A major country is defined as one with total revenues greater than 10% of consolidated total revenues. 2022 2021 2020 Brazil $ 587.0 $ 627.0 $ 729.9 Mexico (1) — 249.2 420.2 All other 2,182.2 2,528.3 2,475.1 Total $ 2,769.2 $ 3,404.5 $ 3,625.2 (1) On July 1, 2021, the Company sold Avon Luxembourg, including our Mexican business, to a subsidiary of Natura &Co Holding. As a result, from the same date, the results of Avon Luxembourg are no longer included within Avon's consolidated results. The year ended December 31, 2021 includes the results of Avon Luxembourg for the period from January 1 to June 30, 2021. The years ended December 31, 2020 include the results of Avon Luxembourg.
Schedule of Long-Lived Assets by Major Country	Long-lived assets in Brazil, Poland and Mexico consist primarily of property, plant and equipment related to manufacturing and distribution facilities, long-lived assets in the U.S. consist primarily of property, plant and equipment, including our global research and development facility and right-of-use assets related to equipment. 2022 2021 2020 U.S. $ 106.4 $ 122.7 $ 135.3 Brazil 76.8 75.4 86.4 Poland 81.0 95.0 96.8 Mexico (1) — — 55.2 All other 162.5 183.9 220.8 Total $ 426.7 $ 477.0 $ 594.5 (1) On July 1, 2021, the Company sold Avon Luxembourg, including our Mexican business, to a subsidiary of Natura &Co Holding. As a result, balances at December 31, 2021 do not include the assets of Avon Luxembourg. Balances at December 31, 2020 include the assets of Avon Luxembourg.

Leases and Commitments (Tables)

Leases and Commitments (Tables)	12 Months Ended
	Dec. 31, 2022
Leases [Abstract]
Assets and Liabilities, Lessee	Classification 2022 2021 Assets Operating right-of-use assets Right-of-use asset $ 92.1 $ 111.1 Finance right-of-use assets Property, Plant and Equipment 1.6 2.2 Total right-of-use assets 93.7 113.3 Liabilities Current Operating lease liabilities Other accrued liabilities $ 31.5 $ 37.1 Finance lease liabilities Other accrued liabilities 0.9 1.2 Total current lease liabilities 32.4 38.3 Noncurrent Operating lease liabilities Long-term operating lease liability 71.5 87.5 Finance lease liabilities Long-term debt 0.8 1.3 Total noncurrent lease liabilities $ 72.3 $ 88.8 Total lease liability $ 104.7 $ 127.1
Lease Cost	The table below shows the lease income and expenses recorded in the Consolidated Statement of Operations incurred during the years ended December 31: Lease Costs Classification 2022 2021 2020 Operating lease cost (1) Selling, general and administrative expenses $ 44.5 $ 51.7 $ 63.6 Finance lease cost Amortization of right-of-use assets Selling, general and administrative expenses 1.1 1.3 1.2 Interest on lease liabilities Interest Expense .2 .2 .3 Short-term leases costs Selling, general and administrative expenses 7.1 11.0 2.3 Sublease income (2) Selling, general and administrative expenses (14.9) (14.5) (15.3) Net lease cost $ 38.0 $ 49.7 $ 52.1 (1) Includes variable lease costs which are immaterial. These are presented in selling, general and administrative expenses in our Consolidated Statements of Operations.
Operating Lease Maturity Analysis	The maturity analysis of the finance and operating lease liabilities is reflected below. This table also reflects the reconciliation of the undiscounted cash flows to the discounted finance and operating lease liabilities as recognized in the December 31, 2022 Consolidated Balance Sheet: Maturity of Lease Liabilities Operating Leases Finance Leases Total 2023 39.4 1.0 40.4 2024 31.0 .5 31.5 2025 25.6 .3 25.9 2026 14.3 .2 14.5 2027 2.8 — 2.8 Thereafter 13.7 — 13.7 Total lease payments $ 126.8 $ 2.0 $ 128.8 Less: Interest 23.8 .3 24.1 Present value of lease liabilities $ 103.0 $ 1.7 $ 104.7
Finance Lease Maturity Analysis	The maturity analysis of the finance and operating lease liabilities is reflected below. This table also reflects the reconciliation of the undiscounted cash flows to the discounted finance and operating lease liabilities as recognized in the December 31, 2022 Consolidated Balance Sheet: Maturity of Lease Liabilities Operating Leases Finance Leases Total 2023 39.4 1.0 40.4 2024 31.0 .5 31.5 2025 25.6 .3 25.9 2026 14.3 .2 14.5 2027 2.8 — 2.8 Thereafter 13.7 — 13.7 Total lease payments $ 126.8 $ 2.0 $ 128.8 Less: Interest 23.8 .3 24.1 Present value of lease liabilities $ 103.0 $ 1.7 $ 104.7
Lease Terms	As noted in our lease accounting policy (See Note 1, Description of the Business and Summary of Significant Accounting Policies), the Company uses the incremental borrowing rate as the lease discount rate. Lease Term and Discount Rate 2022 2021 Weighted-average remaining lease term (years) Operating leases 4.3 4 Finance leases 2.6 2.7 Weighted-average discount rate Operating leases 9.1 % 8.3 % Finance leases 10.5 % 9.6 %
Cash Flow Classification	The table below sets out the classification of lease payments in the Consolidated Statement of Cash Flows. The ROU assets obtained in exchange for new finance and operating lease liabilities represent the new operating and finance leases entered into during the years ended December 31. Other Information 2022 2021 2020 Operating Cash Flows From Operating Leases $ 47.3 $ 54.0 $ 63.7 Operating Cash Flows From Finance Leases .2 .2 .3 Financing Cash Flows From Finance Leases 1.2 1.3 1.3 Cash Paid For Amounts Included In Measurement of Liabilities $ 48.7 $ 55.5 $ 65.3 Right-of-use Assets Obtained In Exchange For New Finance Liabilities $ .7 $ 1.4 $ .9 Right-of-use Assets Obtained In Exchange For New Operating Liabilities $ 17.4 $ 8.8 $ 24.9
Purchase Obligations	Purchase obligations include commitments to purchase paper, inventory and other services. At December 31, 2022, our purchase obligations by due date were as follows: Year Purchase Obligations 2023 $ 101.8 2024 51 2025 28.9 2026 26.2 2027 14.4 Later years 1.3 Total $ 223.6

Restructuring Initiatives (Tabl

Restructuring Initiatives (Tables)	12 Months Ended
	Dec. 31, 2022
Restructuring and Related Activities [Abstract]
Schedule of Restructuring and Related Costs	The costs during the twelve months ended December 31, 2022, 2021 and 2020 consisted of the following: Year ended December 31, 2022 2021 2020 CTI recorded in operating profit - COGS Inventory write-off 1.3 — (1.8) 1.3 — (1.8) CTI recorded in operating profit - SG&A Net charges for employee-related costs, including severance benefits 39.2 36.7 5.2 Implementation costs, primarily related to professional service fees 16.8 17.5 10.3 Dual running costs 2.3 1.1 3.1 Contract termination and other net costs 5.9 10.5 3.9 Impairment of other assets — 1.0 .8 Accelerated depreciation 3.1 .3 .4 Variable lease charges — 1.6 1.8 Foreign Currency Translation Adjustment Write-offs — — — 67.3 68.7 25.5 CTI recorded in operating profit 68.6 68.7 23.7 CTI recorded in other (income) expense Gain on sale of business / assets — (9.9) (1.5) Total CTI $ 68.6 $ 58.8 $ 22.2 Avon Integration $ 25.5 $ 15.4 $ 16.1 Open Up & Grow $ 44.1 $ 44.0 $ 10.9 Transformation Plan & Other $ (1.0) $ (.6) $ (4.8)
Schedule of Restructuring Reserve	The liability balance included in other accrued liabilities in our Consolidated Balance Sheet for the restructuring actions associated with Open Up & Grow at December 31, 2022 is as follows: Employee-Related Costs Inventory/ Asset Write-offs Contract Terminations/Other Total Balance at December 31, 2020 $ 9.0 $ — $ 2.8 $ 11.8 2021 charges 33.8 1.0 3.4 38.2 Adjustments (1.3) — — (1.3) Cash payments (26.8) — (5.0) (31.8) Non-cash write-offs — (1.0) — (1.0) Foreign exchange (.7) — — (.7) Balance at December 31, 2021 $ 14.0 $ — $ 1.2 $ 15.2 2022 charges 27.0 1.3 3.0 31.3 Adjustments — — — — Cash payments (20.7) — (2.5) (23.2) Non-cash write-offs — (1.3) — (1.3) Foreign exchange (.7) — (.1) (.8) Balance at December 31, 2022 $ 19.6 $ — $ 1.6 $ 21.2
Schedule of Restructuring Charges Reportable	The following table presents the restructuring charges incurred to date, under the Avon Integration , Open Up & Grow and the Transformation Plan, along with the estimated charges expected to be incurred on approved initiatives under the plans: Employee- Related Costs Inventory/ Asset Write-offs Contract Foreign Currency Translation Adjustment Write-offs Total Avon Integration Charges incurred to-date $ 24.5 $ 3.1 $ 27.6 Estimated charges to be incurred on approved initiatives — — — — — Total expected charges on approved initiatives $ 24.5 $ — $ 3.1 $ — $ 27.6 Open Up & Grow Charges incurred to-date $ 142.8 $ 108.7 $ 18.9 $ (10.9) $ 259.5 Estimated charges to be incurred on approved initiatives $ .4 — — — $ .4 Total expected charges on approved initiatives $ 143.2 $ 108.7 $ 18.9 $ (10.9) $ 259.9 Transformation Plan Charges incurred to-date $ 122.7 $ 2.5 $ 40.9 $ 3.4 $ 169.5 Estimated charges to be incurred on approved initiatives — — — — — Total expected charges on approved initiatives $ 122.7 $ 2.5 $ 40.9 $ 3.4 $ 169.5 The charges, net of adjustments, of initiatives under the Open Up & Grow and the Transformation Plan, along with the estimated charges expected to be incurred on approved initiatives under the plans, by reportable segment are as follows: Avon International Avon LATAM Total Avon Integration 2020 6.2 4.6 $ 10.8 2021 (1.2) 3.0 $ 1.8 2022 .6 14.4 15.0 Charges incurred to-date 5.6 22.0 27.6 Estimated charges to be incurred on approved initiatives — — — Total expected charges on approved initiatives $ 5.6 $ 22.0 $ 27.6 Open Up & Grow 2018 52.8 64.3 $ 117.1 2019 34.7 36.9 71.6 2020 3.2 (.8) 2.4 2021 36.9 .2 37.1 2022 31.3 31.3 Charges incurred to-date 158.9 100.6 259.5 Estimated charges to be incurred on approved initiatives .4 — .4 Total expected charges on approved initiatives $ 159.3 $ 100.6 $ 259.9

Goodwill (Tables)

Goodwill (Tables)	12 Months Ended
	Dec. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Goodwill	Avon International Avon LATAM Total Gross balance at December 31, 2021 $ 106.9 $ 54.5 $ 161.4 Accumulated impairments (89.3) — (89.3) Net balance at December 31, 2021 $ 17.6 $ 54.5 $ 72.1 Changes during the period ended December 31, 2022: Impairment — (35.8) (35.8) Foreign exchange (1.0) (9.4) (10.4) Gross balance at December 31, 2022 $ 105.9 $ 45.1 $ 151.0 Accumulated impairments (89.3) (35.8) (125.1) Net balance at December 31, 2022 $ 16.6 $ 9.3 $ 25.9

Supplemental Balance Sheet In_2

Supplemental Balance Sheet Information (Tables)	12 Months Ended
	Dec. 31, 2022
Balance Sheet Related Disclosures [Abstract]
Components of Prepaid Expenses and Other	At December 31, 2022 and 2021, prepaid expenses and other included the following: Components of Prepaid expenses and other 2022 2021 Prepaid taxes and tax refunds receivable $ 60.9 $ 84.0 Receivables other than trade 18.8 27.8 Prepaid brochure costs, paper and other literature 7.4 8.3 Other 40.8 45.5 Prepaid expenses and other $ 127.9 $ 165.6
Components of Other Assets	At December 31, 2022 and 2021, other assets included the following: Components of Other assets 2022 2021 Capitalized software (Note 1) 73.5 74.9 Judicial deposits 23.4 47.2 Net overfunded pension plans (Note 13) 110.7 162.5 Long-term receivables including taxes 198.3 180.2 Trust assets associated with supplemental benefit plans (Note 13) 28.5 30.4 Other 11.1 14.2 Other assets $ 445.5 $ 509.4

Description of the Business a_3

Description of the Business and Summary of Significant Accounting Policies (Narrative) (Details) $ / shares in Units, $ in Millions		1 Months Ended		12 Months Ended
	Jul. 01, 2021 USD ($)	Jan. 31, 2020 USD ($) $ / shares	Dec. 31, 2019 $ / shares	Dec. 31, 2022 USD ($) segment region businessChannel	Dec. 31, 2021 USD ($)		Dec. 31, 2020 USD ($)	Nov. 07, 2022 USD ($)	Mar. 31, 2022 USD ($)	Mar. 31, 2021 USD ($)	May 31, 2020 USD ($)
Property, Plant and Equipment [Line Items]
Number of business channels | businessChannel				1
Number of regions where company has geographic operations | region				2
Dividend paid (in USD per share) | $ / shares		$ 0.016
Dividends declared (in USD per share) | $ / shares			$ 0.016
Payments of dividends		$ 9		$ 0	$ 0		$ 8.6
Proceeds from divestiture of businesses				$ 0	16.9		11.3
Maximum borrowing capacity								$ 226
Gain on sale of business	$ 148				148.4	[1]
Number of reportable segments | segment				2
Prepaid expenses and other				$ 127.9	165.6
Brochure costs							77.1
Brochure income				29.6	49.3		66.8
Capitalized software				73.5	74.9
Amortization of capitalized software				19.8	22.4		24.5
Shipping and handling costs				1,705.4	2,001.4		2,152.9
Advertising costs				59.1	67.8		59.9
Research and development costs				$ 40.8	39.3		36.5
Amortization period for gains and losses, period 1				3 years
Amortization period for gains and losses, period 2				5 years
Minimum
Property, Plant and Equipment [Line Items]
Prepaid brochures, campaign period				21 days
Number of years used in calculating the estimated fair value of reporting units				5 years
Maximum
Property, Plant and Equipment [Line Items]
Prepaid brochures, campaign period				28 days
Number of years used in calculating the estimated fair value of reporting units				10 years
Natura Revolving Facility
Property, Plant and Equipment [Line Items]
Amount repaid	150
Maximum borrowing capacity	250								$ 250	$ 250	$ 100
Deferred Brochure Costs
Property, Plant and Equipment [Line Items]
Prepaid expenses and other				$ 3.1	4
Cost of Sales
Property, Plant and Equipment [Line Items]
Brochure costs				36.1	54.8		75.8
Selling, General and Administrative Expenses
Property, Plant and Equipment [Line Items]
Brochure costs				68.5	72.6
Shipping and Handling
Property, Plant and Equipment [Line Items]
Shipping and handling costs				$ 290.5	339.4		$ 373.1
Buildings
Property, Plant and Equipment [Line Items]
Estimated useful lives				45 years
Land Improvements
Property, Plant and Equipment [Line Items]
Estimated useful lives				20 years
Machinery and Equipment
Property, Plant and Equipment [Line Items]
Estimated useful lives				15 years
Office Equipment | Minimum
Property, Plant and Equipment [Line Items]
Estimated useful lives				5 years
Office Equipment | Maximum
Property, Plant and Equipment [Line Items]
Estimated useful lives				10 years
Deferred Brochure Costs
Property, Plant and Equipment [Line Items]
Inventory				$ 2.7	$ 4.1
Avon Luxembourg Holdings
Property, Plant and Equipment [Line Items]
Proceeds from divestiture of businesses	$ 150
[1]On July 1, 2021, the Company sold Avon Luxembourg Holdings S.à r.l. and its subsidiaries ("Avon Luxembourg"), including our Mexican business, to a subsidiary of Natura &Co Holding S.A. for $150. The sale was accounted for as a transaction under common control in accordance with ASC805 - Business Combinations, with the resulting gain of $148, representing the difference between the proceeds, the net assets of Avon Luxembourg on the date of sale, and the cumulative foreign currency translation adjustment, taken directly to Retained Earnings

New Accounting Standards (Detai

New Accounting Standards (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021	[1]	Dec. 31, 2020	[1]	Dec. 31, 2019
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Decrease in shareholders' deficit	$ 1,241.2	$ 854.7		$ 867.2		$ 983.8
Retained Earnings
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Decrease in shareholders' deficit	$ 832.3	$ 404.2		$ 360.5		(2,138.9)
Cumulative Effect, Period of Adoption, Adjustment
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Decrease in shareholders' deficit						2
Cumulative Effect, Period of Adoption, Adjustment | Retained Earnings
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Decrease in shareholders' deficit						2
Cumulative Effect, Period of Adoption, Adjustment | Retained Earnings | Accounting Standards Update 2016-13
New Accounting Pronouncements or Change in Accounting Principle [Line Items]
Decrease in shareholders' deficit						$ 2
[1]The number of shares of Common Stock (par value $0.01 per share) outstanding at December 31, 2022, 2021 and 2020 was 101.34.

Discontinued Operations and A_3

Discontinued Operations and Assets and Liabilities Held for Sale (Narrative) (Details) $ in Millions

1 Months Ended

3 Months Ended

6 Months Ended

12 Months Ended

Dec. 23, 2021 USD ($)

Nov. 17, 2021 USD ($)

Jul. 01, 2021 USD ($)

Dec. 31, 2022 USD ($) property

Sep. 30, 2021 USD ($)

Jun. 30, 2021 USD ($)

Aug. 31, 2020 USD ($)

Jun. 30, 2020 USD ($)

Apr. 30, 2020 USD ($)

Mar. 31, 2020 USD ($)

Dec. 31, 2022 USD ($) property

Dec. 31, 2021 USD ($) property

Sep. 30, 2021 USD ($)

Jun. 30, 2021 USD ($)

Sep. 30, 2020 USD ($)

Jun. 30, 2020 USD ($)

Jun. 30, 2020 USD ($)

Dec. 31, 2022 USD ($) property

Dec. 31, 2021 USD ($) property

Dec. 31, 2020 USD ($)

Nov. 07, 2022 USD ($)

Mar. 31, 2022 USD ($)

Mar. 31, 2021 USD ($)

May 31, 2020 USD ($)

Mar. 01, 2016

Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]

Number of properties held for sale | property

0

0

1

0

1

Proceeds from divestiture of businesses

$ 0

$ 16.9

$ 11.3

Gain (loss) on sale of business

0

9.9

1.5

Maximum borrowing capacity

$ 226

Gain on sale of business

$ 148

148.4

[1]

Restricted cash

$ 0.3

$ 0.3

$ 0

$ 0.3

$ 0

$ 7.8

Natura Revolving Facility

Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]

Amount repaid

150

Maximum borrowing capacity

250

$ 250

$ 250

$ 100

Polish Freehold Office

Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]

Proceeds from divestiture of businesses

$ 12.5

Gain (loss) on sale of business

1.8

Gain on disposition of business, after tax

$ 1.5

Avon Beauty Arabia

Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]

Gain (loss) on sale of business

(1.1)

Write-off of loan balance

$ 3.9

Cosmetics Manufacturing Operations In India

Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]

Proceeds from divestiture of businesses

$ 2.9

Gain (loss) on sale of business

$ 1.1

Spanish Distribution Center

Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]

Proceeds from divestiture of businesses

$ 14.7

Gain (loss) on sale of business

$ 8.3

Gain on sale

$ 6.2

Avon Luxembourg Holdings

Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]

Proceeds from divestiture of businesses

$ 150

Italy Branch

Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]

Proceeds from divestiture of businesses

$ 1.7

Gain (loss) on sale of business

$ 1.4

Avon Shanghai

Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]

Proceeds from divestiture of businesses

$ 2.9

Gain (loss) on sale of business

1.4

Hungary Distribution Center in Gödöllő

Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]

Proceeds from divestiture of businesses

$ 3.1

$ 3.4

Gain (loss) on sale of business

$ 0.1

Deposit

$ 0.3

China Wellness Plant

Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]

Proceeds from divestiture of businesses

$ 6.6

$ 6.6

Gain (loss) on sale of business

$ 1.4

Restricted cash

$ 3.3

$ 3.3

$ 3.3

$ 3.3

New Avon

Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]

Ownership

19.90%

Avon Beauty Arabia

Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]

Ownership

51%

[1]On July 1, 2021, the Company sold Avon Luxembourg Holdings S.à r.l. and its subsidiaries ("Avon Luxembourg"), including our Mexican business, to a subsidiary of Natura &Co Holding S.A. for $150. The sale was accounted for as a transaction under common control in accordance with ASC805 - Business Combinations, with the resulting gain of $148, representing the difference between the proceeds, the net assets of Avon Luxembourg on the date of sale, and the cumulative foreign currency translation adjustment, taken directly to Retained Earnings

Discontinued Operations and A_4

Discontinued Operations and Assets and Liabilities Held for Sale (Financial Components of Discontinued Operations) (Details) - Discontinued Operations - North America Segment - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Disposal Group, Including Discontinued Operation, Income Statement Disclosures [Abstract]
Selling, general and administrative expenses	$ (73.2)	$ (18.5)	$ (27.9)
Operating loss	(73.2)	(18.5)	(27.9)
Loss from discontinued operations, net of tax	$ (73.2)	$ (18.5)	$ (27.9)

Discontinued Operations and A_5

Discontinued Operations and Assets and Liabilities Held for Sale (Assets and Liabilities Held For Sale) (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Current held for sale assets
Held for sale assets	$ 1.8	$ 0
Current held for sale liabilities
Held for sale liabilities	79.9	31.7
Held-for-sale
Current held for sale assets
Property, Plant & Equipment (net)	0	2.8
Held for sale assets	0	2.8
Current held for sale liabilities
Accounts payable	0	0
Other liabilities	0	0
Held for sale liabilities	$ 0	$ 0

Related Party Transactions (Det

Related Party Transactions (Details) $ in Millions	3 Months Ended	12 Months Ended
	Jun. 30, 2018 USD ($) installment	Dec. 31, 2022 USD ($) promissory_note	Dec. 31, 2021 USD ($)	Dec. 31, 2020 USD ($)	Jun. 30, 2021 USD ($)
Related Party Transaction [Line Items]
Revenue from affiliates of Natura &Co		$ 21.7	$ 25.2	$ 6.7
Cost of sales from affiliates of Natura &Co		(20.4)	(22.4)	(5.9)
Interest income		3.9	1.6	0
Interest expense on Loan from affiliates of Natura &Co		(93.8)	(50.6)	(7.5)
Receivables from affiliates of Natura &Co		72.9	34.1
Loans to affiliates of Natura &Co maturing within one year		72.2	46.6
Loans to affiliates of Natura &Co maturing after one year		54.8	46.7
Loans from affiliates of Natura &Co maturing within one year		(537.2)	(371.7)
Loans from affiliates of Natura &Co maturing after one year		(1,427.2)	(736.3)
Notional amounts of derivative contracts		546.3
Cash Flow Hedging
Related Party Transaction [Line Items]
Notional amounts of derivative contracts		289.7
Foreign Exchange Contract
Related Party Transaction [Line Items]
Notional amounts of derivative contracts		38.1
Foreign Exchange Contract | Cash Flow Hedging
Related Party Transaction [Line Items]
Notional amounts of derivative contracts		290
3.13% related party loan
Related Party Transaction [Line Items]
Loans from affiliates of Natura &Co maturing within one year			(207.3)
Six Point Seven One Percent Promissory Note, Due May 2029
Related Party Transaction [Line Items]
Loans from affiliates of Natura &Co maturing after one year		(405)
Six Point Five One Percent Promissory Note, Due June 2029
Related Party Transaction [Line Items]
Loans from affiliates of Natura &Co maturing after one year		$ (330)
Number of promissory notes | promissory_note		2
Debt Instrument, Redemption, Period Two | 3.13% related party loan
Related Party Transaction [Line Items]
Loans from affiliates of Natura &Co maturing after one year		$ (692.2)	(736.3)
Avon Cosmeticos LTDA | Natura &Co Pay Holding Financeira S.A.
Related Party Transaction [Line Items]
Ownership					10%
Avon Cosmeticos LTDA | Instituto Avon
Related Party Transaction [Line Items]
Ownership	7%
Licensing Agreements
Related Party Transaction [Line Items]
Revenue from affiliates of Natura &Co			1
Gross profit from affiliates of Natura &Co			1
Natura & Co
Related Party Transaction [Line Items]
Interest income		3.9	1.6	0
Interest expense on Loan from affiliates of Natura &Co		(93.8)	(50.6)	(7.5)
Receivables from affiliates of Natura &Co		30.7	32.7
Derivative Receivables due from affiliates of Natura &Co		9.5	0
Other receivables due from affiliates of Natura &Co		32.7	1.4
Loans to affiliates of Natura &Co maturing within one year		72.2	46.6
Loans to affiliates of Natura &Co maturing after one year		54.8	46.7
Right-of-use asset from affiliates of Natura &Co		6	0
Trade Payables due to affiliates of Natura &Co		(33.7)	(24.5)
Derivative Payables due to affiliates of Natura &Co		(12.9)	0
Other payables due to affiliates of Natura &Co		(11.5)	(4.9)
Loans from affiliates of Natura &Co maturing within one year		(537.2)	(371.7)
Loans from affiliates of Natura &Co maturing after one year		(1,427.2)	(736.3)
Lease liability to affiliates of Natura &Co		(6)	0
Investments in affiliates of Natura &Co		0.1	0.1		$ 0.5
Natura & Co | Manufacturing and Supply Agreement
Related Party Transaction [Line Items]
Revenue from affiliates of Natura &Co		21.7	25.2	6.7
Cost of sales from affiliates of Natura &Co		(20.4)	(22.4)	(5.9)
Gross profit from affiliates of Natura &Co		1.3	2.8	0.8
Instituto Avon
Related Party Transaction [Line Items]
Interest income		$ 0	$ 0	$ 0.1
Affiliated Entity | Loan To Related Party | Instituto Avon
Related Party Transaction [Line Items]
Loan amount	$ 12
Loan term	5 years
Loan annual installments | installment	5

Revenue (Disaggregation of Reve

Revenue (Disaggregation of Revenue) (Details) - USD ($) $ in Millions	1 Months Ended	3 Months Ended	12 Months Ended
	Jun. 30, 2022	Jun. 30, 2022	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Disaggregation of Revenue [Line Items]
Net sales			$ 2,600.5	$ 3,202.9	$ 3,431.2
Other			22.3	27.4	18.9
Total Revenues			2,769.2	3,404.5	3,625.2
Revenue from affiliates of Natura &Co			21.7	25.2	6.7
Proceeds from legal settlements	$ 27
Revenue recognized related to contract liability			28.3
Collectibility of Receivables
Disaggregation of Revenue [Line Items]
Revenue recognized related to contract liability	$ 3.3	$ 23.7
Total Beauty
Disaggregation of Revenue [Line Items]
Net sales			2,041.6	2,353.3	2,546.3
Skincare
Disaggregation of Revenue [Line Items]
Net sales			874.1	1,043.4	1,110.6
Fragrance
Disaggregation of Revenue [Line Items]
Net sales			795	890	972.4
Color
Disaggregation of Revenue [Line Items]
Net sales			372.5	419.9	463.3
Total Fashion & Home
Disaggregation of Revenue [Line Items]
Net sales			568.9	828.1	884.9
Fashion
Disaggregation of Revenue [Line Items]
Net sales			290.7	418.1	459.9
Home
Disaggregation of Revenue [Line Items]
Net sales			278.2	410	425
Certain Brazil taxes
Disaggregation of Revenue [Line Items]
Net sales			(10)	21.5
Total Revenues			10	21
Net sales
Disaggregation of Revenue [Line Items]
Net sales			2,600.5	3,202.9	3,431.2
Representative fees
Disaggregation of Revenue [Line Items]
Representative fees**			146.4	174.2	175.1
Other revenue
Disaggregation of Revenue [Line Items]
Other revenue			168.7	201.6	194
Operating Segments
Disaggregation of Revenue [Line Items]
Other			0.6	2.2	12.2
Total Revenues			2,747.5	3,379.3	3,618.5
Operating Segments | Total Beauty
Disaggregation of Revenue [Line Items]
Net sales			2,041.6	2,353.3	2,546.3
Operating Segments | Skincare
Disaggregation of Revenue [Line Items]
Net sales			874.1	1,043.4	1,110.6
Operating Segments | Fragrance
Disaggregation of Revenue [Line Items]
Net sales			795	890	972.4
Operating Segments | Color
Disaggregation of Revenue [Line Items]
Net sales			372.5	419.9	463.3
Operating Segments | Total Fashion & Home
Disaggregation of Revenue [Line Items]
Net sales			568.9	828.1	884.9
Operating Segments | Fashion
Disaggregation of Revenue [Line Items]
Net sales			290.7	418.1	459.9
Operating Segments | Home
Disaggregation of Revenue [Line Items]
Net sales			278.2	410	425
Operating Segments | Certain Brazil taxes
Disaggregation of Revenue [Line Items]
Net sales			(10)	21.5
Operating Segments | Net sales
Disaggregation of Revenue [Line Items]
Net sales			2,600.5	3,202.9	3,431.2
Operating Segments | Representative fees
Disaggregation of Revenue [Line Items]
Representative fees**			146.4	174.2	175.1
Operating Segments | Other revenue
Disaggregation of Revenue [Line Items]
Other revenue			147	176.4	187.3
Other reconciling items
Disaggregation of Revenue [Line Items]
Other			21.7	25.2	6.7
Total Revenues			21.7	25.2	6.7
Revenue from affiliates of Natura &Co			21.7	25.2	6.7
Other reconciling items | Other revenue
Disaggregation of Revenue [Line Items]
Other revenue			21.7	25.2	6.7
Avon International | Operating Segments
Disaggregation of Revenue [Line Items]
Other			0.1	0.5	6.4
Total Revenues			1,415.9	1,724.6	1,772.6
Avon International | Operating Segments | Total Beauty
Disaggregation of Revenue [Line Items]
Net sales			1,089.3	1,329.8	1,376.5
Avon International | Operating Segments | Skincare
Disaggregation of Revenue [Line Items]
Net sales			458.7	577.6	594.7
Avon International | Operating Segments | Fragrance
Disaggregation of Revenue [Line Items]
Net sales			442.7	514.2	516
Avon International | Operating Segments | Color
Disaggregation of Revenue [Line Items]
Net sales			187.9	238	265.8
Avon International | Operating Segments | Total Fashion & Home
Disaggregation of Revenue [Line Items]
Net sales			248.5	327.9	323
Avon International | Operating Segments | Fashion
Disaggregation of Revenue [Line Items]
Net sales			197.2	258.3	267.4
Avon International | Operating Segments | Home
Disaggregation of Revenue [Line Items]
Net sales			51.3	69.6	55.6
Avon International | Operating Segments | Certain Brazil taxes
Disaggregation of Revenue [Line Items]
Net sales			0	0
Avon International | Operating Segments | Net sales
Disaggregation of Revenue [Line Items]
Net sales			1,337.8	1,657.7	1,699.5
Avon International | Operating Segments | Representative fees
Disaggregation of Revenue [Line Items]
Representative fees**			78	66.4	66.7
Avon International | Operating Segments | Other revenue
Disaggregation of Revenue [Line Items]
Other revenue			78.1	66.9	73.1
Avon LATAM | Operating Segments
Disaggregation of Revenue [Line Items]
Other			0.5	1.7	5.8
Total Revenues			1,331.6	1,654.7	1,845.9
Avon LATAM | Operating Segments | Total Beauty
Disaggregation of Revenue [Line Items]
Net sales			952.3	1,023.5	1,169.8
Avon LATAM | Operating Segments | Skincare
Disaggregation of Revenue [Line Items]
Net sales			415.4	465.8	515.9
Avon LATAM | Operating Segments | Fragrance
Disaggregation of Revenue [Line Items]
Net sales			352.3	375.8	456.4
Avon LATAM | Operating Segments | Color
Disaggregation of Revenue [Line Items]
Net sales			184.6	181.9	197.5
Avon LATAM | Operating Segments | Total Fashion & Home
Disaggregation of Revenue [Line Items]
Net sales			320.4	500.2	561.9
Avon LATAM | Operating Segments | Fashion
Disaggregation of Revenue [Line Items]
Net sales			93.5	159.8	192.5
Avon LATAM | Operating Segments | Home
Disaggregation of Revenue [Line Items]
Net sales			226.9	340.4	369.4
Avon LATAM | Operating Segments | Certain Brazil taxes
Disaggregation of Revenue [Line Items]
Net sales			(10)	21.5
Avon LATAM | Operating Segments | Net sales
Disaggregation of Revenue [Line Items]
Net sales			1,262.7	1,545.2	1,731.7
Avon LATAM | Operating Segments | Representative fees
Disaggregation of Revenue [Line Items]
Representative fees**			68.4	107.8	108.4
Avon LATAM | Operating Segments | Other revenue
Disaggregation of Revenue [Line Items]
Other revenue			$ 68.9	$ 109.5	$ 114.2

Revenue (Summary of Receivables

Revenue (Summary of Receivables and Contract Liabilities) (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Revenue from Contract with Customer [Abstract]
Accounts receivable, net of allowances of $35.4 and $37.1	$ 183.4	$ 198.7
Contract liabilities	31.6	37.1
Allowances	$ 35.4	$ 37.1

Revenue (Narrative) (Details)

Revenue (Narrative) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Revenue from Contract with Customer [Abstract]
Revenue recognized related to contract liability	$ 28.3
Deferred revenue related to contract liability		$ 25.6

Inventories (Components of Inve

Inventories (Components of Inventories) (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Inventory, Net [Abstract]
Raw materials	$ 91.2	$ 103.4
Finished goods	241	280.7
Total	$ 332.2	$ 384.1

Debt and Other Financing (Debt)

Debt and Other Financing (Debt) (Details) - USD ($) $ in Millions	Dec. 31, 2022	May 31, 2022	Dec. 31, 2021	Sep. 30, 2020	Sep. 30, 2019	Jul. 31, 2019	Dec. 31, 2018	Dec. 31, 2016	Mar. 31, 2013
Debt maturing within one year:
Short term debt	$ 5.7		$ 32.6
Loans from affiliates of Natura &Co	537.2		371.7
Total	542.9		404.3
Long-term debt:
Finance lease liabilities	0.8		1.3
Loans from affiliates of Natura &Co, due 2028 and 2029	1,427.2		736.3
Total	1,642		1,412.3
5.00% Notes, due March 2023
Long-term debt:
Notes	$ 0		460.8
Interest rate, stated percentage	5%					5%	5%	5%	5%
6.95% Notes, due March 2043
Long-term debt:
Notes	$ 214		$ 213.9
Interest rate, stated percentage	6.95%	5%		6.95%	6.95%			6.95%	6.95%

Debt and Other Financing (Narra

Debt and Other Financing (Narrative) (Details) - USD ($)	1 Months Ended			3 Months Ended				12 Months Ended
	May 31, 2022	Nov. 30, 2020	Sep. 30, 2020	Jun. 30, 2022	Dec. 31, 2021	Dec. 31, 2020	Sep. 30, 2020	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020	Nov. 07, 2022	Mar. 31, 2022	Jul. 01, 2021	Mar. 31, 2021	May 31, 2020	Sep. 30, 2019	Jul. 31, 2019	Dec. 31, 2018	Dec. 31, 2016	Aug. 31, 2016	Mar. 31, 2013
Debt Instrument [Line Items]
Loss on extinguishment of debt					$ 25,600,000			$ 15,700,000	$ 0	$ 37,700,000
Write off of debt issuance cost						$ 7,900,000
Loss on debt extinguishment						$ 17,700,000
Senior notes					0			0	0
Maximum borrowing capacity											$ 226,000,000
Loans from affiliates of Natura &Co					371,700,000			537,200,000	371,700,000
Loans from affiliates of Natura &Co					736,300,000			1,427,200,000	736,300,000
Loans from affiliates of Natura &Co maturing within one year					1,108,000,000				1,108,000,000
Long-term debt, current maturities								537,000,000
Total								223,600,000
Short term purchase obligation								101,800,000
Operating lease								39,000,000
Short term debt					32,600,000			5,700,000	32,600,000
Letters of credit outstanding					11,300,000			$ 5,600,000	11,300,000
Loans Payable
Debt Instrument [Line Items]
Short-term debt, interest rate								7.50%
Minimum | U.S. Pension and Postretirement Plans
Debt Instrument [Line Items]
Expected contributions related to continuing operations								$ 5,000,000
Maximum | U.S. Pension and Postretirement Plans
Debt Instrument [Line Items]
Expected contributions related to continuing operations								10,000,000
Avon Cosmetics Limited
Debt Instrument [Line Items]
Maximum borrowing capacity								$ 300,000,000
Natura & Co | Avon Cosmetics Limited
Debt Instrument [Line Items]
Maximum borrowing capacity											$ 300,000,000
Long-term debt, percentage bearing variable interest, percentage rate											3%
5.00% Notes, due March 2023
Debt Instrument [Line Items]
Principal amount of debt																					$ 500,000,000
Interest rate, stated percentage								5%									5%	5%	5%		5%
Repurchase amount																		$ 27,000,000	$ 11,100,000
6.95% Notes, due March 2043
Debt Instrument [Line Items]
Principal amount of debt																					$ 250,000,000
Interest rate, stated percentage	5%		6.95%				6.95%	6.95%								6.95%			6.95%		6.95%
Repurchase amount	$ 461,900,000		$ 27,800,000				$ 27,800,000												$ 6,200,000
Make whole premium	15,000,000		3,800,000	$ 15,000,000			3,800,000
Accrued interest	$ 5,400,000		$ 1,200,000
Loss on extinguishment of debt				15,700,000			4,100,000
Write off of debt issuance cost				700,000			$ 300,000
2013 Notes
Debt Instrument [Line Items]
Increase in interest rate for every one-notch downgrade of long-term credit ratings below investment grade								0.25%
Maximum aggregate increase in interest rate related to downgrade of long-term credit ratings below investment grade								2%
7.875% Senior Secured Notes Due August 2022
Debt Instrument [Line Items]
Principal amount of debt																				$ 500,000,000
Interest rate, stated percentage																				7.875%
Repayment of principal		$ 500,000,000
Payment of premium		9,800,000
Payment of accrued interest		8,400,000
6.50% Senior Secured Notes, Due August 2022
Debt Instrument [Line Items]
Principal amount of debt																	$ 400,000,000
Interest rate, stated percentage																	6.50%
Repayment of principal		400,000,000
Payment of premium		7,900,000
Payment of accrued interest		$ 5,600,000
Natura Revolving Facility
Debt Instrument [Line Items]
Maximum borrowing capacity												$ 250,000,000	$ 250,000,000	$ 250,000,000	$ 100,000,000
3.13% related party loan
Debt Instrument [Line Items]
Interest rate, stated percentage		3.13%
Loans from affiliates of Natura &Co		$ 960,000,000
Loans from affiliates of Natura &Co								$ 692,000,000
Six Point Seven One Percent Promissory Note, Due May 2029
Debt Instrument [Line Items]
Interest rate, stated percentage	6.71%
Loans from affiliates of Natura &Co								405,000,000
Six Point Seven One Percent Promissory Note, Due May 2029 | Avon Cosmetics Limited
Debt Instrument [Line Items]
Loans from affiliates of Natura &Co maturing within one year	$ 215,000,000
Six Point Seven One Percent Promissory Note, Due May 2029 | Avon Products, Inc
Debt Instrument [Line Items]
Loans from affiliates of Natura &Co maturing within one year	$ 405,000,000
Six Point Five One Percent Promissory Note, Due May 2022 | Avon Cosmetics Limited
Debt Instrument [Line Items]
Loans from affiliates of Natura &Co maturing within one year				$ 115,000,000
Six Point Five One Percent Promissory Note, Due June 2029
Debt Instrument [Line Items]
Loans from affiliates of Natura &Co								330,000,000
Six Point Five One Percent Promissory Note, Due June 2029 | Avon Cosmetics Limited
Debt Instrument [Line Items]
Interest rate, stated percentage				6.51%
Unsecured Notes
Debt Instrument [Line Items]
Accrued interest					$ 14,700,000			$ 5,800,000	$ 14,700,000

Debt and Other Financing (Sched

Debt and Other Financing (Schedule of Public Notes) (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
5.00% Notes, due March 2023
Debt Instrument [Line Items]
Remaining Principal	$ 0	$ 461.9
Unamortized Discounts	0	(0.5)
Unamortized Debt Issuance Costs	0	(0.6)
Total	0	460.8
6.95% Notes, due March 2043
Debt Instrument [Line Items]
Remaining Principal	216.1	216.1
Unamortized Discounts	(1.6)	(1.7)
Unamortized Debt Issuance Costs	(0.5)	(0.5)
Total	$ 214	$ 213.9

Debt and Other Financing (Matur

Debt and Other Financing (Maturities of Long-Term Debt) (Details) $ in Millions	Dec. 31, 2022 USD ($)
Debt Disclosure [Abstract]
2023	$ 0
2024	0.5
2025	0.3
2026	0.2
2027	0
2028 and Beyond	1,643.3
Total	$ 1,644.3

Debt and Other Financing (Other

Debt and Other Financing (Other Financing) (Details) - USD ($) $ in Millions	Dec. 31, 2022	Nov. 07, 2022	Jun. 30, 2022	May 31, 2022	Mar. 31, 2022	Dec. 31, 2021	Jul. 01, 2021	Mar. 31, 2021	Nov. 30, 2020	May 31, 2020
Debt Instrument [Line Items]
Maximum borrowing capacity		$ 226
Loans from affiliates of Natura &Co maturing within one year	$ 537.2					$ 371.7
Loans from affiliates of Natura &Co	1,427.2					736.3
Loans from affiliates of Natura &Co maturing within one year						1,108
Short term debt	5.7					32.6
Letters of credit outstanding	5.6					11.3
Natura & Co
Debt Instrument [Line Items]
Loans from affiliates of Natura &Co maturing within one year	537.2					371.7
Loans from affiliates of Natura &Co	1,427.2					736.3
Loans from affiliates of Natura &Co maturing within one year	1,964.4					$ 164.4
Avon Cosmetics Limited
Debt Instrument [Line Items]
Maximum borrowing capacity	300
Avon Cosmetics Limited | Natura & Co
Debt Instrument [Line Items]
Maximum borrowing capacity		$ 300
Long-term debt, percentage bearing variable interest, percentage rate		3%
Six Point Seven One Percent Promissory Note, Due May 2029
Debt Instrument [Line Items]
Interest rate, stated percentage				6.71%
Loans from affiliates of Natura &Co	405
Six Point Seven One Percent Promissory Note, Due May 2029 | Avon Products, Inc
Debt Instrument [Line Items]
Loans from affiliates of Natura &Co maturing within one year				$ 405
Six Point Seven One Percent Promissory Note, Due May 2029 | Avon Cosmetics Limited
Debt Instrument [Line Items]
Loans from affiliates of Natura &Co maturing within one year				$ 215
Six Point Five One Percent Promissory Note, Due May 2022 | Avon Cosmetics Limited
Debt Instrument [Line Items]
Loans from affiliates of Natura &Co maturing within one year			$ 115
Six Point Five One Percent Promissory Note, Due June 2029
Debt Instrument [Line Items]
Loans from affiliates of Natura &Co	330
Six Point Five One Percent Promissory Note, Due June 2029 | Avon Cosmetics Limited
Debt Instrument [Line Items]
Interest rate, stated percentage			6.51%
Natura Revolving Facility Due May 2022
Debt Instrument [Line Items]
Maximum borrowing capacity					$ 250		$ 250	$ 250		$ 100
3.13% related party loan
Debt Instrument [Line Items]
Loans from affiliates of Natura &Co maturing within one year									$ 960
Interest rate, stated percentage									3.13%
Loans from affiliates of Natura &Co	$ 692

Accumulated Other Comprehensi_3

Accumulated Other Comprehensive Income (Loss) (Components of Comprehensive Loss) (Details) - USD ($) $ in Millions		12 Months Ended
		Dec. 31, 2022	Dec. 31, 2021
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning balance	[1]	$ (854.7)	$ (867.2)
Ending balance		(1,241.2)	(854.7)	[1]
Amortization of net actuarial loss and prior service cost, tax		0.8	0.8
Accumulated Other Comprehensive Loss
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning balance	[1]	(1,085.5)	(1,133.8)
Other comprehensive income other than reclassifications		28.4	43.2
Sale of Avon Luxembourg			0
Total reclassifications into earnings		4.9	5.1
Ending balance		(1,052.2)	(1,085.5)	[1]
Foreign Currency Translation Adjustments
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning balance		(1,062.2)	(1,038.2)
Other comprehensive income other than reclassifications		44.1	(24.1)
Sale of Avon Luxembourg			0.1
Total reclassifications into earnings		0	0
Ending balance		(1,018.1)	(1,062.2)
Net Investment Hedges
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning balance		(4.3)	(4.3)
Other comprehensive income other than reclassifications		0	0
Sale of Avon Luxembourg
Total reclassifications into earnings		0	0
Ending balance		(4.3)	(4.3)
Cash Flow Hedges
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning balance		0
Other comprehensive income other than reclassifications		0.3
Total reclassifications into earnings		0
Ending balance		0.3	0
Pension and Postretirement Benefits
AOCI Including Portion Attributable to Noncontrolling Interest, Net of Tax [Roll Forward]
Beginning balance		(19)	(91.3)
Other comprehensive income other than reclassifications		(16)	67.3
Sale of Avon Luxembourg			(0.1)
Total reclassifications into earnings		4.9	5.1
Ending balance		$ (30.1)	$ (19)
[1]The number of shares of Common Stock (par value $0.01 per share) outstanding at December 31, 2022, 2021 and 2020 was 101.34.

Accumulated Other Comprehensi_4

Accumulated Other Comprehensive Income (Loss) (Narrative) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Accumulated Other Comprehensive Income (Loss), Net of Tax [Abstract]
Foreign exchange (losses) gains	$ (5)	$ (5.3)	$ 8.8

Income Taxes (Income from Conti

Income Taxes (Income from Continuing Operations before Taxes) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Income Tax Disclosure [Abstract]
United States	$ (23.8)	$ 19.3	$ (89.6)
Foreign	(293.5)	(178.1)	(214)
Loss from continuing operations, before taxes	$ (317.3)	$ (158.8)	$ (303.6)

Income Taxes (Provision For Inc

Income Taxes (Provision For Income Taxes) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Federal:
Current	$ 0	$ 0.2	$ (9.5)
Deferred	0	0	8.9
Total Federal	0	0.2	(0.6)
Foreign:
Current	25.6	35.5	31.4
Deferred	11.8	(20)	2.6
Total Foreign	37.4	15.5	34
State and Local:
Current	0	0.5	0.6
Deferred	0	0	0
Total State and other	0	0.5	0.6
Total	$ 37.4	$ 16.2	$ 34

Income Taxes (Effective Tax Rat

Income Taxes (Effective Tax Rate Reconciliation) (Details)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Income Tax Disclosure [Abstract]
Statutory federal rate	21%	21%	21%
State and local taxes, net of federal tax benefit	0%	(0.30%)	(0.20%)
Tax on foreign income	10.80%	67.10%	(1.80%)
Tax on uncertain tax positions	0.60%	3.70%	1.10%
Reorganizations	0%	0%	(10.00%)
Net change in valuation allowances	(44.60%)	(103.10%)	(21.40%)
Other	0.40%	1.40%	0.10%
Effective tax rate	(11.80%)	(10.20%)	(11.20%)

Income Taxes (Narrative) (Detai

Income Taxes (Narrative) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Tax Credit Carryforward [Line Items]
Change in estimate related to restructuring transactions			$ 30.5
Deferred tax assets, tax credit carryforwards, excluding adoption of ASU 2013-11	$ 120.3
Tax credit carryforward, valuation allowance	120.3
Foreign tax credit carryforwards	87.6
Tax credit carryforwards, research	24.8
Tax credit carryforward	7.9
Deferred tax assets, net operating loss	432.2
Operating loss carryforwards subject to offset in accordance with ASU 2013--11	77.5
Tax loss and deduction carryforwards	478.5	$ 425
Valuation allowance	941.4	815.4
Undistributed earnings of foreign subsidiaries	1,200
Decrease in deferred tax liability associated with undistributed earnings of foreign subsidiaries	10.2
Potential offset to valuation allowance	52.1
Total gross unrecognized tax benefits	249.8	251.7	372.1	$ 331.7
Unrecognized tax benefits that would impact effective tax rate	14.1
Expense (reversal of expense) for interest and penalties	0.2	0.5	1
Accrued interest and penalties	6.3	7.1
Increase in unrecognized tax benefits is reasonably possible	0.8
Minimum
Tax Credit Carryforward [Line Items]
Increase in unrecognized tax benefits is reasonably possible	85
Maximum
Tax Credit Carryforward [Line Items]
Increase in unrecognized tax benefits is reasonably possible	90
United Kingdom Tax Authority
Tax Credit Carryforward [Line Items]
Foreign income tax benefit		89.1	21
Foreign
Tax Credit Carryforward [Line Items]
Tax loss and deduction carryforwards	18
Valuation allowance	414.2
Operating loss carryforwards	2,480.8
Deferred tax asset, not subject to expiration	924.9
Deferred tax assets, operating loss carryforwards, subject to expiration	1,555.9
Domestic
Tax Credit Carryforward [Line Items]
Tax loss and deduction carryforwards	46.3
Deferred tax asset, not subject to expiration	220.4
Deferred Tax Assets That Cannot Be Benefitted
Tax Credit Carryforward [Line Items]
Net increase (decrease) in valuation allowance	141.4	163.7	65.1
Deferred Tax Assets Generated In Current Year
Tax Credit Carryforward [Line Items]
Net increase (decrease) in valuation allowance	115	70.9	69.9
Deferred Tax Assets, Change In Judgment
Tax Credit Carryforward [Line Items]
Net increase (decrease) in valuation allowance	26.4	3.7	4.7
Deferred Tax Asset, Tax On Foreign Income
Tax Credit Carryforward [Line Items]
Net increase (decrease) in valuation allowance		$ 89.1	21
Deferred Tax Assets, True-up Adjustment
Tax Credit Carryforward [Line Items]
Net increase (decrease) in valuation allowance			$ (30.5)
Valuation Allowance, Federal Loss Carryforwards | Domestic
Tax Credit Carryforward [Line Items]
Valuation allowance	$ 46.3

Income Taxes (Deferred Tax Asse

Income Taxes (Deferred Tax Assets (Liabilities) Resulting From Temporary Differences) (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Deferred tax assets:
Tax loss and deduction carryforwards	$ 478.5	$ 425
Intangibles	187.6	218.5
Tax credit carryforwards	120.3	119.7
Interest carryforwards	93.6	76.3
All other future deductions	168.4	199.8
Valuation allowance	(941.4)	(815.4)
Total deferred tax assets	107	223.9
Deferred tax liabilities:
Deferred tax liabilities	(59.2)	(105)
Net deferred tax assets	$ 47.8	$ 118.9

Income Taxes (Deferred Tax As_2

Income Taxes (Deferred Tax Assets (Liabilities) Classification) (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Deferred tax assets:
Deferred tax asset	$ 52.1	$ 121.4
Deferred tax liabilities:
Long-term income taxes	(4.3)	(2.5)
Net deferred tax assets	$ 47.8	$ 118.9

Income Taxes (Reconciliation Of

Income Taxes (Reconciliation Of Beginning And Ending Amount Of Unrecognized Tax Benefits) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Reconciliation of Unrecognized Tax Benefits, Excluding Amounts Pertaining to Examined Tax Returns [Roll Forward]
Unrecognized tax benefits, beginning balance	$ 251.7	$ 372.1	$ 331.7
Additions based on tax positions related to the current year	3.3	6.8	90.6
Additions for tax positions of prior years	0	24.1	0.6
Reductions for tax positions of prior years	(1.8)	(136.8)	(34.1)
Reductions due to lapse of statute of limitations	(1.1)	(11.2)	(16.5)
Reductions due to settlements with tax authorities	(2.3)	(3.3)	(0.2)
Unrecognized tax benefits, ending balance	$ 249.8	$ 251.7	$ 372.1

Financial Instruments and Ris_3

Financial Instruments and Risk Management (Fair Value of Derivative Instruments) (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Derivative [Line Items]
Asset	$ 9.8	$ 0
Liability	$ 13.7	$ 2.7
Derivative asset, statement of financial position	Prepaid expenses and other	Prepaid expenses and other
Derivative liability, statement of financial position	Accounts payable	Accounts payable
Derivatives designated as hedges: | Foreign exchange forward contracts
Derivative [Line Items]
Asset	$ 9.2
Liability	9.1
Derivatives not designated as hedges: | Foreign exchange forward contracts
Derivative [Line Items]
Asset	0.6	$ 0
Liability	$ 4.6	$ 2.7

Financial Instruments and Ris_4

Financial Instruments and Risk Management (Narrative) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Derivative [Line Items]
Total exposure to floating rate interest rates	3%	5%
Notional amounts of derivative contracts	$ 546.3
Cash Flow Hedging
Derivative [Line Items]
Notional amounts of derivative contracts	289.7
Natura & Co
Derivative [Line Items]
Derivative receivables, related parties	9.5	$ 0
Derivative payables, related parties	12.9	0
Foreign Exchange Contract
Derivative [Line Items]
Notional amounts of derivative contracts	38.1
Gain (loss) in other expense from undesignated foreign currency exchange contracts	12.1	$ (0.3)
Foreign Exchange Contract | Cash Flow Hedging
Derivative [Line Items]
Notional amounts of derivative contracts	$ 290

Fair Value (Assets and Liabilit

Fair Value (Assets and Liabilities) (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Assets:
Foreign exchange forward contracts	$ 9.8	$ 0
Liabilities:
Foreign exchange forward contracts	13.7	2.7
Fair Value
Assets:
Foreign exchange forward contracts	0.3
Total	0.3
Liabilities:
Foreign exchange forward contracts	0	2.7
Total	0	2.7
Fair Value | Level 1
Assets:
Foreign exchange forward contracts	0
Total	0
Liabilities:
Foreign exchange forward contracts	0	0
Total	0	0
Fair Value | Level 2
Assets:
Foreign exchange forward contracts	0.3
Total	0.3
Liabilities:
Foreign exchange forward contracts	0	2.7
Total	$ 0	$ 2.7

Fair Value (Fair Value of Finan

Fair Value (Fair Value of Financial Instruments) (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Loans to affiliates of Natura &Co maturing within one year	$ 72.2	$ 46.6
Loans to affiliates of Natura &Co maturing after one year	54.8	46.7
Carrying Amount
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale securities	0	0
Loans to affiliates of Natura &Co maturing within one year	72.2	46.6
Loans to affiliates of Natura &Co maturing after one year	54.8	46.7
Debt maturing within one year	(5.7)	(32.6)
Loans from affiliates of Natura &Co maturing within one year	(537.2)	(371.7)
Long-term debt	(214.8)	(676)
Loans from affiliates of Natura &Co maturing after one year	(1,427.2)	(736.3)
Carrying Amount | Foreign exchange forward contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Foreign exchange forward contracts	0.3	(2.7)
Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Available-for-sale securities	0	0
Loans to affiliates of Natura &Co maturing within one year	72.2	46.6
Loans to affiliates of Natura &Co maturing after one year	54.8	46.7
Debt maturing within one year	(5.7)	(32.6)
Loans from affiliates of Natura &Co maturing within one year	(537.2)	(371.7)
Long-term debt	(206.8)	(754.2)
Loans from affiliates of Natura &Co maturing after one year	(1,427.2)	(736.3)
Fair Value | Foreign exchange forward contracts
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Foreign exchange forward contracts	$ 0.3	$ (2.7)

Share-Based Compensation Plan_2

Share-Based Compensation Plans (Narrative) (Details) $ / shares in Units, $ in Millions

1 Months Ended

12 Months Ended

Mar. 27, 2020

Jan. 03, 2020 USD ($) Rate shares

Jan. 31, 2020 USD ($)

Dec. 31, 2019 USD ($) shares

May 31, 2019 Rate shares

Mar. 31, 2019 shares

Mar. 31, 2018 shares

Feb. 28, 2018 $ / shares shares

Dec. 31, 2022 USD ($) installment tranche $ / shares Rate shares

Dec. 31, 2021 USD ($) $ / shares shares

Dec. 31, 2020 USD ($)

Dec. 31, 2019 USD ($) $ / shares shares

Dec. 31, 2018 $ / shares

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Weighted-average grant-date fair value per share (in dollars per share) | $ / shares

$ 1.13

Outstanding stock options (in shares)

14,900,000

0

0

Cash settlement of options, recorded to equity | $

$ 20.5

Cash settlement of options, recorded to SG&A expenses | $

$ 3.5

Share modification and incremental fair value expense | $

$ 1.5

Accelerated costs | $

1.7

Compensation cost for share-based payments | $

0.5

$ 13.1

$ 13.4

$ 24.9

Merger Agreement

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Exchange ratio | Rate

30%

Share modification and incremental fair value expense | $

$ 3.4

Accelerated costs | $

$ 10

$ 10

Transaction costs | $

$ 44

$ 44

Stock Options

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Vesting period

3 years

Contractual term

10 years

10 years

Stock Options | 2019 Award Date

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Vesting period

3 years

Options, grant date premium on exercise price

25%

Restricted Stock Units (RSUs)

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Vesting period

3 years

Outstanding shares (in shares)

4,400,000

0

0

Shares exchanged (in shares)

2,083,872

Nonvested, ending balance (in shares)

4,400,000

0

0

Restricted Stock Units (RSUs) | Director

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Vesting period

1 year

Performance Restricted Stock Units (PRSUs)

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Vesting period

3 years

3 years

Contractual term

1 year

1 year

Granted (in dollars per share) | $ / shares

$ 2.98

$ 2.79

Outstanding shares (in shares)

3,000,000

400,000

0

0

400,000

Granted (in shares)

200,000

200,000

Shares exchanged (in shares)

3,276,774

Vested (in shares)

0

Nonvested, ending balance (in shares)

3,000,000

400,000

0

0

400,000

Performance Restricted Stock Units (PRSUs) | 2019 Award Date

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Vesting period

3 years

Granted (in dollars per share) | $ / shares

$ 2.63

Performance Share Units (PSUs)

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Vesting period

3 years

Granted (in dollars per share) | $ / shares

$ 9.96

Outstanding shares (in shares)

3,065,000

1,854,000

Granted (in shares)

1,226,000

Unrecognized compensation cost | $

$ 25.9

Unrecognized compensation costs, recognized over a weighted average period

1 year 6 months

Nonvested, ending balance (in shares)

3,065,000

1,854,000

Restricted Stock Units - Treasury Stock

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Vesting period

3 years

Granted (in dollars per share) | $ / shares

$ 2.25

Outstanding shares (in shares)

600,000

600,000

Granted (in shares)

600,000

Nonvested, ending balance (in shares)

600,000

600,000

Compensation cost for share-based payments | $

$ 0.4

Restricted Stock

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Vesting period

3 years

Shares exchanged (in shares)

4,808,534

Shares cancelled to satisfy withholding tax obligations (in shares)

1,400,010

Restricted Stock | Merger Agreement

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Outstanding awards converted (in shares)

3,408,524

Nominal Cost Options

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Vesting period

3 years

Outstanding stock options (in shares)

1,152,000

2,326,000

Unrecognized compensation cost | $

$ 4.1

Unrecognized compensation costs, recognized over a weighted average period

2 years 3 months

2016 Plan

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Maximum award (in shares)

20,451,976

Additional shares (in shares)

5,000,000

Unused shares (in shares)

15,451,976

Multiplier for grant award | Rate

135%

Natura & Co Long Term Incentive Plan

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Number of tranches | tranche

2

Natura & Co Long Term Incentive Plan | Performance Share Units (PSUs) | Natura & Co

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Vesting period

3 years

Granted (in dollars per share) | $ / shares

$ 9.96

$ 17.32

Exchange ratio | Rate

100%

Granted (in shares)

1,226,298

627,983

Number of installments | installment

3

Employment period

3 years

Natura & Co Long Term Incentive Plan | Performance Share Units (PSUs) | Share-based Payment Arrangement, Tranche One | Natura & Co

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Vesting percentage

50%

Natura & Co Long Term Incentive Plan | Performance Share Units (PSUs) | Share-based Payment Arrangement, Tranche Two | Natura & Co

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Vesting percentage

50%

Natura & Co Long Term Incentive Plan | Nominal Cost Options | Natura & Co

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Granted (in dollars per share) | $ / shares

$ 3.38

Granted (in shares)

355,000

Natura & Co Long Term Incentive Plan | Nominal Cost Options | Share-based Payment Arrangement, Tranche One

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Vesting period

3 years

Natura & Co Long Term Incentive Plan | Nominal Cost Options | Share-based Payment Arrangement, Tranche Two

Share-based Compensation Arrangement by Share-based Payment Award [Line Items]

Vesting period

4 years

Share-Based Compensation Plan_3

Share-Based Compensation Plans (Schedule of Compensation Cost and Income Tax Benefit) (Details) - USD ($) $ in Millions	1 Months Ended	12 Months Ended
	Dec. 31, 2019	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Share-Based Payment Arrangement [Abstract]
Compensation cost for stock-based compensation	$ 0.5	$ 13.1	$ 13.4	$ 24.9
Total income tax (cost)/ benefit recognized for share-based arrangements		$ 0.7	$ (0.2)	$ 1.9

Share-Based Compensation Plan_4

Share-Based Compensation Plans (Schedule of Weighted-Average Assumptions for Stock Options) (Details) - Stock Options	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Risk-free rate		2.40%
Expected term		7 years
Expected Avon volatility		45%
Expected dividends		0%
Contractual term	10 years	10 years

Share-Based Compensation Plan_5

Share-Based Compensation Plans (Schedule of Weighted Average Assumptions (PRSUs)) (Details) - Performance Restricted Stock Units (PRSUs)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vesting period	3 years	3 years
2019 Award Date
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Risk-free rate		2.40%
Expected Avon volatility		54.80%
Expected average volatility		29.90%
Expected dividends		0%
Vesting period		3 years

Share-Based Compensation Plan_6

Share-Based Compensation Plans (Schedule of Nominal Cost Option) (Details)	12 Months Ended
	Dec. 31, 2022 $ / shares shares
Nominal Cost Options
Outstanding, beginning balance (in shares)	0
Outstanding, ending balance (in shares)	0
Nominal Cost Options
Nominal Cost Options
Outstanding, beginning balance (in shares)	2,326,000
Granted (in shares)	355,000
Exercised (in shares)	(902,000)
Forfeited (in shares)	(77,000)
Modified from option to restricted units (in shares)	(550,000)
Outstanding, ending balance (in shares)	1,152,000
Weighted-Average Modification-Date Fair Value
Outstanding, beginning balance (in dollars per share) | $ / shares	$ 10
Exercised (in dollars per share) | $ / shares	3.38
Exercised (in dollars per share) | $ / shares	(12.36)
Forfeited (in dollars per share) | $ / shares	(9.13)
Modified from option to restricted units (in dollars per share) | $ / shares	(8.73)
Outstanding, ending balance (in dollars per share) | $ / shares	$ 6.78

Share-Based Compensation Plan_7

Share-Based Compensation Plans (Schedule of Summary of Performance Restricted Stock Units) (Details) - Performance Share Units (PSUs) shares in Thousands	12 Months Ended
	Dec. 31, 2022 $ / shares shares
Performance Restricted Stock Units
Nonvested, beginning balance (in shares) | shares	1,854
Granted (in shares) | shares	1,226
Exercised (in shares) | shares	(2)
Forfeited (in shares) | shares	(563)
Modified from option to restricted units (in shares) | shares	550
Nonvested, ending balance (in shares) | shares	3,065
Weighted-Average Modification-Date Fair Value
Nonvested, beginning balance (in dollars per share) | $ / shares	$ 19.78
Granted (in dollars per share) | $ / shares	9.96
Exercised (in dollars per share) | $ / shares	(16.99)
Forfeited (in dollars per share) | $ / shares	(16.31)
Modified from option to restricted units (in dollars per share) | $ / shares	5.82
Nonvested, ending balance (in dollars per share) | $ / shares	$ 15.03

Employee Benefit Plans (Narrati

Employee Benefit Plans (Narrative) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Defined Benefit Plan Disclosure [Line Items]
Amortization period for gains and losses, period 1	3 years
Amortization period for gains and losses, period 2	5 years
Postemployment benefits liability	$ 2.2	$ 6.5
Pension Plan
Defined Benefit Plan Disclosure [Line Items]
Weighted average discount rate	4.83%	2.15%
Rate of return on assets	2.35%
Minimum | U.S. Pension and Postretirement Plans
Defined Benefit Plan Disclosure [Line Items]
Expected contributions related to continuing operations	$ 5
Maximum | U.S. Pension and Postretirement Plans
Defined Benefit Plan Disclosure [Line Items]
Expected contributions related to continuing operations	10
Non-U.S. Plans | Pension Plan
Defined Benefit Plan Disclosure [Line Items]
Qualified pension plans, benefit obligations	418.8	$ 671.2	$ 767.5
Qualified pension plans, plan assets	$ 490	$ 764.4	$ 762
Weighted average discount rate	4.79%	2.09%
Rate of return on assets	2.19%	2.32%	2.55%
UK Defined Contribution Plan
Defined Benefit Plan Disclosure [Line Items]
Employer match toward contributions, doubled	5%
Maximum contribution percent of eligible compensation	10%
Employer contribution	$ 6.5	$ 8.1	$ 7.6
Personal Savings Account Plan
Defined Benefit Plan Disclosure [Line Items]
Employer contribution	$ 0.8	0.9	$ 1
Maximum employee contribution to plan	25%
Maximum contribution for eligible participants	3%
Employer match toward contributions, fifty cents for dollar, minimum	4%
Employer match toward contributions, fifty cents for dollar, maximum	6%
Retirement Savings Account Plan
Defined Benefit Plan Disclosure [Line Items]
Employer match toward contributions, fifty cents for dollar, minimum	3%
Employer match toward contributions, fifty cents for dollar, maximum	6%
Vesting period	3 years
U.S. Qualified Pension Plan
Defined Benefit Plan Disclosure [Line Items]
Qualified pension plans, benefit obligations	$ 41.5	53.6
Qualified pension plans, plan assets	36.7	54.3
UK Pension Plan
Defined Benefit Plan Disclosure [Line Items]
Qualified pension plans, benefit obligations	295.6	492
Qualified pension plans, plan assets	$ 404.3	$ 653.6
Rate of return on assets	1.90%
UK Pension Plan | Liability Driven Investments
Defined Benefit Plan Disclosure [Line Items]
Liability driven investments allocation	94%
UK Pension Plan | Equity Securities, Emerging Market Debt and High Yield Securities
Defined Benefit Plan Disclosure [Line Items]
Equity securities allocation	6%

Employee Benefit Plans (Reconci

Employee Benefit Plans (Reconciliation of Benefit Obligations, Plan Assets and Funded Status) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Amount Recognized in Balance Sheet:
Other assets	$ 445.5	$ 509.4
Accrued compensation	(77.2)	(81.5)
Other Postretirement Benefits Plan
Change in Benefit Obligation:
Beginning balance	(9.7)	(7.7)
Service cost	0	0	$ 0
Interest cost	(0.3)	(0.3)	(0.7)
Actuarial gain (loss)	0.8	0.4
Benefits paid	2.3	0.6
Actual expenses and taxes	0	0
Curtailments	0	0
Settlements	0	0
Special termination benefits	0	(3)
Foreign currency changes and other	(0.3)	0.3
Sale of Avon Luxembourg	0	0
Ending balance	(7.2)	(9.7)	(7.7)
Change in Plan Assets:
Beginning balance	0	0
Actual return on plan assets	0	0
Company contributions	2.3	0.6
Benefits paid	(2.3)	(0.6)
Actual expenses and taxes	0	0
Settlements	0	0
Transfers	0	0
Foreign currency changes and other	0	0
Ending balance	0	0	0
Funded Status:
Funded status at end of year	(7.2)	(9.7)
Amount Recognized in Balance Sheet:
Other assets	0	0
Accrued compensation	(4.2)	(6.3)
Employee benefit plans liability	(3)	(3.4)
Net amount recognized	(7.2)	(9.7)
Pretax Amounts Recognized in Accumulated Other Comprehensive Loss:
Net actuarial loss	0	0.8
Prior service (credit) cost	(0.7)	(0.8)
Total pretax amount recognized	(0.7)	0
U.S. | Pension Plan
Change in Benefit Obligation:
Beginning balance	(60.3)	(67.9)
Service cost	(0.8)	(0.9)	(1.2)
Interest cost	(1.7)	(1)	(1.4)
Actuarial gain (loss)	9.5	1.8
Benefits paid	6.7	7.7
Actual expenses and taxes	0	0
Curtailments	(0.4)	0
Settlements	0	0
Special termination benefits	0	0
Foreign currency changes and other	0	0
Sale of Avon Luxembourg	0	0
Ending balance	(47)	(60.3)	(67.9)
Change in Plan Assets:
Beginning balance	54.3	59.7
Actual return on plan assets	(11.6)	1.6
Company contributions	0.7	0.7
Benefits paid	(6.7)	(7.7)
Actual expenses and taxes	0	0
Settlements	0	0
Transfers	0	0
Foreign currency changes and other	0	0
Ending balance	36.7	54.3	59.7
Funded Status:
Funded status at end of year	(10.3)	(6)
Amount Recognized in Balance Sheet:
Other assets	0	0
Accrued compensation	(0.8)	(0.7)
Employee benefit plans liability	(9.5)	(5.3)
Net amount recognized	(10.3)	(6)
Pretax Amounts Recognized in Accumulated Other Comprehensive Loss:
Net actuarial loss	16.8	14.7
Prior service (credit) cost	0	0
Total pretax amount recognized	16.8	14.7
Supplemental Information:
Accumulated benefit obligation	46.6	59.5
Plans with Projected Benefit Obligation in Excess of Plan Assets:
Projected benefit obligation	47.1	60.3
Fair value plan assets	36.7	54.3
Plans with Accumulated Benefit Obligation in Excess of Plan Assets:
Accumulated benefit obligation	46.6	59.5
Fair value plan assets	36.7	54.3
Non-U.S. Plans | Pension Plan
Change in Benefit Obligation:
Beginning balance	(671.2)	(767.5)
Service cost	(2.9)	(4.3)	(4.3)
Interest cost	(11)	(8.7)	(11.7)
Actuarial gain (loss)	185.1	54.6
Benefits paid	22.2	25.7
Actual expenses and taxes	0.4	0.4
Curtailments	0	0.2
Settlements	0.4	1.8
Special termination benefits	0	0
Foreign currency changes and other	58.2	13.5
Sale of Avon Luxembourg	0	13.1
Ending balance	(418.8)	(671.2)	(767.5)
Change in Plan Assets:
Beginning balance	764.4	762
Actual return on plan assets	(177.7)	29.3
Company contributions	(3.1)	10.1
Benefits paid	(22.2)	(25.7)
Actual expenses and taxes	(0.4)	(0.4)
Settlements	(0.4)	(1.8)
Transfers	0	0
Foreign currency changes and other	(70.6)	(9.1)
Ending balance	490	764.4	$ 762
Funded Status:
Funded status at end of year	71.2	93.2
Amount Recognized in Balance Sheet:
Other assets	110.8	162.4
Accrued compensation	(1.2)	(1.2)
Employee benefit plans liability	(38.4)	(68)
Net amount recognized	71.2	93.2
Pretax Amounts Recognized in Accumulated Other Comprehensive Loss:
Net actuarial loss	115.3	122.8
Prior service (credit) cost	1.7	2
Total pretax amount recognized	117	124.8
Supplemental Information:
Accumulated benefit obligation	108.2	159.4
Plans with Projected Benefit Obligation in Excess of Plan Assets:
Projected benefit obligation	115.9	170
Fair value plan assets	76.3	100.8
Plans with Accumulated Benefit Obligation in Excess of Plan Assets:
Accumulated benefit obligation	103.4	153.6
Fair value plan assets	$ 68.5	$ 91.7

Employee Benefit Plans (Compone

Employee Benefit Plans (Components of Net Periodic Benefit Cost and Other Amounts Recognized in Other Comprehensive Income) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Pension Plan | U.S.
Net Periodic Benefit Cost:
Service cost	$ 0.8	$ 0.9	$ 1.2
Interest cost	1.7	1	1.4
Expected return on plan assets	(2.1)	(2)	(2.6)
Amortization of prior service credit	0	0	0
Amortization of net actuarial losses	1.1	2.4	2.9
Amortization of transition obligation	0	0	0
Settlements/curtailments	1.5	1	2.6
Special termination benefits	0	0	0
Net periodic benefit cost	3	3.3	5.5
Other Changes in Plan Assets and Benefit Obligations Recognized in Other Comprehensive (Loss) Income:
Actuarial losses (gains)	4.6	(1.4)	0.8
Prior service cost (credit)	0	0	0
Amortization of prior service credit	0	0	0
Amortization of net actuarial losses	(2.6)	(3.4)	(5.5)
Foreign currency changes	0	0	0
Total recognized in other comprehensive loss	2	(4.8)	(4.7)
Total recognized in net periodic benefit cost and other comprehensive loss	5	(1.5)	0.8
Pension Plan | Non-U.S. Plans
Net Periodic Benefit Cost:
Service cost	2.9	4.3	4.3
Interest cost	11	8.7	11.7
Expected return on plan assets	(14.2)	(16)	(16)
Amortization of prior service credit	0.1	0	(0.1)
Amortization of net actuarial losses	4.1	7.5	6.3
Amortization of transition obligation	0	0	0
Settlements/curtailments	0	0.1	0.1
Special termination benefits	0	0	0
Net periodic benefit cost	3.9	4.6	6.3
Other Changes in Plan Assets and Benefit Obligations Recognized in Other Comprehensive (Loss) Income:
Actuarial losses (gains)	6.8	(68.1)	15.9
Prior service cost (credit)	(0.1)	0	0
Amortization of prior service credit	0	0	0
Amortization of net actuarial losses	(4.1)	(7.6)	(6.4)
Foreign currency changes	(10.5)	(5.9)	11.6
Total recognized in other comprehensive loss	(7.9)	(81.6)	21.1
Total recognized in net periodic benefit cost and other comprehensive loss	(4)	(77)	27.4
Other Postretirement Benefits Plan
Net Periodic Benefit Cost:
Service cost	0	0	0
Interest cost	0.3	0.3	0.7
Expected return on plan assets	0	0	0
Amortization of prior service credit	(0.1)	(4.5)	(0.2)
Amortization of net actuarial losses	0.1	0.7	0
Amortization of transition obligation	0	0	0
Settlements/curtailments	0	0	0
Special termination benefits	0	3	(4.2)
Net periodic benefit cost	0.3	(0.5)	(3.7)
Other Changes in Plan Assets and Benefit Obligations Recognized in Other Comprehensive (Loss) Income:
Actuarial losses (gains)	(0.7)	(0.4)	1.5
Prior service cost (credit)	0.1	4.5	(4.1)
Amortization of prior service credit	0	0	0.2
Amortization of net actuarial losses	(0.1)	(0.7)	(1.6)
Foreign currency changes	0	0	0
Total recognized in other comprehensive loss	(0.7)	3.4	(4)
Total recognized in net periodic benefit cost and other comprehensive loss	$ (0.4)	$ 2.9	$ (7.7)

Employee Benefit Plans (Weighte

Employee Benefit Plans (Weighted-Average Assumptions Used to Determine Benefit Obligations) (Details)	Dec. 31, 2022	Dec. 31, 2021
Pension Plan
Defined Benefit Plan Disclosure [Line Items]
Discount rate	4.83%	2.15%
Pension Plan | U.S.
Defined Benefit Plan Disclosure [Line Items]
Discount rate	5.19%	2.81%
Rate of compensation increase	4%	4%
Interest crediting rate	3.99%	1.78%
Pension Plan | Non-U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Discount rate	4.79%	2.09%
Rate of compensation increase	3.16%	2.56%
Interest crediting rate	2.74%	2.75%
Other Postretirement Benefits Plan
Defined Benefit Plan Disclosure [Line Items]
Discount rate	7.67%	3.61%

Employee Benefit Plans (Weigh_2

Employee Benefit Plans (Weighted-Average Assumptions used to Determine Net Benefit Cost) (Details)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Pension Plan
Defined Benefit Plan Disclosure [Line Items]
Rate of return on assets	2.35%
Pension Plan | U.S.
Defined Benefit Plan Disclosure [Line Items]
Discount rate	2.81%	2.42%	3.16%
Rate of compensation increase	4%	4%	4%
Rate of return on assets	4.60%	4.15%	4.90%
Interest crediting rate	1.94%	1.49%	2.49%
Pension Plan | Non-U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Discount rate	1.97%	1.45%	2.05%
Rate of compensation increase	2.38%	2.51%	2.54%
Rate of return on assets	2.19%	2.32%	2.55%
Interest crediting rate	2.75%	2.74%	2.69%
Other Postretirement Benefits Plan
Defined Benefit Plan Disclosure [Line Items]
Discount rate	3.61%	3.95%	3.66%

Employee Benefit Plans (Pension

Employee Benefit Plans (Pension and Postretirement Plans Target and Weighted-Average Asset Allocations) (Details) - Pension Plan	Dec. 31, 2022	Dec. 31, 2021
U.S.
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan, target plan asset allocations	100%
Defined benefit plan, actual plan asset allocation	100%	100%
U.S. | Equity securities
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan, target plan asset allocations	30%
Defined benefit plan, actual plan asset allocation	31%	30%
U.S. | Debt securities
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan, target plan asset allocations	70%
Defined benefit plan, actual plan asset allocation	69%	70%
U.S. | Other
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan, target plan asset allocations	0%
Defined benefit plan, actual plan asset allocation	0%	0%
Non-U.S. Plans
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan, target plan asset allocations	100%
Defined benefit plan, actual plan asset allocation	100%	100%
Non-U.S. Plans | Equity securities
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan, target plan asset allocations	17%
Defined benefit plan, actual plan asset allocation	18%	23%
Non-U.S. Plans | Debt securities
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan, target plan asset allocations	60%
Defined benefit plan, actual plan asset allocation	86%	72%
Non-U.S. Plans | Other
Defined Benefit Plan Disclosure [Line Items]
Defined benefit plan, target plan asset allocations	23%
Defined benefit plan, actual plan asset allocation	(4.00%)	5%

Employee Benefit Plans (Fair Va

Employee Benefit Plans (Fair Value Hierarchy for Pension and Postretirement Assets) (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Level 3
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	$ 2.1	$ 2.3	$ 1.6
U.S. | Pension Plan
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	36.7	54.3	59.7
U.S. | Pension Plan | Equity securities
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	11.3	16.5
U.S. | Pension Plan | Domestic equity
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	5.6	8.3
U.S. | Pension Plan | International equity
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	5.7	6.6
U.S. | Pension Plan | Emerging markets
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0	1.6
U.S. | Pension Plan | Fixed Income Securities
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	25.4	37.7
U.S. | Pension Plan | Corporate bonds
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	15.2	21.6
U.S. | Pension Plan | Government securities
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	5.1	8.8
U.S. | Pension Plan | Other
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	5.1	7.3
U.S. | Pension Plan | Other Securities
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0
U.S. | Pension Plan | Cash
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0	0.1
U.S. | Pension Plan | Level 1
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0	0
U.S. | Pension Plan | Level 1 | Equity securities
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0	0
U.S. | Pension Plan | Level 1 | Domestic equity
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0	0
U.S. | Pension Plan | Level 1 | International equity
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0	0
U.S. | Pension Plan | Level 1 | Emerging markets
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0	0
U.S. | Pension Plan | Level 1 | Fixed Income Securities
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0	0
U.S. | Pension Plan | Level 1 | Corporate bonds
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0	0
U.S. | Pension Plan | Level 1 | Government securities
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0	0
U.S. | Pension Plan | Level 1 | Other
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0	0
U.S. | Pension Plan | Level 1 | Other Securities
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0
U.S. | Pension Plan | Level 1 | Cash
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0	0
U.S. | Pension Plan | Level 2
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	36.7	54.3
U.S. | Pension Plan | Level 2 | Equity securities
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	11.3	16.5
U.S. | Pension Plan | Level 2 | Domestic equity
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	5.6	8.3
U.S. | Pension Plan | Level 2 | International equity
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	5.7	6.6
U.S. | Pension Plan | Level 2 | Emerging markets
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0	1.6
U.S. | Pension Plan | Level 2 | Fixed Income Securities
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	25.4	37.7
U.S. | Pension Plan | Level 2 | Corporate bonds
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	15.2	21.6
U.S. | Pension Plan | Level 2 | Government securities
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	5.1	8.8
U.S. | Pension Plan | Level 2 | Other
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	5.1	7.3
U.S. | Pension Plan | Level 2 | Other Securities
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0
U.S. | Pension Plan | Level 2 | Cash
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0	0.1
Non-U.S. Plans | Pension Plan
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	490	764.4	$ 762
Non-U.S. Plans | Pension Plan | Equity securities
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	88.5	174.6
Non-U.S. Plans | Pension Plan | Domestic equity
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	20.6	29.4
Non-U.S. Plans | Pension Plan | International equity
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	67.9	145.2
Non-U.S. Plans | Pension Plan | Fixed Income Securities
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	421.3	551
Non-U.S. Plans | Pension Plan | Corporate bonds
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	140	257.6
Non-U.S. Plans | Pension Plan | Government securities
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	189.2	256.9
Non-U.S. Plans | Pension Plan | Other
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	92.1	36.5
Non-U.S. Plans | Pension Plan | Other Securities
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	(19.8)	38.8
Non-U.S. Plans | Pension Plan | Cash
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	1.4	34.3
Non-U.S. Plans | Pension Plan | Derivatives
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	(23.4)	2.2
Non-U.S. Plans | Pension Plan | Real estate
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	2.1	2.3
Non-U.S. Plans | Pension Plan | Other
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0.1
Non-U.S. Plans | Pension Plan | Level 1
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	1.4	34.3
Non-U.S. Plans | Pension Plan | Level 1 | Equity securities
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0	0
Non-U.S. Plans | Pension Plan | Level 1 | Domestic equity
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0	0
Non-U.S. Plans | Pension Plan | Level 1 | International equity
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0	0
Non-U.S. Plans | Pension Plan | Level 1 | Fixed Income Securities
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0	0
Non-U.S. Plans | Pension Plan | Level 1 | Corporate bonds
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0	0
Non-U.S. Plans | Pension Plan | Level 1 | Government securities
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0	0
Non-U.S. Plans | Pension Plan | Level 1 | Other
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0	0
Non-U.S. Plans | Pension Plan | Level 1 | Other Securities
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	1.4	34.3
Non-U.S. Plans | Pension Plan | Level 1 | Cash
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	1.4	34.3
Non-U.S. Plans | Pension Plan | Level 1 | Derivatives
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0	0
Non-U.S. Plans | Pension Plan | Level 1 | Real estate
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0	0
Non-U.S. Plans | Pension Plan | Level 1 | Other
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0
Non-U.S. Plans | Pension Plan | Level 2
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	486.4	727.8
Non-U.S. Plans | Pension Plan | Level 2 | Equity securities
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	88.5	174.6
Non-U.S. Plans | Pension Plan | Level 2 | Domestic equity
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	20.6	29.4
Non-U.S. Plans | Pension Plan | Level 2 | International equity
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	67.9	145.2
Non-U.S. Plans | Pension Plan | Level 2 | Fixed Income Securities
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	421.3	551
Non-U.S. Plans | Pension Plan | Level 2 | Corporate bonds
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	140	257.6
Non-U.S. Plans | Pension Plan | Level 2 | Government securities
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	189.2	256.9
Non-U.S. Plans | Pension Plan | Level 2 | Other
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	92.1	36.5
Non-U.S. Plans | Pension Plan | Level 2 | Other Securities
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	(23.4)	2.2
Non-U.S. Plans | Pension Plan | Level 2 | Cash
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0	0
Non-U.S. Plans | Pension Plan | Level 2 | Derivatives
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	(23.4)	2.2
Non-U.S. Plans | Pension Plan | Level 2 | Real estate
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0	0
Non-U.S. Plans | Pension Plan | Level 2 | Other
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0
Non-U.S. Plans | Pension Plan | Level 3
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	2.2	2.3
Non-U.S. Plans | Pension Plan | Level 3 | Equity securities
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0	0
Non-U.S. Plans | Pension Plan | Level 3 | Domestic equity
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0	0
Non-U.S. Plans | Pension Plan | Level 3 | International equity
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0	0
Non-U.S. Plans | Pension Plan | Level 3 | Fixed Income Securities
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0	0
Non-U.S. Plans | Pension Plan | Level 3 | Corporate bonds
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0	0
Non-U.S. Plans | Pension Plan | Level 3 | Government securities
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0	0
Non-U.S. Plans | Pension Plan | Level 3 | Other
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0	0
Non-U.S. Plans | Pension Plan | Level 3 | Other Securities
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	2.2	2.3
Non-U.S. Plans | Pension Plan | Level 3 | Cash
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0	0
Non-U.S. Plans | Pension Plan | Level 3 | Derivatives
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	0	0
Non-U.S. Plans | Pension Plan | Level 3 | Real estate
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	2.1	$ 2.3
Non-U.S. Plans | Pension Plan | Level 3 | Other
Defined Benefit Plan Disclosure [Line Items]
Fair value of plan assets	$ 0.1

Employee Benefit Plans (Recon_2

Employee Benefit Plans (Reconciliation of the Beginning and Ending Balances for Investments) (Details) - Level 3 $ in Millions	12 Months Ended
	Dec. 31, 2022 USD ($)
Change in Plan Assets:
Beginning balance	$ 2.3
Actual return on plan assets held	(0.2)
Ending balance	$ 2.1

Employee Benefit Plans (Total B

Employee Benefit Plans (Total Benefit Payments) (Details) $ in Millions	Dec. 31, 2022 USD ($)
Pension Plan
Defined Benefit Plan Disclosure [Line Items]
2023	$ 30.3
2024	34.1
2025	165.7
2026	28
2027	29.5
2028-2032	149.3
Other Postretirement Benefits Plan
Defined Benefit Plan Disclosure [Line Items]
2023	4.2
2024	0.3
2025	0.3
2026	0.3
2027	0.3
2028-2032	1.4
U.S. | Pension Plan
Defined Benefit Plan Disclosure [Line Items]
2023	7.1
2024	8.9
2025	3.7
2026	2.5
2027	2.4
2028-2032	14
Non-U.S. Plans | Pension Plan
Defined Benefit Plan Disclosure [Line Items]
2023	23.2
2024	25.2
2025	162
2026	25.5
2027	27.1
2028-2032	$ 135.3

Employee Benefit Plans (Supplem

Employee Benefit Plans (Supplemental Retirement Programs) (Narrative) (Details) $ in Millions	12 Months Ended
	Dec. 31, 2022 USD ($) investment	Dec. 31, 2021 USD ($)	Dec. 31, 2020 USD ($)
Deferred Compensation Plan
Defined Benefit Plan Disclosure [Line Items]
Maximum deferral of base salary	50%
Maximum deferral of incentive compensation bonuses	100%
Number of permitted investment alternatives | investment	3
Expenses associated with deferred compensation plan	$ 0	$ 0	$ 0.1
Deferred compensation liability	0.6	0.7	0.8
Supplemental Employee Retirement Plan
Defined Benefit Plan Disclosure [Line Items]
Net periodic benefit cost SERP Restoration	0.9	1	$ 1.2
Benefit obligation SERP Restoration	$ 5.6	$ 6.7

Employee Benefit Plans (Assets

Employee Benefit Plans (Assets Held In Trust) (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Defined Benefit Plan Disclosure [Line Items]
Assets held-in-trust	$ 28.5	$ 30.4
Corporate-owned life insurance policies
Defined Benefit Plan Disclosure [Line Items]
Assets held-in-trust	23.1	24.6
Cash and cash equivalents
Defined Benefit Plan Disclosure [Line Items]
Assets held-in-trust	$ 5.4	$ 5.8

Segment Information (Total Reve

Segment Information (Total Revenue) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Segment Reporting Information [Line Items]
Revenues	$ 2,769.2	$ 3,404.5	$ 3,625.2
Operating Segments
Segment Reporting Information [Line Items]
Revenues	2,747.5	3,379.3	3,618.5
Operating Segments | Avon International
Segment Reporting Information [Line Items]
Revenues	1,415.9	1,724.6	1,772.6
Operating Segments | Avon LATAM
Segment Reporting Information [Line Items]
Revenues	1,331.6	1,654.7	1,845.9
Other reconciling items
Segment Reporting Information [Line Items]
Revenues	$ 21.7	$ 25.2	$ 6.7

Segment Information (Operating

Segment Information (Operating Profit) (Details) - USD ($)	1 Months Ended			12 Months Ended
	Jun. 30, 2022	Jan. 31, 2020	Dec. 31, 2019	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019
Segment Reporting Information [Line Items]
Operating (loss) profit				$ (178,600,000)	$ (58,400,000)	$ (122,200,000)
Certain Brazil indirect taxes				0
CTI restructuring initiatives				(68,600,000)	(68,700,000)	(23,700,000)
Costs related to the Transaction				0	0	(85,800,000)
Impairment				(35,800,000)	0	0
Cash compensation amount	$ 27,000,000
Settlement of historically recognized revenues	3,300,000
Remaining recognized amount of revenue	$ 23,700,000
Revenues				2,769,200,000	3,404,500,000	3,625,200,000
Central expenses				96,700,000	206,700,000	197,600,000
Accelerated costs			$ 1,700,000
Merger Agreement
Segment Reporting Information [Line Items]
Acquisition related expense						46,000,000	$ 44,000,000
Severance costs		$ 25,000,000				25,000,000
Accelerated costs		$ 10,000,000				10,000,000
Brazil IPI tax release
Segment Reporting Information [Line Items]
Revenues				10,000,000	21,000,000
Avon International
Segment Reporting Information [Line Items]
Impairment				0
Avon LATAM
Segment Reporting Information [Line Items]
Impairment				(35,800,000)
Operating Segments
Segment Reporting Information [Line Items]
Operating (loss) profit				(51,000,000)	39,000,000	(11,700,000)
Revenues				2,747,500,000	3,379,300,000	3,618,500,000
Operating Segments | Avon International
Segment Reporting Information [Line Items]
Operating (loss) profit				60,400,000	49,900,000	27,400,000
Revenues				1,415,900,000	1,724,600,000	1,772,600,000
Operating Segments | Avon LATAM
Segment Reporting Information [Line Items]
Operating (loss) profit				(111,400,000)	(10,900,000)	(39,100,000)
Revenues				1,331,600,000	1,654,700,000	1,845,900,000
Other reconciling items
Segment Reporting Information [Line Items]
Revenues				21,700,000	25,200,000	6,700,000
Corporate, non-segment
Segment Reporting Information [Line Items]
Operating (loss) profit				500,000	1,500,000	7,300,000
Unallocated global expenses				(23,200,000)	(27,000,000)	(11,600,000)
Certain Brazil indirect taxes				0	(1,700,000)	10,600,000
Revenues				$ 500,000	$ 4,700,000	$ 14,500,000

Segment Information (Total Asse

Segment Information (Total Assets) (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Segment Reporting Information [Line Items]
Assets	$ 2,161.7	$ 2,307.8	$ 2,564.3
Operating Segments | Avon International
Segment Reporting Information [Line Items]
Assets	1,308.2	1,362	1,364.4
Operating Segments | Avon LATAM
Segment Reporting Information [Line Items]
Assets	$ 853.5	$ 945.8	$ 1,199.9

Segment Information (Capital Ex

Segment Information (Capital Expenditures) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Segment Reporting Information [Line Items]
Total capital expenditures	$ 53.5	$ 68.3	$ 44.6
Operating Segments | Avon International
Segment Reporting Information [Line Items]
Total capital expenditures	39.5	53.3	36
Operating Segments | Avon LATAM
Segment Reporting Information [Line Items]
Total capital expenditures	$ 14	$ 15	$ 8.6

Segment Information (Depreciati

Segment Information (Depreciation and Amortization) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Segment Reporting Information [Line Items]
Depreciation and amortization	$ 64.5	$ 72.8	$ 81.8
Avon International | Operating Segments
Segment Reporting Information [Line Items]
Depreciation and amortization	44.6	48.1	49.5
Avon LATAM | Operating Segments
Segment Reporting Information [Line Items]
Depreciation and amortization	$ 19.9	$ 24.7	$ 32.3

Segment Information (Total Re_2

Segment Information (Total Revenue by Major Country) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Disaggregation of Revenue [Line Items]
Revenues	$ 2,769.2	$ 3,404.5	$ 3,625.2
Brazil
Disaggregation of Revenue [Line Items]
Revenues	587	627	729.9
Mexico
Disaggregation of Revenue [Line Items]
Revenues	0	249.2	420.2
All other
Disaggregation of Revenue [Line Items]
Revenues	$ 2,182.2	$ 2,528.3	$ 2,475.1

Segment Information (Long-Lived

Segment Information (Long-Lived Assets by Major Country) (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Segment Reporting, Asset Reconciling Item [Line Items]
Long-lived assets	$ 426.7	$ 477	$ 594.5
U.S.
Segment Reporting, Asset Reconciling Item [Line Items]
Long-lived assets	106.4	122.7	135.3
Brazil
Segment Reporting, Asset Reconciling Item [Line Items]
Long-lived assets	76.8	75.4	86.4
Poland
Segment Reporting, Asset Reconciling Item [Line Items]
Long-lived assets	81	95	96.8
Mexico
Segment Reporting, Asset Reconciling Item [Line Items]
Long-lived assets	0	0	55.2
All other
Segment Reporting, Asset Reconciling Item [Line Items]
Long-lived assets	$ 162.5	$ 183.9	$ 220.8

Leases and Commitments (Balance

Leases and Commitments (Balance Sheet Implication) (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Assets
Right-of-use assets	$ 92.1	$ 111.1
Finance right-of-use assets	$ 1.6	$ 2.2
Finance lease, right-of-use asset, statement of financial position	Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization	Property, Plant, and Equipment and Finance Lease Right-of-Use Asset, after Accumulated Depreciation and Amortization
Total right-of-use assets	$ 93.7	$ 113.3
Current Liabilities
Operating lease, liability, statement of financial position	Other accrued liabilities	Other accrued liabilities
Operating lease liabilities	$ 31.5	$ 37.1
Finance lease, liability, current, statement of financial position	Other accrued liabilities	Other accrued liabilities
Finance lease liabilities	$ 0.9	$ 1.2
Total current lease liabilities	32.4	38.3
Noncurrent
Operating lease liabilities	$ 71.5	$ 87.5
Finance lease, liability, noncurrent, statement of financial position	Long-term debt	Long-term debt
Finance lease liabilities	$ 0.8	$ 1.3
Total noncurrent lease liabilities	72.3	88.8
Total lease liability	$ 104.7	$ 127.1

Leases and Commitments (Income

Leases and Commitments (Income and Expenses) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Leases [Abstract]
Operating lease cost	$ 44.5	$ 51.7	$ 63.6
Amortization of right-of-use assets	1.1	1.3	1.2
Interest on lease liabilities	0.2	0.2	0.3
Short-term leases costs	7.1	11	2.3
Sublease Income	(14.9)	(14.5)	(15.3)
Net lease cost	$ 38	$ 49.7	$ 52.1

Leases and Commitments (Maturit

Leases and Commitments (Maturity of Lease Liability) (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Operating Leases
2023	$ 39.4
2024	31
2025	25.6
2026	14.3
2027	2.8
Thereafter	13.7
Total lease payments	126.8
Less: Interest	23.8
Present value of lease liabilities	103
Finance Leases
2023	1
2024	0.5
2025	0.3
2026	0.2
2027	0
Thereafter	0
Total lease payments	2
Less: Interest	0.3
Present value of lease liabilities	1.7
Total
2023	40.4
2024	31.5
2025	25.9
2026	14.5
2027	2.8
Thereafter	13.7
Total lease payments	128.8
Less: Interest	24.1
Present value of lease liabilities	$ 104.7	$ 127.1

Leases and Commitments (Lease T

Leases and Commitments (Lease Term and Discount Rate) (Details)	Dec. 31, 2022	Dec. 31, 2021
Weighted-average remaining lease term (years)
Operating leases	4 years 3 months 18 days	4 years
Finance leases	2 years 7 months 6 days	2 years 8 months 12 days
Lease, Weighted Average Discount Rate [Abstract]
Operating leases	9.10%	8.30%
Finance leases	10.50%	9.60%

Leases and Commitments (Other I

Leases and Commitments (Other Information) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Leases [Abstract]
Operating Cash Flows From Operating Leases	$ 47.3	$ 54	$ 63.7
Operating Cash Flows From Finance Leases	0.2	0.2	0.3
Financing Cash Flows From Finance Leases	1.2	1.3	1.3
Cash Paid For Amounts Included In Measurement of Liabilities	48.7	55.5	65.3
Right-of-use Assets Obtained In Exchange For New Finance Liabilities	0.7	1.4	0.9
Right-of-use Assets Obtained In Exchange For New Operating Liabilities	$ 17.4	$ 8.8	$ 24.9

Leases and Commitments (Schedul

Leases and Commitments (Schedule of Purchase Obligations) (Details) $ in Millions	Dec. 31, 2022 USD ($)
Leases [Abstract]
2023	$ 101.8
2024	51
2025	28.9
2026	26.2
2027	14.4
Later years	1.3
Total	$ 223.6

Restructuring Initiatives (Narr

Restructuring Initiatives (Narrative) (Details) - USD ($) $ in Millions		12 Months Ended
	Nov. 03, 2022	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020	May 31, 2020
Restructuring Cost and Reserve [Line Items]
Restructuring and related activities, return to growth period					3 years
CTI restructuring initiative		$ 68.6	$ 58.8	$ 22.2
Accelerated depreciation		3.1
Facility Closing
Restructuring Cost and Reserve [Line Items]
Restructuring costs	$ 37
Capital expenditures incurred but not yet paid	10
Employee Relocation
Restructuring Cost and Reserve [Line Items]
Restructuring costs	$ 10
Accelerated depreciation
Restructuring Cost and Reserve [Line Items]
CTI restructuring initiative		3.1	0.3	0.4
Accelerated depreciation | Minimum
Restructuring Cost and Reserve [Line Items]
CTI restructuring initiative		15
Accelerated depreciation | Maximum
Restructuring Cost and Reserve [Line Items]
CTI restructuring initiative		20
Avon Integration
Restructuring Cost and Reserve [Line Items]
CTI restructuring initiative		25.5	15.4	16.1
Employee-related liabilities		1.5	1.6
Open Up & Grow
Restructuring Cost and Reserve [Line Items]
CTI restructuring initiative		44.1	44	10.9
Transformation Plan & Other
Restructuring Cost and Reserve [Line Items]
CTI restructuring initiative		(1)	(0.6)	$ (4.8)
Employee-related liabilities		$ 1.3	$ 1.5

Restructuring Initiatives (Summ

Restructuring Initiatives (Summary) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Restructuring Cost and Reserve [Line Items]
CTI restructuring initiative	$ 68.6	$ 58.8	$ 22.2
Cost of Sales
Restructuring Cost and Reserve [Line Items]
CTI restructuring initiative	$ 1.3	$ 0	$ (1.8)
Restructuring, incurred cost, statement of income or comprehensive income	Cost of Revenue	Cost of Revenue	Cost of Revenue
Selling, General and Administrative Expenses
Restructuring Cost and Reserve [Line Items]
CTI restructuring initiative	$ 67.3	$ 68.7	$ 25.5
Restructuring, incurred cost, statement of income or comprehensive income	Shipping and handling costs	Shipping and handling costs	Shipping and handling costs
Operating Profit
Restructuring Cost and Reserve [Line Items]
CTI restructuring initiative	$ 68.6	$ 68.7	$ 23.7
Restructuring, incurred cost, statement of income or comprehensive income	Operating Income (Loss)	Operating Income (Loss)	Operating Income (Loss)
Avon Integration
Restructuring Cost and Reserve [Line Items]
CTI restructuring initiative	$ 25.5	$ 15.4	$ 16.1
Open Up & Grow
Restructuring Cost and Reserve [Line Items]
CTI restructuring initiative	44.1	44	10.9
Transformation Plan & Other
Restructuring Cost and Reserve [Line Items]
CTI restructuring initiative	(1)	(0.6)	(4.8)
Inventory write-off
Restructuring Cost and Reserve [Line Items]
CTI restructuring initiative	1.3	0	(1.8)
Net charges for employee-related costs, including severance benefits
Restructuring Cost and Reserve [Line Items]
CTI restructuring initiative	39.2	36.7	5.2
Implementation costs, primarily related to professional service fees
Restructuring Cost and Reserve [Line Items]
CTI restructuring initiative	16.8	17.5	10.3
Dual running costs
Restructuring Cost and Reserve [Line Items]
CTI restructuring initiative	2.3	1.1	3.1
Contract termination and other net costs
Restructuring Cost and Reserve [Line Items]
CTI restructuring initiative	5.9	10.5	3.9
Impairment of other assets
Restructuring Cost and Reserve [Line Items]
CTI restructuring initiative	0	1	0.8
Accelerated depreciation
Restructuring Cost and Reserve [Line Items]
CTI restructuring initiative	3.1	0.3	0.4
Variable lease charges
Restructuring Cost and Reserve [Line Items]
CTI restructuring initiative	0	1.6	1.8
Foreign Currency Translation Adjustment Write-offs
Restructuring Cost and Reserve [Line Items]
CTI restructuring initiative	0	0	0
Gain on sale of business / assets
Restructuring Cost and Reserve [Line Items]
CTI restructuring initiative	$ 0	$ (9.9)	$ (1.5)

Restructuring Initiatives (Open

Restructuring Initiatives (Open Up Avon) (Details) - Open Up & Grow - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Restructuring Reserve [Roll Forward]
Beginning Balance	$ 15.2	$ 11.8
Charges	31.3	38.2
Adjustments	0	(1.3)
Cash payments	(23.2)	(31.8)
Non-cash write-offs	(1.3)	(1)
Foreign exchange	(0.8)	(0.7)
Ending Balance	21.2	15.2
Employee-Related Costs
Restructuring Reserve [Roll Forward]
Beginning Balance	14	9
Charges	27	33.8
Adjustments	0	(1.3)
Cash payments	(20.7)	(26.8)
Non-cash write-offs	0	0
Foreign exchange	(0.7)	(0.7)
Ending Balance	19.6	14
Inventory Asset Write Offs
Restructuring Reserve [Roll Forward]
Beginning Balance	0	0
Charges	1.3	1
Adjustments	0	0
Cash payments	0	0
Non-cash write-offs	(1.3)	(1)
Foreign exchange	0	0
Ending Balance	0	0
Contract termination and other net costs
Restructuring Reserve [Roll Forward]
Beginning Balance	1.2	2.8
Charges	3	3.4
Adjustments	0	0
Cash payments	(2.5)	(5)
Non-cash write-offs	0	0
Foreign exchange	(0.1)	0
Ending Balance	$ 1.6	$ 1.2

Restructuring Initiatives (Rest

Restructuring Initiatives (Restructuring Initiatives by Charge Type) (Details) $ in Millions	Dec. 31, 2022 USD ($)
Avon Integration
Restructuring Cost and Reserve [Line Items]
Charges incurred to-date	$ 27.6
Estimated charges to be incurred on approved initiatives	0
Total expected charges on approved initiatives	27.6
Avon Integration | Employee-Related Costs
Restructuring Cost and Reserve [Line Items]
Charges incurred to-date	24.5
Estimated charges to be incurred on approved initiatives	0
Total expected charges on approved initiatives	24.5
Avon Integration | Inventory write-off
Restructuring Cost and Reserve [Line Items]
Charges incurred to-date
Estimated charges to be incurred on approved initiatives	0
Total expected charges on approved initiatives	0
Avon Integration | Contract termination and other net costs
Restructuring Cost and Reserve [Line Items]
Charges incurred to-date	3.1
Estimated charges to be incurred on approved initiatives	0
Total expected charges on approved initiatives	3.1
Avon Integration | Foreign Currency Translation Adjustment Write-offs
Restructuring Cost and Reserve [Line Items]
Charges incurred to-date
Estimated charges to be incurred on approved initiatives	0
Total expected charges on approved initiatives	0
Open Up & Grow
Restructuring Cost and Reserve [Line Items]
Charges incurred to-date	259.5
Estimated charges to be incurred on approved initiatives	0.4
Total expected charges on approved initiatives	259.9
Open Up & Grow | Employee-Related Costs
Restructuring Cost and Reserve [Line Items]
Charges incurred to-date	142.8
Estimated charges to be incurred on approved initiatives	0.4
Total expected charges on approved initiatives	143.2
Open Up & Grow | Inventory write-off
Restructuring Cost and Reserve [Line Items]
Charges incurred to-date	108.7
Estimated charges to be incurred on approved initiatives	0
Total expected charges on approved initiatives	108.7
Open Up & Grow | Contract termination and other net costs
Restructuring Cost and Reserve [Line Items]
Charges incurred to-date	18.9
Estimated charges to be incurred on approved initiatives	0
Total expected charges on approved initiatives	18.9
Open Up & Grow | Foreign Currency Translation Adjustment Write-offs
Restructuring Cost and Reserve [Line Items]
Charges incurred to-date	(10.9)
Estimated charges to be incurred on approved initiatives	0
Total expected charges on approved initiatives	(10.9)
Transformation Plan & Other
Restructuring Cost and Reserve [Line Items]
Charges incurred to-date	169.5
Estimated charges to be incurred on approved initiatives	0
Total expected charges on approved initiatives	169.5
Transformation Plan & Other | Employee-Related Costs
Restructuring Cost and Reserve [Line Items]
Charges incurred to-date	122.7
Estimated charges to be incurred on approved initiatives	0
Total expected charges on approved initiatives	122.7
Transformation Plan & Other | Inventory write-off
Restructuring Cost and Reserve [Line Items]
Charges incurred to-date	2.5
Estimated charges to be incurred on approved initiatives	0
Total expected charges on approved initiatives	2.5
Transformation Plan & Other | Contract termination and other net costs
Restructuring Cost and Reserve [Line Items]
Charges incurred to-date	40.9
Estimated charges to be incurred on approved initiatives	0
Total expected charges on approved initiatives	40.9
Transformation Plan & Other | Foreign Currency Translation Adjustment Write-offs
Restructuring Cost and Reserve [Line Items]
Charges incurred to-date	3.4
Estimated charges to be incurred on approved initiatives	0
Total expected charges on approved initiatives	$ 3.4

Restructuring Initiatives (Char

Restructuring Initiatives (Charges Reportable by Business Segment) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019	Dec. 31, 2018
Avon Integration
Restructuring Cost and Reserve [Line Items]
Charges incurred	$ 15	$ 1.8	$ 10.8
Charges incurred to-date	27.6
Estimated charges to be incurred on approved initiatives	0
Total expected charges on approved initiatives	27.6
Avon Integration | Avon International
Restructuring Cost and Reserve [Line Items]
Charges incurred	0.6	(1.2)	6.2
Charges incurred to-date	5.6
Estimated charges to be incurred on approved initiatives	0
Total expected charges on approved initiatives	5.6
Avon Integration | Avon LATAM
Restructuring Cost and Reserve [Line Items]
Charges incurred	14.4	3	4.6
Charges incurred to-date	22
Estimated charges to be incurred on approved initiatives	0
Total expected charges on approved initiatives	22
Open Up & Grow
Restructuring Cost and Reserve [Line Items]
Charges incurred	31.3	37.1	2.4	$ 71.6	$ 117.1
Charges incurred to-date	259.5
Estimated charges to be incurred on approved initiatives	0.4
Total expected charges on approved initiatives	259.9
Open Up & Grow | Avon International
Restructuring Cost and Reserve [Line Items]
Charges incurred	31.3	36.9	3.2	34.7	52.8
Charges incurred to-date	158.9
Estimated charges to be incurred on approved initiatives	0.4
Total expected charges on approved initiatives	159.3
Open Up & Grow | Avon LATAM
Restructuring Cost and Reserve [Line Items]
Charges incurred		$ 0.2	$ (0.8)	$ 36.9	$ 64.3
Charges incurred to-date	100.6
Estimated charges to be incurred on approved initiatives	0
Total expected charges on approved initiatives	$ 100.6

Contingencies (Narrative) (Deta

Contingencies (Narrative) (Details) $ in Thousands		1 Months Ended	3 Months Ended	12 Months Ended
	Mar. 01, 2023 USD ($)	Dec. 31, 2022 USD ($)	Dec. 31, 2022 USD ($) lawsuit	Dec. 31, 2022 USD ($) lawsuit	Dec. 31, 2021 USD ($)
Loss Contingencies [Line Items]
Number of litigation suits | lawsuit				227
Number of litigation suits, new | lawsuit			39	128
Number of litigation suits, dismissed | lawsuit			23	52
IPI Tax On Manufactured Products - Minimum Pricing Rules
Loss Contingencies [Line Items]
Loss contingency, estimate of possible loss		$ 483,000	$ 483,000	$ 483,000	$ 360,000
IPI Tax On Manufactured Products - Decree Equated Certain Commercial Companies
Loss Contingencies [Line Items]
Loss contingency, estimate of possible loss		301,000	301,000	301,000	243,000
Brazilian Financial Indemnities
Loss Contingencies [Line Items]
Loss contingency, estimate of possible loss		181,000	181,000	181,000	157,000
Brazil labor-related
Loss Contingencies [Line Items]
Estimated litigation liability		10,000	$ 10,000	$ 10,000	$ 11,000
Compensatory Damages | Subsequent Event
Loss Contingencies [Line Items]
Loss contingency, damages awarded, value	$ 29,300
Compensatory Damages | Pending Litigation
Loss Contingencies [Line Items]
Loss contingency, damages awarded, value		36,000
Compensatory Damages | Pending Litigation | Subsequent Event
Loss Contingencies [Line Items]
Loss contingency, damages awarded, value	$ 29,300
Punitive Damages
Loss Contingencies [Line Items]
Loss contingency, damages awarded, value		$ 10,300

Goodwill (Schedule of Goodwill)

Goodwill (Schedule of Goodwill) (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Goodwill [Roll Forward]
Gross balance at period start	$ 161.4
Accumulated impairments	(89.3)
Net balance at period start	72.1
Impairment	(35.8)	$ 0	$ 0
Foreign exchange	(10.4)
Gross balance at period end	151	161.4
Accumulated impairments at period end	(125.1)	(89.3)
Net balance at period end	25.9	72.1
Avon International
Goodwill [Roll Forward]
Gross balance at period start	106.9
Accumulated impairments	(89.3)
Net balance at period start	17.6
Impairment	0
Foreign exchange	(1)
Gross balance at period end	105.9	106.9
Accumulated impairments at period end	(89.3)	(89.3)
Net balance at period end	16.6	17.6
Avon LATAM
Goodwill [Roll Forward]
Gross balance at period start	54.5
Accumulated impairments	0
Net balance at period start	54.5
Impairment	(35.8)
Foreign exchange	(9.4)
Gross balance at period end	45.1	54.5
Accumulated impairments at period end	(35.8)	0
Net balance at period end	$ 9.3	$ 54.5

Supplemental Balance Sheet In_3

Supplemental Balance Sheet Information (Components of Prepaid Expenses and Other) (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Balance Sheet Related Disclosures [Abstract]
Prepaid taxes and tax refunds receivable	$ 60.9	$ 84
Receivables other than trade	18.8	27.8
Prepaid brochure costs, paper and other literature	7.4	8.3
Other	40.8	45.5
Prepaid expenses and other	$ 127.9	$ 165.6

Supplemental Balance Sheet In_4

Supplemental Balance Sheet Information (Components of Other Assets) (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Balance Sheet Related Disclosures [Abstract]
Capitalized software	$ 73.5	$ 74.9
Judicial deposits	23.4	47.2
Net overfunded pension plans	110.7	162.5
Long-term receivables including taxes	198.3	180.2
Trust assets associated with supplemental benefit plans	28.5	30.4
Other	11.1	14.2
Other assets	$ 445.5	$ 509.4

Supplemental Balance Sheet In_5

Supplemental Balance Sheet Information (Narrative) (Details) - USD ($) $ in Millions	Dec. 31, 2022	Dec. 31, 2021
Balance Sheet Related Disclosures [Abstract]
Brazil indirect taxes receivables	$ 133	$ 128
Brazil indirect taxes, additional receivable	$ 18

Merger with Natura Cosm_ticos_2

Merger with Natura Cosméticos S.A. (Narrative) (Details) - USD ($) $ / shares in Units, $ in Millions		1 Months Ended		3 Months Ended	12 Months Ended
	May 22, 2019	Jan. 31, 2020	Dec. 31, 2019	Dec. 31, 2020	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019	Jan. 03, 2020	Dec. 30, 2019
Business Combination, Separately Recognized Transactions [Line Items]
Shares authorized (in shares)			1,525,000,000					1,525,000,000
Common stock, shares authorized (in shares)		1,000	1,500,000,000		1,000	1,000		1,500,000,000
Common stock, par value (in dollars per share)		$ 0.01	$ 0.25	$ 0.01	$ 0.01	$ 0.01	$ 0.01	$ 0.25		$ 0.25
Preferred stock, shares authorized (in shares)			25,000,000					25,000,000
Preferred stock, par value (in USD per share)		$ 0.01	$ 1					$ 1
Shares canceled (in shares)		550,890,788
Common stock shares outstanding (in shares)		101.34		101.34	101.34	101.34	101.34
Accelerated costs			$ 1.7
Settlement of stock options					$ 0	$ 0	$ 25.8
Write off of debt issuance cost				$ 7.9
Minimum
Business Combination, Separately Recognized Transactions [Line Items]
Tax attributes lost due to transaction		$ 546
Maximum
Business Combination, Separately Recognized Transactions [Line Items]
Tax attributes lost due to transaction		616
Merger Agreement
Business Combination, Separately Recognized Transactions [Line Items]
Share conversion ratio	60%
Acquisition related expense							46	$ 44
Severance costs		25					25
Accelerated costs		10					$ 10
Settlement of stock options		26
Deferred compensation payment		12
Write off of debt issuance cost		$ 7.8
Merger Agreement | Natura & Co
Business Combination, Separately Recognized Transactions [Line Items]
Common stock composing one American depository shares (in shares)									2
American Depositary Shares | Merger Agreement
Business Combination, Separately Recognized Transactions [Line Items]
Share conversion ratio	30%

Subsequent Events (Details)

Subsequent Events (Details) - Subsequent Event - USD ($) $ in Thousands	Mar. 01, 2023	Jan. 12, 2023
Compensatory Damages
Subsequent Event [Line Items]
Loss contingency, damages awarded, value	$ 29,300
Avon Cosmetics Limited
Subsequent Event [Line Items]
Loss contingency, surety bonds		$ 75,500

Schedule II - Valuation and Q_2

Schedule II - Valuation and Qualifying Accounts (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Allowance for doubtful accounts receivable
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]
Balance at Beginning of Period	$ 37.1	$ 51.1	$ 66.6
Charged to Costs and Expenses	51.7	62.4	78.3
Charged to Revenue	0	0	0
Deductions	(53.6)	(76.4)	(93.8)
Balance at End of Period	35.2	37.1	51.1
Refund liability
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]
Balance at Beginning of Period	4.3
Charged to Costs and Expenses	0
Charged to Revenue	52.8
Deductions	(54.1)
Balance at End of Period	3	4.3
Refund liability
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]
Balance at Beginning of Period	4.3	9.1	10.7
Charged to Costs and Expenses		0	0
Charged to Revenue		75.9	101.4
Deductions		(80.7)	(103)
Balance at End of Period		4.3	9.1
Allowance for inventory obsolescence
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]
Balance at Beginning of Period	54.8	70.4	82
Charged to Costs and Expenses	22.6	26.8	37.9
Charged to Revenue	0	0	0
Deductions	(31.3)	(42.4)	(49.5)
Balance at End of Period	46.1	54.8	70.4
Deferred tax asset valuation allowance
SEC Schedule, 12-09, Movement in Valuation Allowances and Reserves [Roll Forward]
Balance at Beginning of Period	815.4	2,327.6	2,960
Charged to Costs and Expenses	126	125.7	(632.4)
Charged to Revenue	0	0	0
Deductions	0	(1,637.9)	0
Balance at End of Period	$ 941.4	$ 815.4	$ 2,327.6

Uncategorized Items - avp-20221

Label	Element	Value
Accounting Standards Update [Extensible Enumeration]	us-gaap_AccountingStandardsUpdateExtensibleList	Accounting Standards Update 2016-13 [Member]